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The Hippo Pathway is a highly conserved regulator of tissue growth and size 
determination, limiting the activity of the transcriptional co-activator Yorkie (Yki), 
which promotes proliferation and inhibits apoptosis. Hippo signalling integrates 
and transduces cell polarity and cell-cell adhesion inputs thereby responding to 
the state of tissue architecture. The transmembrane apical polarity protein 
Crumbs (Crb) controls the activity of Yki by regulating Expanded (Ex), a protein 
that promotes Hippo signalling through kinase-dependent and -independent 
mechanisms to robustly inhibit Yki activity. Crb plays a dual role in the regulation 
of Ex by controlling its apical localisation, facilitating Yki inhibition, and by 
promoting Ex degradation, thus activating Yki. Crb regulates the stability of Ex by 
stimulating a phosphorylation-dependent ubiquitylation and proteasomal 
degradation. Characterisation of the precise mechanisms by which Crb regulates 
Ex has been the focus of this thesis.  
Based on candidates identified by mass spectrometry and from literature, the 
Casein Kinase 1 (CK1) family of kinases, and the deubiquitylating enzyme (DUB) 
Usp2 have both been identified as novel regulators of Ex stability. CK1s promote 
Ex phosphorylation and degradation, acting as Ex inhibitors, while Usp2 
promotes Ex function by promoting its stabilisation. Furthermore, in a screen to 
identify DUBs that regulate Drosophila adult wing size, CG10889 has been 
established as a novel regulator of growth that interacts with members of the 
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 The Use of Drosophila melanogaster as a Model to Study 
Tissue Growth 
The use of model organisms is vitally important for our understanding of basic 
biology and human disease. Use of model organisms relies on the premise that 
most fundamental biological processes are vital to all life, and as such have 
remained relatively unchanged throughout evolution from simple to complex 
organisms. Furthermore, due to the relative simplicity of the model organisms 
used, these fundamental processes are potentially easier to elucidate (Hariharan  
and Haber 2003).  However, no individual model is perfect, and thus our 
understanding of biology and disease is most efficiently enhanced if studies in 
human cell lines and tissues, are augmented with the models at our disposal, 
namely Saccharomyces cerevisiae (yeast), Caenorhabditis elegans (worm), 
Danio rerio (zebra fish), Mus musculus (mouse) and last but not least, Drosophila 
melanogaster (fruit fly) (Hunter, 2008).  
Drosophila melanogaster has remained one of the primary animal models since 
the early twentieth century, when T. H. Morgan, along with notable students A. 
H. Sturtevant, C. B. Bridges, and H. J. Muller defined the theory of chromosomal 
heritability, which led to Morgan being awarded the Nobel Prize in Physiology or 
Medicine in 1933 (Morgan, 1910). This power house of early genetics went on to 
define how genes are arranged in a linear order (Sturtevant, 1913), that genes 
are contained within the chromosome (Bridges, 1916), and that ionising radiation 
causes genetic damage, which resulted in H. J. Muller receiving the Nobel Prize 
in Physiology or Medicine in 1946 (Muller, 1928; Rubin and Lewis, 2000).  
Since the early days of Drosophila research, a vast array of transgenic and 
mutant stocks, and genetic tools have become available making the fruit fly one 
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of the most genetically tractable model organisms. These techniques include the 
development of transgenic organisms (Rubin and Spradling, 1982; Spradling and 
Rubin, 1982), clonal/mosaic mutation analysis (Lee and Luo, 1999; Xu and Rubin, 
1993), a tissue-specific bipartite expression system (Brand and Perrimon, 1993), 
genome-wide Interference RNA (RNAi) libraries (Dietzl et al., 2007; Perrimon et 
al., 2010), and more recently, the development of the Clustered Regularly 
Interspaced Palindromic Repeats (CRISPR)/CRISPR associated (Cas) 
technology (Port et al., 2014). 
The Drosophila genome contains approximately half the number of genes 
compared to humans. The haploid genome consists of four chromosomes: one 
sex chromosome (chromosome 1), and three autosomes (chromosomes 2-4). 
The sequencing of the Drosophila genome in the year 2000 (Adams et al., 2000) 
confirmed the benefits of the fly as a model, as at least 70% of genes known to 
be involved in human pathologies are conserved in flies (Reiter et al., 2001). It is 
this evolutionary conservation, associated with low chromosome number, rapid 
life cycle, high fecundity and ease of maintenance, that make the fly an ideal 
model organism for the study of fundamental biology and disease.  
Drosophila undergo dramatic morphological changes during their lifetime. 
Initially, rapid development occurs in the embryo, which after 24 hours hatches 
into the first instar larva. Larvae grow rapidly, moulting twice to form the third 
instar larva. During larval growth, all adult structures, whether ultimately located 
internally or externally, develop precursor counterparts within the protective larval 
cuticle. Once mature, the third instar larva will crawl from the food to pupate, 
forming a protective pupal case. Within the hard pupal case, the pupa undergoes 
metamorphosis, and most larval tissue disintegrates, dramatically reorganising 
the body plan from that of a larva, to the adult fly. The pupa will eventually eclose 
and emerge from the pupal case, after which the exoskeleton hardens, and the 
wings expand, and after only a short time, the animal is ready to mate and restart 
the cycle (Beira and Paro, 2016; Jennings, 2011).  
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The larval imaginal discs are of particular note, and form the precursors to many 
of the external adult appendages, including the eyes, wings, legs and halteres. 
These imaginal discs are derived from clusters of cells within the embryo that 
invaginate from the epidermal sheet, and become sac-like structures of single 
columnar epithelial tissue (Bate and Arias, 1991). The larger discs, the wing, leg 
and eye, proliferate exponentially from 20-50 cells to a final size of 20,000-50,000 
cells (Bryant and Simpson, 1984; Garcia-Bellido, 1975; Hufnagel et al., 2007). 
The development of these structures is remarkably autonomous, as 
demonstrated through transplantation experiments, where immature larval 
imaginal discs grow to approximately the correct size and shape, when inserted 
into an adult abdomen (Bryant and Levinson, 1985). Due to this rapid and 
autonomous growth phase, the ease of dissection and imaging, and the genetic 
tools available for tissue specific manipulation, the imaginal discs are an excellent 
model to study the regulation of tissue growth, and as such will be used 
extensively in this thesis. 
Indeed, much of what is known about growth and organ size control has involved 
the study of these Drosophila imaginal discs. In terms of growth, it seems likely 
that the basal state for unicellular organisms is one of constant proliferation, 
which is almost entirely dependent on nutritional supply (Edgar, 2006). With the 
evolution of more complex multi-cellular organisms, a degree of altruistic 
behaviour at the level of the individual cell was acquired. This allowed the 
construction of highly intricate body plans, which are homeostatically maintained 
throughout the life of that organism. In terms of tissue growth, at the cellular level 
this altruistic behaviour requires cooperation between cell growth and 
proliferation, as well as cell death, demanding complex interactions between 
many cells (Edgar, 2006). How the intrinsic property of cell growth is coordinated 
across an entire organ is a complex procedure involving only a handful of 
dynamic, integrated and plastic signalling pathways. These pathways integrate 
both through a ‘top-down’ mechanism of regulating growth, that is, an organising 
signalling centre to coordinate growth across the whole tissue, and ‘bottom-up’ 
mechanisms, in which local interactions of cells sense the intrinsic properties of 
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the tissue ultimately regulating proliferation. A balance between these two 
appears to occur, culminating in the precise regulation of final organ size 
(Hariharan, 2015).  
One of the key signalling pathways involved in the regulation of cell growth is the 
conserved Hippo Pathway, which will be discussed in detail in ‘The Tumour 
Suppressor Hippo Pathway’.  
 The Ubiquitin System 
1.2.1. The Machinery of Ubiquitylation 
The dynamic relationship between protein synthesis and degradation is key to 
most cellular processes. Prior to the discovery of the lysosome and the ubiquitin-
proteasome-system (UPS) it was believed that proteins were stable components 
of the cell, and dietary uptake compensated for the natural breakdown of proteins 
over time (Ciechanover, 2012).  In the 1950s, the lysosome was discovered and 
was considered the mechanism for protein degradation (De Duve et al., 1953). 
However, subsequent studies challenged this paradigm, including the 
observation that protein half-lives vary; that, in certain contexts, lysosomal 
inhibitors did not affect degradation of intracellular proteins and that proteolysis 
was an Adenosine Triphosphate (ATP)-dependent process (Ciechanover, 2012). 
This led to the initial discovery of the UPS (Ciechanover et al., 1978), which 
suggested that lysosome-independent protein degradation required two 
complementary features, a protease component (subsequently identified as the 
proteasome) and a heat–stable protein (later identified as ubiquitin) 
(Ciechanover, 2012). This discovery resulted in Ciechanover, Hershko and Rose 
being awarded the Nobel Prize for Chemistry in 2004.  
Ubiquitin (Ubi) is a small, highly stable protein of 76 amino acids (8.5 kilo Daltons 
(kDa)) that is conserved throughout eukaryotic organisms, with only three minor 
changes from yeast to humans (Komander and Rape, 2012).  Ubi contains a C-
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terminal glycine residue that mediates its covalent linkage, typically to the side 
chain of lysine residues present in protein substrates. Importantly, Ubi itself can 
be subjected to post-translational Ubi conjugation, through several exposed 
lysine residues, and the N-terminal methionine. This facilitates the formation of 
polyubiquitin (polyUbi) chains, which are vital to the function of Ubi as a post-
translational modification.  
 
Figure 1-1 The Ubiquitylation system 
Schematic representations of the ubiquitin conjugation pathway (A) and a generic SCF- β-TrCP 
complex (B). See text for details. 
 
Ubi conjugation to substrates is a three-step process. Firstly, Ubi activating 
enzymes (E1s) activate the C-terminal glycine of Ubi in a two-step reaction. Initial 
formation of a Ubi-adenylate intermediate facilitates formation of a high energy 
thio-ester bond between the C-terminus of Ubi, and a cysteine of the E1 enzyme, 
which requires the breakdown of one ATP molecule into Adenosine 
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Monophosphate (AMP) and Pyrophosphate (PPi) (Pickart and Eddins, 2004).  
Activated Ubi, bound to the E1 is then transferred to a cysteine residue on the 
Ubi conjugating enzyme (E2). The Ubi ligases (E3s) provide the final link in the 
ubiquitylation machinery by promoting the transfer of Ubi from the E2 to a lysine 
or the N-terminal methionine residue of the substrate, forming an isopeptide bond 
(Figure 1-1A) (Komander and Rape, 2012; Pickart and Eddins, 2004). Humans 
contain only two E1s, approximately 30 E2s, but hundreds of E3s, most of which 
can modify multiple substrates, this stratification in the distribution of the Ubi 
conjugating enzymes allows ubiquitylation of a vast number of substrates with a 
high degree of specificity (Pickart and Eddins, 2004; Skaar et al., 2013). At least 
80% of proteins are targeted by ubiquitin highlighting the diversity of substrates 
recognised, and the importance of the ubiquitylation system (Yen et al., 2008). 
As alluded to, an important feature of the UPS is that within Ubi, at least seven 
lysine residues, and the N-terminus can be targeted for ubiquitylation: M1, K6, 
K11, K27, K29, K33, K48 and K63. The specific residue targeted, the subsequent 
Ubi chain length and the branching of these polyUbi chains are all important 
determinants of the fate of the protein substrate. The array of varied Ubi chain 
types helps explain the large number of biological outputs of ubiquitylation 
beyond proteasomal degradation, which include the regulation of lysosomal 
degradation, protein-protein interactions, protein activity and protein localisation 
(Komander and Rape, 2012).  
1.2.2. E3 Ligases 
The E3 ligases are a large and varied collection of genes, which can be grouped 
into four families: Homologous to E6AP Carboxy Terminus (HECT), Really 
Interesting New Gene (RING), UFD2 homology (U-box) and RING-In-Between-
RING (RBR) proteins, which employ different mechanisms to recognise and 
ubiquitylate their substrates. Unlike other E3s, HECTs accept the activated Ubi 
from the E2 and form an intermediate thioester bond between Ubi and a catalytic 
cysteine residue. Large conformational changes are required to transfer the Ubi 
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from the E2 to the HECT E3, which is facilitated by a flexible hinge between the 
C-terminal HECT domain and the N-terminal E2 interaction region (Metzger et 
al., 2012; Pickart and Eddins, 2004). Determination of chain topologies is not well 
understood, although it appears to involve specific interactions between the 
HECT protein, the E2 and Ubi itself (Komander and Rape, 2012). RING and U-
box E3s assist the direct transfer of activated Ubi from E2s to the substrate, 
bridging the E2 to the substrate lysine (Pickart and Eddins, 2004). U-box E3s 
coordinate the transfer of activated Ubi with hydrogen-bonds and salt-bridges, 
whereas RING E3s use zinc ions coordinated by zinc finger domains (Metzger et 
al., 2012; Pickart and Eddins, 2004). RBR E3s are hybrids of RING and HECTs, 
using a RING domain to recruit the E2 enzyme, which transfers activated Ubi to 
a cysteine in the RING-like domain forming a thioester intermediate (Komander 
and Rape, 2012). RING proteins can be monomers, dimers or multi-subunit 
complexes (Komander and Rape, 2012; Metzger et al., 2012). Interestingly, the 
polyUbi chain topology created by the RING or U-box proteins is specified by the 
E2 enzymes, and not the E3s. If the E3 can bind multiple E2s, this E3 will be able 
to catalyse the construction of multiple Ubi chain topologies. If the E3 binds to 
one specific E2, then it is likely that only one Ubi chain type can be created 
(Komander and Rape, 2012; Ye and Rape, 2009).  
1.2.3. F-box E3 Ligases 
The cullin-RING-ligase family complexes form a large group of the modular RING 
E3 ligases, the S phase kinase-associated protein 1 (Skp1) - Cullin 1 (Cul1) - F-
box (SCF) complexes being the best characterised, and most important to this 
study (Petroski and Deshaies, 2005; Skaar et al., 2013). SCF complexes contain 
the catalytically inert Cul1 scaffold, which bridges the RING protein Rbx1 with 
Skp1, which in turn binds to an F-box subunit, which confers substrate specificity 
(Figure 1-1B) (Skaar et al., 2013). F-box proteins can be subdivided into three 
classes, the F-Box and WD40 Repeat Domain Containing (FBXW), the F-box and 
Leucine-Rich Repeat Containing (FBXL) and the remaining F-box Other (FBXO) 
class (Skaar et al., 2013). Each class of F-box proteins contain C-terminal 
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protein-protein interaction motifs that are important for substrate recognition 
(Fuchs et al., 2004). In the canonical model, F-box proteins recognise their 
substrates through recruitment to a phosphorylated degradation motif or 
phosphodegron (Skaar et al., 2013). Phosphodegrons can be substrates for 
multiple kinases, or require priming phosphorylation, which creates a hierarchical 
sequence of phosphorylation events, leading to F-box recruitment. Importantly, 
these phosphodegrons are also subject to the action of phosphatases, which 
inhibits the function of the SCF complex and subsequent target ubiquitylation 
(Skaar et al., 2013).  Variations on this phosphodegron include the substitution of 
the S/T residue with a phosphomimetic amino acid, such as aspartate or 
glutamate (Skaar et al., 2013). The delicate and precise regulation of substrate 
status allows for very accurate regulation of F-box binding, and therefore 
ubiquitylation, providing the cell with excellent control of protein dynamics. In 
addition to the canonical phosphodegron sequences, many other degrons exist, 
for example, unmodified degrons, cofactor-dependent degrons, restricted access 
degrons (which require conformational change of the substrate to expose the 
degron sequence) and inducible, non-covalent degrons to name a few (Skaar et 
al., 2013). 
An F-box protein of particular relevance to this study is Drosophila supernumerary 
limbs (slmb), the orthologue of the mammalian β-transducin repeats-containing 
protein (β-TrCP). Slmb/β-TrCP is a FBXW family protein, containing an N-terminal 
F-box motif, and seven C-terminal WD40 repeats, interacting with 
phosphorylated substrates conforming to a canonical DpSGX(1-2)pS 
phosphodegron motif, although the space between the G and the C-terminal pS 
may extend further than two amino acids in some instances (Fuchs et al., 2004; 
Skaar et al., 2013). Upon substrate phosphorylation and recognition by Slmb/β-
TrCP, the SCF complex targets substrates for ubiquitylation and degradation via 
the proteasome (Fuchs et al., 2004). Slmb/β-TrCP is involved in a large number 
of vital cellular processes, including NF-kB (Nuclear Factor κ-Light-Chain-
Enhancer of Activated B Cell), Wnt and Hedgehog (Hh) signalling and the cell 
cycle among others (Frescas and Pagano, 2008; Fuchs et al., 2004). In 
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Drosophila, slmb directly regulates the stability of Armadillo (Arm), Cubitus 
interruptus (Ci) (Jiang and Struhl, 1998), Period (Per) (Grima et al., 2002; Ko et 
al., 2002), Polo-like-kinase-4 (Klebba et al., 2013) and Oskar (Morais-de-Sa et 
al., 2013) highlighting the range of functions slmb is involved in. Moreover, slmb 
has recently been identified as a regulator of the Hippo pathway component 
Expanded (Ex) interacting with both N-terminal and C-terminal phosphodegrons 
(Ribeiro et al., 2014; Zhang et al., 2015a), and the regulation of this interaction 
will be the main focus of this study. It is important to note that Slmb recognises 
phosphorylated substrates, as is normal for F-box proteins, and this aspect will 
be discussed in more depth in ‘Results 3 – The Role of Casein Kinase 1 Family 
Kinases in the Regulation of Expanded’. 
1.2.4. Deubiquitylating Enzymes 
Like many protein post-translational modifications, ubiquitylation is a reversible 
process. Deubiquitylating Enzymes (DUBs) act analogously to phosphatases, 
their function being divided into three categories: generation of free Ubi molecules 
from polyUbi precursor genes, often co-translationally; removal of Ubi from post-
translationally modified proteins, thereby reversing the Ubi-chain signal; and 
editing of Ubi chain length and/or type to alter the Ubi-chain signal (Komander et 
al., 2009; Reyes-Turcu et al., 2009). 
There are approximately one hundred DUBs in the human genome, although not 
all are predicted to be catalytically active, and can be broken down into seven 
families. Five DUB families are composed of papain-like cysteine proteases: the 
Ubiquitin C-Terminal Hydrolases (UCHs), Ubiquitin-Specific Proteases (USPs), 
Ovarian Tumour Proteases (OTUs), the Machado-Josephin Domain (MJD) and 
the recently discovered Motif Interacting with Ubi-Containing Novel DUB Family 
(MINDY) (Abdul Rehman et al., 2016; Kristariyanto et al., 2017) DUBs. The sixth 
family, the JAB1/MPN/MOV34 metalloenzymes (JAMMs) are dependent on zinc 
ions to coordinate their enzymatic activity (Komander et al., 2009; Reyes-Turcu 
et al., 2009). The Monocyte Chemotactic Protein-Induced Proteins (MCPIPs) 
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DUBs remain a controversial group without definitive DUB activity (Fraile et al., 
2012). Most of these DUBs rely on two or three crucial amino acid residues 
constituting a catalytic diad or triad motif (Komander et al., 2009).  
Ubi chain cleavage can occur in various ways, some DUBs having exo-
deubiquitylating activity, removing Ubi from the end of a chain, some have endo-
deubiquitylating activity, cleaving an isopeptide bond from within a Ubi chain. 
Other DUBs selectively remove mono-Ubi directly from the substrate rather than 
from within the Ubi chain. DUBs can also be highly specific to certain Ubi chain 
topologies, others being unspecific in their chain selection, rather, specificity is 
conferred by substrate interactions (Komander et al., 2009; Reyes-Turcu et al., 
2009). 
DUBs must be very tightly regulated in order to limit their protease capacity to a 
specific set of substrates. In order to prevent non-specific protease activity, the 
DUB catalytic site is often not easily accessible to the substrate, with in vitro 
enzymatic capacity of DUBs being very low, suggesting high levels of regulation 
in order to confer full activity and specificity (Komander et al., 2009). Ubi binding 
is often an important step in exposing the DUB active site, the interaction between 
DUB and Ubi covering 20-40% of the surface of Ubi, driving rearrangements 
necessary for access to the active site. These interactions are far in excess of a 
conventional Ubi-Ubi binding interaction domain, which would normally cover 
only 10% of the Ubi surface (Komander et al., 2009; Reyes-Turcu et al., 2009). 
The nature of the isopeptide Ubi-Ubi bond also prevents spurious DUB activity, 
the conventional peptide bond having a much lower degree of rotational freedom 
when compared to the isopeptide bonds commonly targeted by DUBs (Komander 
et al., 2009).  
The activity of DUBs is also regulated by the intrinsic structure of DUBs, which 
contain multiple variations in the N- and C-terminal regions to the catalytic 
domain. These are involved in Ubi binding and protein-protein interactions, which 
are key to enzymatic activation and also the recognition of specific substrates 
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and chain topologies (Komander et al., 2009; Reyes-Turcu et al., 2009). These 
domain interactions help determine DUB specificity by localising the proteins to 
the correct cellular compartment, and by enabling interactions with adaptors or 
scaffold proteins, which can bridge the DUB with the correct substrate. Certain 
DUBs can also be highly transcriptionally regulated, only being expressed within 
a very specific temporal window limiting excessive activity. Moreover, as with 
most proteins, DUBs are post-translationally modified by phosphorylation and 
ubiquitylation, and these can either activate or inhibit DUB activity or substrate 
recognition, adding a further level of regulation to prevent incorrect action of these 
enzymes (Komander et al., 2009; Reyes-Turcu et al., 2009). The importance of 
these layers of regulation is highlighted by the fact that DUBs often work in multi-
protein complexes, for example, within the proteasome, or within the Endosomal 
Sorting Complexes Required for Transport (ESCRT) complex during 
endocytosis, where adaptor/scaffold binding provides the DUBs with relevant 
substrates. Moreover, DUBs can be directly coupled to E3 ligases, which can 
often auto-ubiquitylate themselves, therefore helping to sustain E3 activity. These 
E3 can also regulate their cognate DUB, suggesting trans-regulation between the 
E3 and DUB is highly controlled, with precise regulation of ubiquitin signalling 
being commonplace. This interaction between DUB and E3 ligase is also 
important for Ub chain topology editing, thus changing the fate of the substrate 
protein (Komander et al., 2009; Reyes-Turcu et al., 2009).  
1.2.5. The Proteasome 
A diverse range of outcomes exist for ubiquitylated proteins, depending on the 
polyUbi chain length and branching. Tied up with the initial identification of 
ubiquitin as a post-translational modification is the proteasome, and ubiquitin-
mediated proteasomal degradation (Ciechanover, 2012). Key to this process is 
polyubiquitylation, particular through polyUbi chains consisting of K48 linkages, 
although K11, K29 and K63 have been reported to be proteasome-targeting 
(Komander and Rape, 2012). The reason for certain Ubi linkages targeting 
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substrates to the proteasome and not others remains unclear (Komander and 
Rape, 2012). 
The proteasome is a large, cylindrical, multi-protein complex responsible for the 
hydrolysis and degradation of a vast array of proteins in an ATP-dependent 
manner (Ciechanover, 2012; Tanaka, 2009). Structurally, the proteasome 
consists of a core 20S unit, consisting of two cylinders of 4 rings stacked on top 
of each other, each ring made from seven individual subunits (Adams, 2003; 
Tanaka, 2009). The two inner rings (β-rings) are the catalytic core of the 
proteasome each containing three active threonine protease units: a trypsin-like, 
a chymotrypsin-like and a post-glutamyl peptide hydrolase, which cleave 
peptides at the C-terminus of basic, hydrophobic and acid amino acids 
respectively (Adams, 2003; Tanaka, 2009). This degrades the protein chains 
entering the proteasome into small polypeptide chains, which are degraded into 
individual amino acids upon entering the cytosol. The outer rings (α-rings) of the 
20S core bind the 19S regulatory subunit and facilitate the passage of denatured 
proteins through the 20S β‐rings. In isolation, this 20S subunit of the proteasome 
is catalytically latent, and is only active upon interaction with one or two 19S units, 
forming either the 26S or 30S proteasome (Adams, 2003; Tanaka, 2009). The 
19S regulatory particles contain two distinct subunits, the Regulatory Particle of 
AAA-ATPase (Rpt) subunits, and Regulatory Particle of Non-ATPase (Rpn) 
subunits. Upon binding to the 20S core, the Rpt AAA-ATPase of the 19S unit 
helps capture client proteins, and drive the substrate unfolding into the 20S unit, 
consuming ATP in the process. The Rpns serve to deubiquitylate captured 
polyUbi substrates (Adams, 2003; Tanaka, 2009). 
1.2.6. Functions of Ubiquitylation 
Regulation of protein turnover by ubiquitylation and proteasomal degradation has 
wide reaching consequences for cellular dynamics. Rather than simply removing 
proteins from the cell, the active protein turnover performed by the UPS is crucial 
in the regulation of many cellular functions. For example, proteasomal turnover 
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of proteins helps to fine tune signalling pathways either resulting in their activation 
or inhibition, illustrated by ubiquitylation and activation of the NF-κB pathway, via 
phosphorylation-mediated ubiquitylation and degradation of the NF-κB inhibitor 
IκBα (Nuclear Factor of κ–Light Polypeptide Gene Enhancer in B-Cell Inhibitor-α) 
(Komander and Rape, 2012). Alternatively, degradation of substrates can inhibit 
signalling, as is the case in Wnt signalling, where β-Catenin, an adhesion protein 
that is also involved in modulation of transcription in the nucleus, is constitutively 
degraded in the absence of signalling by a destruction complex that includes β-
TrCP (Aberle et al., 1997; Jiang and Struhl, 1998). An interesting example can 
be seen in Hh signalling, where the main effector Gli (Glioma Associated 
Oncogenes) the mammalian orthologue of Ci, is partially degraded by the 
proteasome, thereby transforming this transcriptional activator into a 
transcriptional repressor (Jiang and Struhl, 1998; Price, 2006).  
However, ubiquitylation does not simply target proteins for proteasomal 
degradation. Ubiquitylation can also help degrade proteins through the lysosome, 
regulate the endocytic pathway, as well as modulating protein-protein 
interactions, protein activity and localisation (Chen and Sun, 2009; Komander 
and Rape, 2012; Mukhopadhyay and Riezman, 2007). In the case of the 
endocytic pathway and lysosomal degradation, mono-ubiquitylation or K63 chain 
formation of plasma membrane proteins can drive internalisation and endocytosis 
(Komander and Rape, 2012; Mukhopadhyay and Riezman, 2007). The Epidermal 
Growth Factor Receptor (EGFR) is a prime example of this, as ubiquitylation of 
its cytoplasmic domain can drive entry of EGFR into endocytic vesicles, which 
modulates downstream signalling (Mukhopadhyay and Riezman, 2007). 
Experimental evidence also suggests that Ubi-mediated endocytosis enables 
EGFR-mediated signalling within the endosome, or drives lysosomal degradation 
(Komander and Rape, 2012; Mukhopadhyay and Riezman, 2007).  
Ubiquitylation can also influence protein-protein interactions through various 
ubiquitin binding domains, for example in the regulation of Deoxyribonucleic Acid 
(DNA) replication and damage response (Chen and Sun, 2009; Komander and 
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Rape, 2012). The Proliferating Cell Nuclear Antigen (PCNA) helps orchestrate 
normal DNA replication, the response to DNA damage and DNA replication 
surveillance (Mailand et al., 2013). Upon DNA damage during replication, 
monoUbi PCNA promotes interaction with the lesion bypass Y-family polymerase 
resulting in trans-lesion DNA synthesis. However, generation of polyUbi PCNA 
chains promotes DNA template switching and error free replication (Mailand et 
al., 2013). Ubiquitylation can also negatively regulate protein interactions, either 
with other proteins, as in the case of the Smad4:Smad2 interaction, or with 
important signalling co-factors, as in the case of Met4 (Komander and Rape, 
2012). Moreover, M1 ubiquitylation of NF-κB  Essential Modulator (NEMO) can 
even drive the allosteric activation of IκB Kinase (IKK), suggesting ubiquitylation 
can directly influence activation of proteins (Komander and Rape, 2012). 
Ubiquitylation can also affect protein localisation, beyond the endocytic 
internalisation discussed above, as in the case of p53, where ubiquitylation 
controls nuclear localisation (Komander and Rape, 2012). 
Just as E3 ligases are analogous to kinases as post-translational modifiers, DUBs 
are analogous to phosphatases, with most of the E3 ligases being antagonised 
on some level by DUBs. Therefore, just as E3s can regulate protein turnover, 
signalling and protein localisation to affect many biological processes, so too can 
DUBs, whether it be in reversing the Ubi-chain signal by removing a poly-Ub 
chain, perpetuating E3 ligase activity by reversing auto-ubiquitylation, or helping 
to change Ubi signals by allowing Ubi-chain editing (Komander et al., 2009; 
Reyes-Turcu et al., 2009). The importance of ubiquitylation is evident with 
multiple components of the ubiquitylation machinery, including DUBs and E3s, 
being mutated or altered in many diseases, including cancer and 
neurodegenerative diseases (Popovic et al., 2014). It is curious to note that whilst 
there are many hundreds of E3s, there are only approximately one hundred 
DUBs. This is perhaps reflective of the capacity of DUBs to recognise and 
enzymatically cleave Ubi-chains independently of the substrate, unlike E3 
ligases, which predominantly require substrate recognition (Isono and Nagel, 
2014).    
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1.2.7. Ubiquitin-Like Proteins 
In addition Ubiquitin-Like Proteins (UBLs) are members of the Ubi family, which 
encompasses nearly 20 proteins. The UBLs regulate a distinct set of biological 
processes from canonical Ubi conjugation, and are involved in nuclear transport, 
translation, autophagy and antiviral signalling (van der Veen and Ploegh, 2012). 
Small-Ubiquitin-Related Modifier (SUMO), and Neural Precursor Cell-Expressed 
Developmentally Downregulated 8 (Nedd8) are two of the best characterised 
classes of UBLs, Nedd8 sharing the highest homology to Ubi, and are subject to 
substrate conjugation by specific ligases and deconjugation by proteases (van 
der Veen and Ploegh, 2012). In this thesis, several UBL proteases were assessed 
for their potential regulation of tissue size in the Drosophila wing.  
1.2.8. Concluding Remarks 
Ubiquitylation is involved in an enormous array of biological functions, including 
the regulation of signalling pathways. In this study, the mechanism of 
ubiquitylation and deubiquitylation of the Drosophila tumour suppressor 
Expanded, a component of the Hippo pathway, known to be regulated by the E3 
ligase Slmb, will be discussed (Ribeiro et al., 2014; Zhang et al., 2015a). In 
addition, the ability of DUBs to regulate tissue growth through an RNAi screen in 
Drosophila adult wings was assessed. 
 The Tumour Suppressor Hippo Pathway 
In multicellular organisms, the regulation of growth requires an exquisite balance 
between cell proliferation and cell death, and the temporal and spatial regulation 
of these processes is vital for development and maintenance of adult 
homeostasis. The mechanisms involved in limiting excess proliferation and 
growth long remained a mystery. However, the development of a technique to 
generate genetic mosaics in Drosophila led to the rapid discovery of many genes 
involved in these growth regulatory pathways (see 2.3.6 – ‘The FLP/FRT 
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System’) (Xu and Rubin, 1993). Genetic screens using this technique allowed the 
identification of genes that, when mutated, caused excessive proliferation and 
tumourigenic phenotypes, but that in the context of the whole animal, would 
otherwise be lethal.  
Many of the genes identified were later recognised as being members of a highly 
conserved tumour suppressive pathway, coined the ‘Hippo pathway’, due to the 
fact that mosaic mutant animals displayed overgrown and folded cuticle, thereby 
resembling the creased hide of the hippopotamus (Udan et al., 2003). The 
importance of this pathway in development is highlighted firstly, by the ancient 
nature of pathway orthologues, which predate the evolution of multicellular 
metazoa (Sebe-Pedros et al., 2012), and secondly, by their highly conserved 
nature throughout most animal species, including vertebrates (Bossuyt et al., 
2014; Meng et al., 2016).  
1.3.1. The Core Hippo Pathway Kinase Cassette 
Large-scale genetic screens aimed at identifying tumour suppressor genes 
initially led to the discovery of the Nuclear Dbf-2-Related (NDR) kinase warts 
(wts) (Justice et al., 1995; Xu et al., 1995), whose name derives from the fact that 
mutant wts clones create ‘wart’-like growths of proliferative cells. Later screens 
isolated three additional genes, salvador (sav) (Kango-Singh et al., 2002; Tapon 
et al., 2002), hippo (hpo) (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 
2003; Udan et al., 2003; Wu et al., 2003) and mob as tumour suppressor (mats) 
(Lai et al., 2005) whose clonal phenotypes are remarkably similar to wts. Mutant 
cells are able to proliferate faster than wild-type cells, with increased cell growth 
and cell cycle progression. Moreover, in the eye, mutations in these genes cause 
a dramatic increase in the number of interommatidial cells (IOCs). During 
development, the IOCs are produced in excess, and then removed by a wave of 
apoptosis to create the highly ordered retina (Cagan and Ready, 1989; Edgar, 
2006; Miller and Cagan, 1998). As mutations in hpo, sav, wts or mats all prevent 
IOC elimination, part of the normal function of these genes is to promote 
35 
 
apoptosis within the eye. Accordingly, mutant cells for any of these genes cause 
an autonomous transcriptional upregulation of the cyclin-E (cycE) and drosophila 
inhibitor of apoptosis-1 (diap1) genes, which promote cell cycle progression and 
apoptosis resistance, respectively (Harvey et al., 2003; Pantalacci et al., 2003; 
Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003). Genetic epistasis 
experiments place wts downstream of hpo, putatively identifying a hierarchical 
kinase cascade, involved in limiting tissue growth (Harvey et al., 2003; Jia et al., 
2003; Udan et al., 2003; Wu et al., 2003).  
Hpo, Sav, Mats and Wts form the core Hippo pathway cassette whereby the two 
serine/threonine (S/T) kinases Hpo and Wts are sequentially phosphorylated and 
activated. The elucidation of the molecular mechanisms involved in the activation 
of the core kinase cassette has been greatly aided by biochemical and structural 
analyses performed on the highly homologous mammalian orthologues 
Mammalian Sterile-20-like Kinase 1/2 (MST1/2; hpo orthologues), and Large 
Tumour Suppressor (LATS1/2; wts orthologues), along with the adaptor proteins 
SAV1 (sav mammalian orthologue) and the mammalian mats orthologue Mps-
one Binder 1 (MOB1). The high level of homology is such that, overgrowth in a 
hpo mutant eye can be recovered by MST2 overexpression (Wu et al., 2003). 
The first step in the kinase cascade is the activation of Hpo (by MST1/2 
heterodimerisation in mammals), either through phosphorylation at T195 within 
the activation loop by the Sterile-20-like Tao-1 (Boggiano et al., 2011; Poon et 
al., 2011), or by autophosphorylation (Glantschnig et al., 2002; Lee and 
Yonehara, 2002; Ni et al., 2015; Pantalacci et al., 2003; Udan et al., 2003). 
Activated Hpo then interacts with, and phosphorylates Sav, Mats and Wts (Callus 
et al., 2006; Chan et al., 2005; Hirabayashi et al., 2008; Ni et al., 2015; Praskova 
et al., 2008; Wei et al., 2007; Wu et al., 2003), where Sav acts as a scaffold 
bridging Hpo and Wts (Wu et al., 2003), while Mats acts as a Wts activating co-
factor primarily at the cell membrane (Hergovich et al., 2006; Ho et al., 2010; Lai 
et al., 2005). Full kinase activity of Wts occurs upon Hpo-mediated 
phosphorylation of the hydrophobic motif at T1077A (Yu et al., 2010), and 
activation loop autophosphorylation (Staley and Irvine, 2012; Wei et al., 2007). 
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These studies proposed that Hpo/MST phosphorylation is essential for 
Mats/MOB allosteric modulation of Wts/LATS (Ni et al., 2015).  
Despite these data revealing the activation mechanism of this core kinase 
cassette, a recent study suggested Hpo phosphorylation is not necessary for the 
allosteric modulation of Wts. In Drosophila, the use of a ‘Wts-FRET (Forster 
Resonance Energy Transfer) sensor’ proposed that Wts conformation is 
modulated by Mats independently from Hpo, with Mats binding driving Wts into 
an open conformation, which allows Wts to be then phosphorylated by Hpo to 
confer full Wts activity (Vrabioiu and Struhl, 2015). The mechanisms proposed in 
these biochemical and in vivo studies can be unified if Mats is considered to 
allosterically modulate Wts both before and after Hpo-mediated phosphorylation 
of Wts and Mats to fully activate Wts (Manning and Harvey, 2015). 
Neither Vrabioiu et al., or Ni et al. address how Sav interacts with Wts/LATS at 
the direct structural level, and this remains an open question. Sav contains two 
WW domains, responsible for the interaction with Wts, the WW domain being a 
protein-protein interaction motif containing two highly conserved tryptophan 
residues, which specifically interacts with the proline-rich PPxY motifs, and define 
many of the Hippo pathway interactions (Salah and Aqeilan, 2011; Tapon et al., 
2002). Sav also contains a C-terminal SARAH (Sav-RASSF-Hpo) domain 
responsible for Hpo binding (Callus et al., 2006; Harvey et al., 2003; Jia et al., 
2003; Lee et al., 2008; Pantalacci et al., 2003; Scheel and Hofmann, 2003; Wu 
et al., 2003). Sav is also inherently unstable, and is stabilised through interactions 
with Hpo (Pantalacci et al., 2003), which prevents Sav ubiquitylation by the E3 
ligase Herc4 (HECT and RLD Domain Containing E3) and subsequent 
proteasomal degradation (Aerne et al., 2015).   
Data obtained in mouse embryonic fibroblasts suggests induction of LATS 
activation loop phosphorylation at high cell density is independent of MST (Zhou 
et al., 2009). This led to the discovery of two new S/T kinases, and the expansion 
of the Hippo kinase cassette to include Drosophila Happyhour (Hppy) and 
37 
 
Misshapen (Msn), mammalian MAP4K1/2/3/5 and MAP4K4/6/7 respectively, all 
part of the MAP4K family (Mitogen-Activated Protein Kinase Kinase Kinase 
Kinase) (Li et al., 2014a; Li et al., 2015; Meng et al., 2015; Zheng et al., 2015). 
These kinases directly phosphorylate and activate Wts/LATS in a partially 
redundant manner (Meng et al., 2015; Zheng et al., 2015). The specific context 
for when Wts/LATS is regulated by Hpo, Hppy or Msn remains to be thoroughly 
investigated, but it may be tissue, temporally or input specific.  
1.3.2. Yorkie – A Warts Substrate 
Early studies of the Hippo pathway focused on identifying tumour suppressors, 
but how these genes directly inhibited tissue growth remained elusive. In order to 
identify substrates of Wts that controlled growth, a yeast-two-hybrid screen using 
the N-terminal portion of Wts as bait, led to the identification of the WW domain-
containing protein Yorkie (Yki), the orthologue of the mammalian Yes-Associated 
Protein (YAP), as the downstream effector of the Hippo pathway (Huang et al., 
2005). Overexpression of yki is able to phenocopy hpo or wts loss of function 
mutations, recapitulating tissue overgrowth and apoptosis through upregulating 
cycE and diap1 respectively (Huang et al., 2005). Moreover, yki mutation results 
in tissue undergrowth, even when wts is also mutated, placing yki downstream of 
hpo, sav and wts (Huang et al., 2005).  
Initial experiments showed that Yki was indeed a Wts substrate (Huang et al., 
2005), which is primarily phosphorylated at S168, a serine residue conserved in 
YAP (S127) (Dong et al., 2007; Oh and Irvine, 2008). Wts phosphorylates Yki at 
three sites (S111, S168, S250), whereas LATS phosphorylates YAP at five sites 
(S61, S109, S127, S164 and S381) (Hao et al., 2008; Oh and Irvine, 2009; Zhao 
et al., 2007), and while all of these conform to the Wts/LATS HXRXXS consensus 
sequence, the S168/S127 site appears to be the most important site for growth 
regulation (Dong et al., 2007; Oh and Irvine, 2008, 2009; Zhao et al., 2007). 
Overexpression of a non-phosphorylatable YkiS111A, YkiS168A and YkiS250A 
transgenes in Drosophila causes overgrowth phenotypes compared to wildtype 
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Yki overexpression, with the YkiS168 being the most important for growth (Dong et 
al., 2007; Oh and Irvine, 2008). Interestingly, unlike in Drosophila where 
mutations disrupting the YkiS168 phosphorylation site are homozygous lethal 
(Zhao et al., 2007), a mutation in the mouse YAPS112, equivalent to human 
YAPS127 does not affect normal development and only results in tissue overgrowth 
when subjected to stress (Chen et al., 2015). Therefore in mammals, it appears 
the existence of the additional LATS phosphorylation sites facilitates robust and 
compensatory inhibition of YAP (Chen et al., 2015). Moreover, this helps explain 
the increased severity of phenotypes when expressing a YAPS5A construct, 
containing S>A point mutations in all the LATS sites (Zhao et al., 2007). 
The region surrounding the S168 Wts phosphorylation site in Yki conforms to the 
14-3-3 family protein binding site consensus sequence RXXpSXP, and thus, Wts 
phosphorylation induces interaction between Yki and 14-3-3, which serves to 
sequester Yki in the cytosol (Oh and Irvine, 2008, 2009). This mechanism of 
regulating Yki localisation is conserved in mammals, LATS phosphorylating YAP 
controlling the interaction with the 14-3-3 protein (Zhao et al., 2007). Interestingly, 
in addition to LATS, Akt can also phosphorylate YAP at S127, thus controlling its 
localisation (Basu et al., 2003). Prior to the delineation of the Hippo pathway, YAP 
was identified as a transcriptional co-activator (Yagi et al., 1999). Therefore, 
exclusion from the nucleus is a potent mechanism to inhibit the function of 
Yki/YAP in the regulation of transcription. Wts-mediated phosphorylation of Yki 
may also have a role in promoting its nuclear export, as well as its retention in 
the cytosol, although this is much less well documented (Ren et al., 2010b). The 
additional Wts sites S111 and S250 do not appear to induce 14-3-3 interaction, 
but instead seem to limit Yki nuclear localisation and to regulate Yki function 
independently of 14-3-3, perhaps by influencing the ability of Wts to 
phosphorylate S168 (Oh and Irvine, 2009; Ren et al., 2010b). An additional 
orthologue of yki was later identified in mammals, TAZ (Transcriptional Co-
Activator with PDZ-Binding Motif), which shares 50% homology with YAP (Lei et 
al., 2008). TAZ was previously described as a 14-3-3-binding partner and its 
function is modulated by a similar mechanism as YAP (Kanai et al., 2000). Like 
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YAP, TAZ also regulates growth and it is phosphorylated by LATS at S89, which 
similarly promotes TAZ cytoplasmic sequestration (Kanai et al., 2000; Lei et al., 
2008). 
In mammals, LATS can also regulate YAP stability in a way not conserved in 
Drosophila. As well as promoting exclusion from the nucleus, LATS-mediated 
phosphorylation of YAP at S381 primes it for additional phosphorylation by 
Casein Kinase 1 (CK1) δ/ε resulting in recognition by the F-box protein β-TrCP 
and culminating in proteasomal degradation of YAP (Zhao et al., 2010). This 
additional mechanism of YAP regulation is at least in part, responsible for the 
viability of mice with a YAPS112 mutation at the endogenous locus (Chen et al., 
2015). In Drosophila, Yki stability can also be modulated, but this is achieved via 
a distinct mechanism that involves lysosomal rather than proteasomal 
degradation, regulated by the α–arrestin Leash (Kwon et al., 2013), and Myopic 
(Mop) a His-Domain Protein Tyrosine Phosphatase (Gilbert et al., 2011).  
More recently, evidence is growing to suggest there are additional Yki/YAP 
kinases other than Wts/LATS. The mammalian orthologue of Nemo, Nemo-Like 
Kinase (NLK), directly phosphorylates YAP at S128, the neighbouring site to the 
canonical LATS S127 site. This phosphorylation appears to disrupt 14-3-3 
binding, thereby promoting nuclear accumulation and activation of YAP, a 
mechanism which appears to be conserved in Drosophila, knockdown of nemo 
regulating the Yki transcriptional target Diap1 (Hong et al., 2017; Moon et al., 
2017). Phosphorylation at YAPS128 directly antagonises Wts/LATS, although the 
functional relevance of this phosphorylation remains to be thoroughly explored 
(Hong et al., 2017; Moon et al., 2017). The NDR kinase family, of which Wts/LATS 
are members, also contains NDR1/2 in mammals. NDR1/2 have been shown to 
phosphorylate YAP at S127 restricting its activity in the intestine (Zhang et al., 
2015b), and can even act downstream of MST, expanding the repertoire of the 
core signalling cassette (Tang et al., 2015).  
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1.3.3. Yorkie – A Transcriptional Co-Activator 
Yki contains no DNA binding sequence and, therefore, is unable to promote gene 
transcription in isolation. However, fusion of Yki to the DNA binding domain of the 
Gal4 transcription factor is sufficient to drive Upstream Activating Sequence 
(UAS)-luciferase expression, which can be inhibited by hpo or wts 
overexpression (Huang et al., 2005). Confirmation of yki as a bona fide 
transcriptional co-activator came when the TEA Domain (TEAD) family 
transcription factor Scalloped (Sd) and the mammalian TEAD1-4 were identified 
as direct Yki/YAP binding partners (Goulev et al., 2008; Wu et al., 2008; Zhang 
et al., 2008; Zhao et al., 2008). Mutations or RNAi-mediated depletion of sd 
abolish the tissue overgrowth caused by yki overexpression or by Hippo pathway 
inactivation, placing sd downstream of the Hippo kinase cassette and yki (Goulev 
et al., 2008; Wu et al., 2008; Zhang et al., 2008). Overexpression of both sd and 
yki also enhances overgrowth of yki overexpressing clones, resulting in increased 
expression of cycE and diap1 (Wu et al., 2008; Zhang et al., 2008). The direct 
interaction of Yki and Sd led to the characterisation of a minimal Hippo-Response 
Element (HRE), based on the diap1 gene locus (Wu et al., 2008; Zhang et al., 
2008). Interestingly, Sd also interacts with the co-transcriptional activator 
Vestigial (Vg), which is specifically expressed in the wing pouch and is 
responsible for determining wing identity (Halder et al., 1998; Simmonds et al., 
1998). Sd interacts with Yki and Vg in a mutually exclusive manner, each co-
activator regulating a distinct set of genes (Halder and Carroll, 2001; Wu et al., 
2008).  
Surprisingly, sd overexpression causes tissue undergrowth rather than the 
excess overgrowth as a result of yki,sd co-overexpression (Wu et al., 2008; 
Zhang et al., 2008). This apparent discrepancy was resolved by the discovery 
that the default function of sd is as a transcriptional repressor, and the yki binding 
alleviates this repression converting sd into an activating transcription factor 
(Koontz et al., 2013). Repression of sd target genes in the absence of nuclear 
Yki is mediated by Tondu-Domain-Containing Growth Inhibitor (Tgi), a Sd-binding 
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co-factor required for default repression, whose function is conserved in 
mammals by Vestigial-like 4 (VGL4) (Koontz et al., 2013). In addition to Sd, 
additional Yki-binding transcription factors have been identified, which include 
Homothorax (Hth) and Teashirt (Tsh) in the developing eye (Peng et al., 2009), 
and Mothers Against Dpp (Mad) (Oh and Irvine, 2011). In mammals, YAP/TAZ 
associate with a plethora of transcription factors in addition to TEAD1-4 including 
YAP binding partners SMAD1/2/3 (Alarcon et al., 2009; Varelas et al., 2008; 
Varelas et al., 2010), Runt-Related Transcription Factor (RUNX) (Yagi et al., 
1999), Erb-B2 Receptor Tyrosine Kinase 4 (ErbB4) (Komuro et al., 2003), p73 
(Strano et al., 2001) and TAZ binding partners RUNX, Peroxisome Proliferator-
Activated Receptor γ (PPARγ) (Hong et al., 2005), Paired Box 3 (Pax3) 
(Murakami et al., 2006), T-Box Transcription Factor 5 (TBX5) (Murakami et al., 
2005) and Thyroid Transcription Factor 1 (TTF-1) (Park et al., 2004) increasing 
the scope of Hippo signalling. 
Tissue growth, as a result of Hpo signalling inhibition, or the activation of Yki 
switches on a transcriptional programme that can be split into three categories. 
Firstly, yki regulates tissue size through genes that control the cell cycle, cell 
growth (that is, cell mass) and apoptosis. Yki promotes cell cycle progression 
through the regulation of cycE (Harvey et al., 2003; Pantalacci et al., 2003; Tapon 
et al., 2002; Udan et al., 2003; Wu et al., 2003), a member of the cyclin family 
that drives the cell cycle from the Gap1 phase (G1) into the Synthesis  phase (S 
phase) (Knoblich et al., 1994), and E2F transcription factor 1 (E2F1) (Goulev et 
al., 2008), which also promotes cycE expression (Neufeld et al., 1998). Yki also 
regulates cell proliferation through the micro-Ribonucleic Acid (RNA) bantam, 
(Brennecke et al., 2003; Nolo et al., 2006; Thompson and Cohen, 2006), and cell 
growth through myc proto-oncogene protein (myc) (Neto-Silva et al., 2010; Ziosi 
et al., 2010). Diap1 inhibits apoptosis-inducing caspases (Wang et al., 1999) and 
is transcriptionally regulated by Yki, thus providing a means to prevent apoptosis 
(Harvey et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; 
Wu et al., 2003). The coordinated, and cell autonomous expression of these 
genes by yki results in increased proliferation rates, cell growth and resistance to 
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apoptotic signals which, together, all contribute to the ability of yki to control tissue 
growth.  
Secondly, the Hippo pathway and many other signalling pathways are highly 
integrated (Hansen et al., 2015; McNeill and Woodgett, 2010). To this end, the 
yki transcriptionally regulates genes crucial to several pathways, including 
ligands for the EGFR pathway vein (vn) and spitz (spi) (Ren et al., 2010a), Notch 
pathway serrate (Cho et al., 2006), Wnt pathway wingless (wg) (Cho et al., 2006; 
Cho and Irvine, 2004), Hh and Decapentaplegic (Dpp) pathways dally and dally-
like (dlp) (Baena-Lopez et al., 2008) and Janus Kinase (JAK)/Signal Transducer 
and Activator of Transcription (STAT) pathway unpaired (upd) 1-3 and 
suppressor of cytokine signalling at 36E (socs36E) (Karpowicz et al., 2010; Ren 
et al., 2010a; Shaw et al., 2010).   
Lastly, genes involved in upstream activation of Hpo signalling also form a large 
portion of the yki-dependent transcriptional programme, including expanded and 
merlin (Hamaratoglu et al., 2006), kibra (Genevet et al., 2010), and four-jointed 
(Cho et al., 2006; Willecke et al., 2006). Expression of these genes results in 
negative feedback of the Hippo pathway by inhibiting excessive yki activity and 
tissue overgrowth. Interestingly, high activity of myc, whilst promoting growth, can 
also inhibit yki through transcriptional and post-transcriptional mechanisms, 
further compounding the negative feedback mechanisms employed by Hippo 
signalling to tightly regulate yki activity (Neto-Silva et al., 2010).  
1.3.4. Upstream Regulation of the Hippo Pathway 
The focus of Hippo signalling is upon the core kinase Wts, and the ultimate Hippo 
effector Yki. A vast amount of work has gone into understanding what 
physiological and cellular signals impact upon these key proteins, leading to the 
identification of a wide array of upstream mediators of the pathway. Unlike with 
typical signalling cascades, the Hippo pathway is not regulated by a defined set 
of ligand-receptor interactions, but it is rather modulated by a diverse set of 
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upstream constituents. The following section will discuss these many and varied 
upstream members of the Hippo pathway, and how they ultimately regulate Wts 
and Yki.  
 
Figure 1-2 The Drosophila Hippo tumour suppressor pathway 
Schematic representation of the Hippo pathway in Drosophila with particular focus on the role 
of Ex. See text for details. 
1.3.5. Regulation by the Kibra, Expanded, Merlin Complex 
Prior to the delineation of the Hippo kinase cascade, early genetic studies in 
Drosophila identified several tumour suppressor genes that would later find a 
place within the Hippo pathway. Two of these genes were expanded (ex) 
(Boedigheimer and Laughon, 1993; Boedigheimer et al., 1997), and merlin (mer), 
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the orthologue of the bona fide tumour  suppressor gene Neurofibromatosis Type-
2 (NF2) encoding mammalian MER (LaJeunesse et al., 1998). Null mutations in 
ex are lethal (Blaumueller and Mlodzik, 2000), whereas hypomorphic mutations 
cause hyperplastic overgrowth of discs by affecting the rate of cell proliferation, 
rather than increasing the growth period (Boedigheimer and Laughon, 1993). Like 
ex, null mutations in mer are lethal, whereas hypomorphic mutations also cause 
overproliferation.  
Ex and Mer both contain a highly conserved N-terminal FERM (4.1 Ezrin Radixin 
Moesin) domain (Boedigheimer et al., 1997; LaJeunesse et al., 1998) and co-
localise at the apical surface of wing imaginal discs, directly interacting in vitro 
(McCartney et al., 2000) (for the domain architecture of Ex see Figure 1-3A). The 
structural and phenotypic similarity between mer and ex led to the discovery that 
these genes act partially redundantly in the regulation of tissue growth. mer, ex 
double mutants display dramatically enhanced tissue overgrowth compared to 
single mutants (McCartney et al., 2000), but despite their partial redundancy, mer 
and ex perform distinct functions. For example, in the developing eye, the main 
function of ex appears to be in the regulation of cell cycle exit, whereas mer 
serves to inhibit apoptosis (Pellock et al., 2007). Moreover, ex appears to inhibit 
Wg function as eyes that are entirely mutant for ex are paradoxically smaller than 
wild-type eyes despite overgrowth of the eye disc, which is attributed to ectopic 
Wg activity, a phenotype that is not observed in mer mutant eyes (Pellock et al., 
2007). Tissue overgrowth of mer;ex double mutants is as a result of regulation of 
cell cycle and apoptosis, and cycE and diap1 transcription is upregulated in the 
mutant tissue, reminiscent of previously identified Hippo pathway mutants 
(Hamaratoglu et al., 2006). This discovery prompted researchers to perform 
epistasis experiments involving core Hippo pathway members, which placed mer 
and ex genetically upstream of hpo and wts, as hpo overexpression phenotypes 
were not suppressed by loss of function of mer;ex. Moreover, mer and ex were 
found to stimulate Wts phosphorylation, resulting in Yki inhibition (Hamaratoglu 
et al., 2006).  
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Interestingly, recent data has suggested that Mer can also directly recruit Wts to 
the plasma membrane to activate Hippo signalling, which may be independent of 
Hpo kinase activity (Yin et al., 2013). These findings placed ex and mer as the 
first identified regulators of Hippo signalling. Moreover, in addition to acting at the 
plasma membrane, mammalian activated MER functions within the nucleus 
interacting with the E3 ligase Cullin4A-RING E3 Ligase (CRL4)-DDB1- and 
CUL4-Associated Factor 1 (DCAF1) (CRL4DCAF1) (Li et al., 2014b). This 
interaction supresses the ability of CRL4DCAF1 to ubiquitylate and inhibit LATS, 
this enabling the phosphorylation and inhibition of YAP (Li et al., 2014b).  
In addition to the role of Ex and Mer regulating the Hippo kinase cassette, these 
proteins may affect growth through endocytosis, negatively regulating the 
membrane abundance of multiple signalling pathways receptors (Maitra et al., 
2006). However as apical hypertrophy is a general outcome of increasing Yki 
activity (Genevet et al., 2009; Hamaratoglu et al., 2009), this could explain the 
increased abundance of  apical receptors, and therefore the apparent effect of 
ex/mer on endocytosis seems likely to be a consequence of Yki regulation, rather 
than through a direct influence on endocytosis. In fact, apical hypertrophy was 
one of the first reported wts mutant phenotypes (Justice et al., 1995).  
Despite the established role of Ex in regulating the Hippo kinase cassette activity, 
the direct mechanism has not been thoroughly characterised. A recent paper 
identified schwannomin/Mer-interacting protein (schip1), as a novel component 
of the Hippo pathway, which interacts with Ex and Tao-1. The formation of this 
complex stimulates Tao-1 kinase activity, thus promoting signalling through the 
Hippo kinase cassette (Chung et al., 2016). This provides a mechanistic link 
between Ex and the core kinase cassette, although the authors speculate that 
Schip1 may also regulate Mer in certain contexts, such as the eye, where Mer 
functions independently of Hpo by directly interacting with Wts (Chung et al., 
2016; Yin et al., 2013) (Figure 1-2). 
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The linear genetic epistasis of ex and the Hippo kinase cassette had to be re-
evaluated once it was discovered that Ex can physically interact with Yki via the 
proline-rich PPxY motifs in the C-terminus of Ex, and the WW domain of Yki 
(Badouel et al., 2009; Oh et al., 2009). The interaction with Ex physically tethers 
Yki to the apical membrane, inhibiting its translocation into the nucleus. 
Therefore, ex has Hippo-dependent and -independent means of regulating Yki, 
and can act up- and downstream of Wts. The interaction between Ex and Yki is 
thought to be subject of regulation by Activated Cdc42 Kinase (Ack), a non-
receptor tyrosine kinase. Ack phosphorylation of Ex at multiple tyrosine residues 
disrupts the interaction between Ex and Yki, thus Ack serves to enhance Yki 
activity (Hu et al., 2016). However, as ack mutants do not display overt growth 
phenotypes (Hu et al., 2016), the physiological relevance of this mechanism 
remains unclear. 
Unlike many members of the Hippo pathway which have clear orthologues in 
mammals, the conservation of ex is unclear. There is no gene of high homology 
to the entirety of ex, rather it has been proposed that the function of ex has been 
split in mammals between FERM Domain Containing 6 (FRMD6) and Angiomotin 
(AMOT) (Genevet and Tapon, 2011). FRMD6, shares sequence homology with 
ex, primarily throughout the FERM domain and has been proposed as an N-
terminal orthologue of ex as overexpression of FRMD6 in mammalian cells 
inhibits YAP activity by luciferase reporter assay (Zhao et al., 2007). Moreover, 
FRMD6 activates the Hippo pathway kinases, increasing phosphorylation of YAP 
(Angus et al., 2012; Moleirinho et al., 2013). However, the role of this gene in 
Hippo signalling is disputed, as another report suggests FRMD6 possesses 
tumour suppressive functions independent of the Hippo pathway perhaps through 
regulation of receptor tyrosine kinases (Visser-Grieve et al., 2012; Xu et al., 
2016), and overexpression of FRMD6 is not able to recover tissue overgrowth in 
ex mutant Drosophila eye discs (Angus et al., 2012).  
Interestingly the unrelated AMOT genes are functionally analogous to the C-
terminus of ex, despite encoding proteins that contain different domains (Bossuyt 
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et al., 2014). In evolutionary terms, AMOT–like genes can be found in all 
bilaterian phyla, except the dipteran lineage, which includes Drosophila. 
Therefore, it seems Drosophila lost AMOT genes, gaining the ex gene 
developing, at least in part, the same function as AMOT in the interaction and 
inhibition yki/YAP (Bossuyt et al., 2014).  
Crucially, both Ex and AMOT contain PPxY motifs, both proteins being able to 
physically interact with Yki or YAP/TAZ respectively (Badouel et al., 2009; 
Paramasivam et al., 2011; Varelas et al., 2010; Wang et al., 2011; Yi et al., 2011; 
Zhao et al., 2011). The precise role of the AMOTs in the regulation of Hippo 
signalling and YAP has been difficult to determine. Initial reports suggested the 
physical interaction between AMOT and YAP inhibits the translocation of YAP to 
the nucleus (Chan et al., 2011; Oka et al., 2012; Varelas et al., 2010; Zhao et al., 
2011), one report suggesting AMOT phosphorylation by LATS aids Atrophin-1 
Interacting Protein 4 (AIP4) dependent degradation of YAP (Adler et al., 2013). 
However, conflicting studies have suggested AMOT promotes YAP function (Lv 
et al., 2015; Yi et al., 2013). Recently, these contradicting findings appear to be 
partially resolved and depend on the context of AMOT interaction with YAP. 
Interaction with the Crumbs (Crb) complex appears to result in AMOT-dependent 
inhibition of YAP (Varelas et al., 2010). In one recent report, AMOTL1 acts 
downstream of Fat4 in the heart to sequester YAP away from the nucleus. 
However, when Fat4 is lost, AMOT:YAP is relocated into the nucleus to drive a 
YAP-dependent transcriptional programme (Ragni et al., 2017). Therefore, the 
interaction partners of AMOT can help dictate its function. Post-translational 
status of AMOT also appears to significantly contribute to its activity in regulating 
YAP, phosphorylation of AMOT by LATS (Adler et al., 2013; Chan et al., 2013; 
Dai et al., 2013; Hirate et al., 2013), or AMP-Activated Protein Kinase (AMPK) 
(DeRan et al., 2014) promotes AMOT-mediated inhibition of YAP. Interestingly, 
AMOT and MER interact in mammals, as they do Ex and Mer in Drosophila (Das 
et al., 2015; McCartney et al., 2000; Moleirinho et al., 2017; Yi et al., 2011) 




Kibra (kib), named due to the high expression levels of KIBRA in mammalian 
kidney and brain (Kremerskothen et al., 2003), was identified as an upstream 
member of the Hippo pathway in Drosophila through the observation that 
overexpression in the developing eye results in a decrease in the adult organ size 
(Baumgartner et al., 2010; Tseng and Hariharan, 2002), and through two 
independent genetic screens (Genevet et al., 2010; Yu et al., 2010). Mutations in 
kib cause mild overgrowth phenotypes and cell autonomous increase in Hippo 
pathway target genes. Moreover, RNAi-mediated knockdown of kib in S2 cells 
causes a decrease in HpoT195 and YkiS168 phosphorylation, consistent with the 
role of Kib as a member of the Hippo pathway (Baumgartner et al., 2010; Genevet 
et al., 2010; Yu et al., 2010). Kib contains two WW domains, which facilitates 
interaction with the PPxY motifs of Ex (Genevet et al., 2010). Interestingly, one 
of the WW domains of Kib only has a single tryptophan residue, similar to Sav. 
The atypical WW domain of Sav allows it to homodimerise (Ohnishi et al., 2007). 
As both Sav and Kib contain a similar atypical WW domain, it was discovered 
they can also heterodimerise (Yu et al., 2010). These interactions allows Kib to 
form a complex with Ex, Mer, Sav and Hpo at cellular junctions that potently 
regulates Wts activity, and thus tissue size through the Hippo kinase cascade 
(Baumgartner et al., 2010; Genevet et al., 2010; Yu et al., 2010) (Figure 1-2). 
The functional relevance of the Kib/Ex/Mer complex has recently come under 
scrutiny, a recent report suggesting Mer/Kib act in parallel to Ex in a complex at 
the apical medial cortex distinct from the junctions, medial Mer/Kib stimulating 
Sav, Hpo and Wts interactions and thus Hippo signalling (Su et al., 2017). Indeed, 
contrary to the current paradigm, in which Crb promotes Hippo signalling solely 
through regulating Ex (Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; 
Ribeiro et al., 2014; Robinson et al., 2010), Crb appears to actively inhibit Kib at 
the apical junctions. However, the physiological relevance of medial Mer/Kib 
remains to be determined.  
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1.3.6. Regulation by Cell-Cell Contact, Tension and the Cytoskeleton 
Hippo signalling and Yki activity is also regulated by many other important stimuli 
other than the Kib, Ex and Mer complex. Cell-cell contacts, mechanical tension 
and the cytoskeleton are major inputs into the Hippo pathway. Early evidence, 
predating the ‘discovery’ of the Hippo pathway suggested that the Mer orthologue 
MER was involved in regulating contact inhibition in mammalian cells (Morrison 
et al., 2001). Indeed, Hippo signalling was found to regulate contact inhibition 
outright on analysis of YAP localisation in sparse or densely cultured cells. At 
high density, YAP is excluded from the nucleus, whereas in sparsely seeded 
cells, YAP is strongly localised within the nucleus, nuclear exclusion upon high 
density being dependent on Hippo pathway activity (Schlegelmilch et al., 2011; 
Zhao et al., 2007).  
Moreover, as FERM domain proteins such as Ex and Mer are associated linking 
the plasma membrane with the cortical cytoskeleton (Bretscher et al., 2002), the 
actin cytoskeleton was discovered to play a major role in Hippo signalling. In 
Drosophila, induction of Filamentous (F)-actin formation, through loss of actin 
capping proteins or activation of formins, promotes yki dependent tissue 
overgrowth (Fernandez et al., 2011; Sansores-Garcia et al., 2011). Zyxin (Zyx), 
a Lin11, IsI-1, Mec3 (LIM) domain containing protein, interacts with Enabled (Ena) 
to promote F-actin and Yki-mediated growth, which antagonises the genetic 
interaction between Ex and Capping Protein (CP) (Fernandez et al., 2011; 
Gaspar et al., 2015). Furthermore, cytoskeletal tension in Drosophila regulates 
wing growth through modulation of Wts and therefore Yki activity (Rauskolb et 
al., 2014). As seen in Drosophila, proteins that regulate F-actin polymerisation 
also regulate YAP/TAZ activity in mammals, and therefore Hippo signalling is able 
to respond to differences in cellular tension (Aragona et al., 2013). The response 
of YAP/TAZ to tension is also modulated by the extracellular matrix (ECM) rigidity 
and cell shape through the action of the Ras Homolog (RHO) GTPase and 
actomyosin, with cells compressed into small areas inactivating YAP/TAZ 
(Dupont et al., 2011). Indeed, loss of cell interaction with the ECM activates LATS 
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to inhibit YAP, which is required for anoikis, apoptosis induced by loss of ECM 
contact (Zhao et al., 2012). It remains controversial as to whether F-actin- and 
tension-mediated activation of YAP/TAZ requires the LATS kinases, as initial 
studies suggested YAP/TAZ activation was independent of the core Hippo 
kinases (Dupont et al., 2011). However, an increasing body of work suggests F-
actin-mediated regulation of YAP/TAZ does require LATS1/2 kinases and AMOT 
(Adler et al., 2013; Dai et al., 2013; Hirate et al., 2013; Wada et al., 2011). 
Additionally, one study has suggested that the activation of YAP upon tension 
requires c-Jun N-Terminal Kinase (JNK) signalling to inhibit LATS activity 
(Codelia et al., 2014).  
In addition to the actin cytoskeleton, the spectrin network has recently been 
identified as a Hippo regulator. Disruption of Spectrin proteins leads to activation 
of Yki, resulting in tissue overgrowth (Deng et al., 2015; Fletcher et al., 2015; 
Wong et al., 2015). However, the precise mechanism by which Spectrins regulate 
Hippo signalling remains to be clarified, one study suggesting apical βHeavy (βH)-
Spectrin binds to Ex to regulate Yki activity (Fletcher et al., 2015), whereas 
another study suggests the Spectrins modulate cortical actomyosin through non 
muscle myosin II to regulate Yki activity (Deng et al., 2015).  
1.3.7. Regulation by Extracellular Ligands 
Although Hippo signalling is not predominantly regulated by a traditional ligand-
receptor structure, Hippo signalling can be regulated by ligands that stimulate G-
Protein Coupled Receptor (GPCR) signalling. In mammals, the discovery that 
cells treated with foetal bovine serum causes dephosphorylation of YAP led to 
the discovery that the molecules lysophosphatidic acid (LPA) and sphingosine-1-
phosphate (S1P), through interaction with their GPCRs, stimulate YAP/TAZ 
activity by inhibiting Hippo signalling (Yu et al., 2012). The LPA and S1P GPCRs, 
when coupled to the Gα12/13 subunit, activate the GTPase RHO, which triggers 
LATS inhibition, and YAP/TAZ activation (Yu et al., 2012). As with the actin 
cytoskeleton and tension, whether RHO affects YAP activity through the 
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modulation of LATS function remains controversial. For instance, it has also been 
reported S1P and LPA stimulate YAP independently of the core kinase cascade 
(Miller et al., 2012). Further studies identified several additional factors that 
regulate Hippo signalling through GPCRs, suggesting that a broad range of 
extracellular signals can regulate the Hippo pathway (Gong et al., 2015; Mo et 
al., 2012; Zhou et al., 2015). Interestingly, activation of the GαS GPCR subunit by 
adrenaline or glucagon inhibits YAP/TAZ activity through stimulation of the LATS 
kinases (Yu et al., 2013; Yu et al., 2012). The adrenaline or glucagon the GαS 
GPCR subunits generate cAMP as a second messenger molecule to stimulate 
Protein Kinase A (PKA) activity. Increased PKA activity stimulates LATS 
dependent phosphorylation of YAP by inhibiting RHO activity, this mechanism 
being conserved in Drosophila wing imaginal discs (Yu et al., 2013; Yu et al., 
2012).  
1.3.8. Regulation by Metabolism 
Metabolic perturbations and nutrient levels have also recently been shown to 
influence Hippo signalling. The mevalonate pathway is a regulator of YAP/TAZ 
activity (Sorrentino et al., 2014; Wang et al., 2014), which is involved in the 
synthesis of isoprenoid precursors, including cholesterol, steroid hormones and 
haem cofactor, as well as the production of prenylation intermediates, and is 
therefore involved in a wide range of biological functions (Santinon et al., 2016). 
It has been suggested that the mevalonate pathway regulates Hippo signalling 
and YAP/TAZ activity through the modulation of RHO prenylation, which 
regulates its localisation and activity. Interestingly, this mechanism of YAP/TAZ 
regulation, although dependent on YAP phosphorylation, seems to be 
independent of LATS, which suggests that additional YAP/TAZ kinases may exist 
(Santinon et al., 2016; Sorrentino et al., 2014; Wang et al., 2014).  
AMPK is crucial for regulating energy homeostasis, and therefore the metabolic 
state of the cell. Several studies have linked AMPK to Hippo signalling, and to 
the negative regulation of Yki-YAP/TAZ activity. Building on the discovery that 
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serum deprivation induces YAP exclusion from the nucleus (Miller et al., 2012; 
Yu et al., 2012), screening of small molecule compounds in this context led to the 
identification of AMPK as an inhibitor of YAP (DeRan et al., 2014). This initial 
study concluded that AMPK inhibits YAP through activating phosphorylation of 
AMOT, thus inhibiting YAP (DeRan et al., 2014). However, subsequent studies 
have suggested that AMPK directly phosphorylates YAP, potentially 
independently of LATS. However, the site of phosphorylation remains 
controversial, as both studies found YAP S94 as an AMPK target, which is 
noteworthy as this residue is vital for the YAP:TEAD interaction (Mo et al., 2015; 
Wang et al., 2015b). Moreover, the regulation of Hippo signalling by AMPK 
appears to be conserved in Drosophila, as AMPK represses Yki activity in the 
central brain/ventral nerve cord downstream of Liver Kinase B1 (LKB1) (Gailite 
et al., 2015).   
The Drosophila Salt-Inducible Kinases 2 and 3 (Sik2/3) respond to nutrient levels 
promoting metabolism of lipids and glycogen (Choi et al., 2011) and are regulated 
by insulin signalling (Wang et al., 2008). Sik2/3 also promotes Yki activity by 
phosphorylation and inhibition of Sav, leading to increased expression of Yki 
target genes (Wehr et al., 2013). Furthermore, Drosophila fed a high sucrose diet 
in combination with oncogenic Ras Oncogene at 85D (Ras)/Src develop highly 
metastatic tumours, which remain sensitive to insulin signalling unlike Drosophila 
fed on a high sucrose diet only, which develop insulin insensitivity (Hirabayashi 
et al., 2013). Interestingly, the ability of these highly tumourigenic Drosophila to 
retain insulin sensitivity, which is essential for their aggressiveness, depends on 
Sik2/3 activity driving increased Yki activity and therefore Wg expression, which 
confers evasion of insulin resistance (Hirabayashi and Cagan, 2015). In addition, 
insulin also activates Yki through Akt mediated inhibition of Hpo (Strassburger et 
al., 2012).   
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1.3.9. The Hippo Pathway and Cell Polarity 
Since the early characterisation of the Hippo pathway, links have been made to 
the organisation of epithelial tissues and their polarity. Epithelia are fundamental 
in the formation of distinct morphologies and the regulation of physiology. 
Epithelial cells are divided into discrete regions to facilitate their function called 
the apical domain and the basolateral domain, which are separated by junctional 
complexes. These junctional complexes are vital in establishing a semipermeable 
barrier, which allows epithelia to spatially control and coordinate their intracellular 
content (Tepass et al., 2001). The key junctional complexes in apicobasal polarity 
include the adherens junctions (AJs) and the septate junctions (SJs).  
AJs form during embryogenesis through the fusion of spot AJs eventually forming 
a belt segregating the apical and basolateral membrane (Tepass and 
Hartenstein, 1994; Tepass et al., 2001). These junctions are characterised by E-
cadherin and catenin localisation (Tepass et al., 2001). Key to the maintenance 
and stability of AJs are two apical protein complexes, the Par (Partitioning-
defective) complex composed of Bazooka (Baz, also known as Par3), Par6 and 
Atypical Protein Kinase C (aPKC) and the more apical Crumbs (Crb) complex 
containing Crb, Stardust (Sdt) and Protein Associated to Tight Junctions (Patj) 
(Flores-Benitez and Knust, 2016; Harris and Peifer, 2004; Harris and Peifer, 
2007; Muller and Wieschaus, 1996; Tepass, 1996, 2012; Wodarz et al., 2000). 
Septate junctions form basally to the AJs, and are functionally analogous to tight 
junctions in vertebrates. As well as providing diffusible barriers between the apical 
and basal compartments within the cell, the AJs and septate unctions form strong 
adhesive cell-cell contacts, effectively creating a two-dimensional sheet of 
epithelia (Tepass et al., 2001). The Scribbled (Scrib) complex is key to the more 
basolateral region of the cell within the region of the septate junctions, containing 
Scrib, Discs Large (Dlg) and Lethal (2) Giant Larvae (Lgl). The Crb, Par and Scrib 
complexes antagonise each other to create and maintain distinct cellular regions 
within individual cells (Flores-Benitez and Knust, 2016; Tepass, 2012).  
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In addition to apicobasal polarity, planar cell polarity (PCP), the polarity within the 
plane of the tissue, is driven by two sets of genes, the Fat (Ft)/Dachsous (Ds) 
system, and the Frizzled (Fz)/Starry Night (Stan) system (Lawrence and Casal, 
2013). Unlike with apicobasal polarity, where many components regulate Hippo 
signalling, only the Ft/Ds PCP system has been directly linked to growth via the 
Hippo pathway thus far.  
1.3.10. The Fat-Dachsous Pathway – A Link Between Planar Cell 
Polarity and Growth 
Like ex, ft was discovered as a tumour suppressor gene long before the 
identification of a conserved Hippo pathway, with the original ft mutants having 
been isolated in the early twentieth century (Mohr, 1923). Imaginal discs mutant 
for ft display enormous tissue overgrowth, as well as defects in bristle polarity 
(Bryant et al., 1988; Mahoney et al., 1991). Subsequent studies confirming the 
polarity defects caused by mutations in ft also identified several other genes 
which affect polarity, including ds, four-jointed (fj) (Adler et al., 1998; Casal et al., 
2002; Rawls et al., 2002; Strutt and Strutt, 2002; Yang et al., 2002; Zeidler et al., 
1999, 2000), and dachs (d) (Mao et al., 2006). These genes were found to interact 
in a common pathway regulating PCP.  
The ft and ds genes encode large transmembrane proteins that are part of the 
cadherin family. Ft contains a large extracellular region with EGF-like and Laminin 
AG-domain-like repeats (Mahoney et al., 1991), whereas Ds contains tandemly 
repeated extracellular cadherin domains (Clark et al., 1995). The gene fj encodes 
a Golgi-resident kinase which can phosphorylate the extracellular domains of 
both Ds and Ft during their maturation (Brittle et al., 2010; Ishikawa et al., 2008; 
Simon et al., 2010). Interestingly, unlike ft which is uniformly expressed,  ds and 
fj are expressed in opposing gradients in developing tissues (Clark et al., 1995; 
Yang et al., 2002; Zeidler et al., 1999), which is instructive in forming correct PCP 
orientation by providing directional information to the cells (Ambegaonkar et al., 
2012; Bosveld et al., 2012; Brittle et al., 2012). Ft and Ds form heterodimers (Cho 
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and Irvine, 2004; Ma et al., 2003; Mao et al., 2006; Matakatsu and Blair, 2004; 
Strutt and Strutt, 2002), and their affinity is modulated by Fj-mediated 
phosphorylation, with phosphorylation of Ft increasing its affinity to Ds, whereas 
phosphorylation of Ds decreases its affinity for Ft (Brittle et al., 2010; Ishikawa et 
al., 2008; Simon et al., 2010). These interactions manifest in the asymmetrical 
localisation of Ft and Ds on opposing edges of a cell (Brittle et al., 2012), this 
polarised organisation of Ft/Ds heterodimers being defined by the ds/fj 
expression gradients, as well as the action of fj in regulating their affinity, the 
overall result creating a gradient of Ft activity throughout the tissue.  
The effect of ft on growth has been difficult to dissect, with initial studies 
suggesting ft and d regulated growth through wg (Cho and Irvine, 2004; 
Rodriguez, 2004). However, upon early delineation of the Hippo pathway, it 
became apparent that ft mutant tissue displays many of the hallmarks of Hippo 
pathway mutants, such as transcriptional regulation of the Hippo pathway target 
genes cycE and diap1, and dependence on yki for overgrowth (Bennett and 
Harvey, 2006; Cho et al., 2006; Silva et al., 2006; Willecke et al., 2006). These 
early studies linking Ft to the Hippo pathway placed ft upstream of ex as loss of 
ft results in a decrease in ex apical localisation, and regulates Ex stability, and 
overgrowth induced by ft mutation in the eye could be rescued by expression of 
Ex (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006). 
Furthermore, it appeared that ft,ex double mutants displayed similar phenotypes 
to ft or ex alone, and were not additive suggesting that ft acted upstream of ex to 
regulate Hippo signalling (Bennett and Harvey, 2006; Cho et al., 2006; Silva et 
al., 2006; Willecke et al., 2006). However, later observations reported that ft,ex 
double mutants phenotypes are in fact additive, and that imaginal discs are larger 
than either ft or ex mutants alone, suggesting that ex and ft act in parallel  (Feng 
and Irvine, 2007; Oh and Irvine, 2008), growth phenotypes being mediated by 
Wts and Yki as overexpression of Wts is able to recover lethality of null ft or ex 
mutants (Feng and Irvine, 2007; Oh and Irvine, 2008).  
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The apically-localised unconventional myosin D was identified as a member of 
Ft-Ds signalling, which acts downstream of Ft to regulate growth (Mao et al., 
2006). Apical localisation of D is antagonised by Ft (Mao et al., 2006). 
Overexpression of ft inhibits the localisation or stability of D, whereas ft mutant 
clones show elevated D levels (Mao et al., 2006). Epistasis experiments 
suggested the influence of ft on growth depended entirely on d, therefore placing 
d downstream of ft (Cho et al., 2006; Feng and Irvine, 2007). When uninhibited 
by Ft, D promotes Yki activity to stimulate growth (Cho et al., 2006; Feng and 
Irvine, 2007; Mao et al., 2006).  
As with PCP, the key proteins Ds and Fj are also involved in regulating growth, 
the interactions between these genes playing a key part in this regulation (Clark 
et al., 1995; Villano and Katz, 1995). However, the regulation of growth by Ft 
does not entirely depend on Ds, as ft mutants have more severe growth defects, 
and these mutants can be rescued by a form of Ft which cannot bind Ds, therefore 
Ft has functions in growth independent of Ds (Matakatsu and Blair, 2006). 
Additional Fat pathway interacting proteins exist to modulate growth through 
Hippo signalling. The CK1 family member discs overgrown (dco) also regulates 
tissue growth, at least in part through Fat-Hippo signalling by phosphorylating the 
cytoplasmic domain of Ft (Cho et al., 2006; Feng and Irvine, 2009; Sopko et al., 
2009). Normal levels of Ft and Ds require the gene lowfat (lft) (Mao et al., 2009), 
while stability and localisation of D is regulated by the E3 ligase FbxL7, which 
may also affect Ft and Ds (Bosch et al., 2014; Rodrigues-Campos and 
Thompson, 2014). Recently, CG10933 named Dachs Ligand with SH3s (Dlish) 
by Zhang et al., or Vamana (Vam) by Misra et al. was intricately involved in 
regulating Fat pathway activity (Misra and Irvine, 2016; Zhang et al., 2016). These 
studies identified that Dlish/Vam promotes localisation of D to the subapical 
region, which is essential for its inhibition of Wts (Misra and Irvine, 2016; Zhang 
et al., 2016). The localisation of D is depend on the palmitoylation of Dlish/Vam 
by the palmitoylatransferase Approximated (App), which had previously been 
shown to regulate both PCP and growth (Matakatsu and Blair, 2008; Zhang et 
al., 2016). Ft also interacts and inhibits App activity reducing D membrane 
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localisation and thus providing a mechanism for Ft-dependent inhibition of growth 
(Zhang et al., 2016). Furthermore, App negatively regulates Ft through direct 
palmitoylation antagonising the function of Dco, and simultaneously stimulates D 
function by driving its subapical localisation through palmitoylation of Dlish/Vam 
(Matakatsu et al., 2017; Zhang et al., 2016). Most of the components discovered 
to regulate growth in the Fat pathway appear to act downstream of Ft, however 
the WD40 protein Riquiqui (Riq) and the kinase Minibrain (Mnb) act downstream 
of Ds. Riq acts as a scaffold for Mnb, which phosphorylates and inactivates Wts 
to inhibit Hippo signalling (Degoutin et al., 2013). 
While it is clear that the components listed above regulate Fat and Hippo 
signalling, how they act mechanistically remains somewhat unclear. A recent 
study, which analysed the conformational status of Wts suggested that, unlike 
many proteins, which regulate the kinase activity of the Hippo pathway and Wts, 
Ft/Ds regulate Wts conformation (Vrabioiu and Struhl, 2015). Ft/Ds activity 
promotes a closed and inactive conformation of Wts. This effect of Ft/Ds seems 
to be entirely dependent on the function of D, and directly antagonises the effect 
of Mats, which promotes the allosteric transition of Wts to an open, active 
confirmation (Vrabioiu and Struhl, 2015). 
However, the mechanisms that convert the cellular distribution of these PCP 
proteins into orientation of polarisation are not well defined, moreover, how this 
regulates coordinated growth also remain mysterious (Matis and Axelrod, 2013). 
Interestingly, it has been reported that Fat signalling is regulated by morphogen 
gradients (Lawrence and Struhl, 1996; Rogulja et al., 2008). The morphogen Dpp 
is able to define the polar localisation of D within cells, which is important in the 
regulation of Fat and Hippo signalling (Rogulja et al., 2008). Intriguingly, a 
contemporary report suggested that differences in concentration of Ft/Ds 
between cell boundaries regulates Fat and Hippo signalling, defining a cell-
communication based mechanism of growth regulation (Willecke et al., 2008), 
which is consistent with the potential of Fat signalling to respond to positional 
signals defined by morphogen gradients. In an alternative model, Fat signalling 
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promotes incorporation of cells into the wing pouch, thus driving imaginal disc 
growth (Zecca and Struhl, 2010). This process is dependent on the steepness of 
the Ds/Fj expression gradient, which is at its maximum at the edge of the pouch, 
and Hippo signalling. This model is dependent on another morphogen Wg, and 
thus multiple morphogenetic signals may feed into the Fat and Hippo pathways 
to help define the overall tissue size (Zecca and Struhl, 2010). However, the 
morphogenetic control of Fat and Hippo signalling remains controversial, as Ds/Fj 
expression gradients, and D polarised localisation are maintained when Dpp is 
expressed uniformly throughout the disc, suggesting Dpp and Fat work in parallel 
to regulate growth, rather than sequentially (Schwank et al., 2011).  
1.3.11. Basolateral Polarity, Junctions and Hippo Signalling 
Mutations in Hippo pathway genes cause ‘hyperplastic’ tumours, that is, tumours 
which extensively proliferate, at a faster rate than wildtype cells, but that retain 
normal morphology and ultimately differentiate into adult tissues (Bilder, 2004). 
The original class of Drosophila tumour suppressors form ‘neoplastic’ tumours, 
where the overproliferative tumours lose all morphological characteristics and are 
incapable of terminal differentiation (Bilder, 2004). Interestingly, in most cases, 
these tumours do not proliferate at a faster rate than wildtype cells, but rather do 
not stop growing (Hariharan and Bilder, 2006). Three junctional proteins Lgl 
(Bridges and Brehme, 1944; Gateff and Schneiderman, 1974), Dlg (Stewart et 
al., 1972) and Scrib (Bilder et al., 2000) were all defined as neoplastic tumour 
suppressors (Hariharan and Bilder, 2006). These genes are required for 
embryonic development, however large maternal contribution facilitates 
development until late larval stages. By this point, proliferative tissues such as 
imaginal discs and the nervous system are dramatically disrupted, and animals 
do not pupate (Bilder, 2004; Hariharan and Bilder, 2006). lgl, dlg and scrib 
genetically interact and are important in the establishment and maintenance of 
apicobasal polarity. Dlg and Scrib are localised primarily to the septate junctions 
on the basolateral membrane, whereas Lgl localisation depends on its 
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phosphorylation status, being excluded from the apical region by aPKC-mediated 
phosphorylation (Bilder, 2004; Hariharan and Bilder, 2006; Humbert et al., 2008).  
One method these basolateral genes use to regulate growth is through Hippo 
signalling, although lgl and scrib appear to have distinct mechanisms of 
regulation. In the case of lgl, there appear to be tissue-specific means of 
regulating yki. In the eye epithelium, overgrowth associated with lgl knockdown 
is highly sensitive to levels of Yki. 
Partial RNAi-mediated knockdown of lgl not strong enough to disrupt apicobasal 
polarity is associated with increased aPKC activity. This disrupts Hpo localisation, 
increasing Yki-mediated transcription, although the mechanism by which Hpo is 
mislocalised remains unclear (Grzeschik et al., 2010). Therefore, Lgl promotes 
Hippo pathway activity by preventing Hpo mislocalisation. However, in the wing, 
where lgl knockdown was strong enough to cause loss of polarity, activation of 
Yki requires JNK signalling. Moreover, in this context, aPKC indirectly activates 
Yki in a seemingly JNK-dependent manner (Richardson and Portela, 2017; Sun 
and Irvine, 2011).   
In addition, lgl loss or aPKC activation causes the mislocalisation of the 
Drosophila Ras Associated Family (Rassf) tumour suppressor away from the cell 
junctions (Grzeschik et al., 2010). Rassf antagonises Hippo signalling by 
perturbing the interactions between Hpo and Sav (Polesello et al., 2006), and by 
recruiting the Stratin Interacting Phosphatase and Kinase (STRIPAK) 
phosphatase complex, to promote Hpo dephosphorylation, inactivation and Yki-
mediated transcription (Ribeiro et al., 2010). Therefore, it was originally 
postulated that mislocalisation of Rassf and Hpo may facilitate the Rassf-
mediated disruption of the interaction between Hpo and Sav and, thus, lead to 
Hippo pathway inactivation (Grzeschik et al., 2010).  However, a subsequent 
study revealed that the STRIPAK complex is also mislocalised in lgl mutant 
tissue, and suggested that the activity of Rassf and the STRIPAK complex in this 
context was not functionally significant to Yki activation (Parsons et al., 2014). 
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Therefore, Yki-mediated tissue overgrowth induced by lgl disruption is dependent 
on the mislocalisation of Hpo, which is dependent on aPKC activation.   
In the case of scrib mutation, the regulation of the Hippo pathway is more 
complex. As with lgl mutations, strong RNAi-mediated knockdown of scrib, 
sufficient to disrupt apicobasal polarity, results in Yki-associated tissue 
overgrowth in the eye imaginal disc (Doggett et al., 2011). Moreover, when an 
entire tissue is mutant for scrib, Yki is activated resulting in tissue overgrowth 
(Chen et al., 2012). However, unlike the situation of lgl mutation, this requires 
aPKC but not JNK signalling (Doggett et al., 2011). However, when scrib mutant 
clones face competition from surrounding wildtype cells, which normally cause 
the mutant clones to be eliminated due to increased cell death mediated by JNK 
signalling (Brumby and Richardson, 2003). This elevated JNK signalling also 
inhibits the scrib clone from overproliferating by inhibiting Yki, artificial increase 
of Yki within the scrib clones being sufficient to rescue the clones from 
elimination, resulting in neoplastic growth (Chen et al., 2012). Therefore, in this 
situation, JNK inhibits Yki activity.  
Recently, the switch in function of JNK to promote or inhibit Yki signalling has 
been more thoroughly elucidated. During tissue homeostasis JNK appears to 
inhibit Yki, as overexpression of the Tumour Necrosis Factor (TNF) ligand eiger 
(egr), which stimulates JNK signalling, inhibits tissue overgrowth induced by yki 
overexpression. Thus JNK acts in an anti-tumorigenic manner (Enomoto et al., 
2015). This inhibition of yki occurs at the level of wts, as overexpression of eiger 
does not suppress tissue overgrowth induced by wts mutation, unlike with hpo, 
where egr overexpression inhibits clonal overgrowth cause by hpo mutation, 
although the precise mechanism of Wts activation is unclear (Enomoto et al., 
2015).  
The switch to promote JNK into pro-tumorigenic activator of Yki, seen with scrib 
and lgl mutation may be influenced by several mechanisms, one key route being 
the hyperactivation of Ras (Enomoto et al., 2015; Yamamoto et al., 2017). In the 
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presence of hyperactive Ras, mediated by an increase in EGFR signalling, JNK 
enhances Yki activity through an increase in F-actin levels, which inhibits Wts 
(Enomoto et al., 2015; Yamamoto et al., 2017). This process may also involve 
the gene ajuba LIM protein (jub), which localises to AJs. Jub is an inhibitor of 
Hippo signalling, interacting with Wts and Sav to inhibit the phosphorylation of Yki 
(Das Thakur et al., 2010; Enomoto et al., 2015; Sun et al., 2015). The inhibition 
of Hippo signalling by Jub is regulated by tension, as high tension exposes 
binding sites within α-Catenin at the AJs, promoting Jub binding and Wts 
inhibition (Rauskolb et al., 2014). Further study in Drosophila and mammals 
revealed that jub is activated by JNK to promote inhibition of wts and therefore 
activate yki (Sun and Irvine, 2013). The mechanisms by which the neoplastic 
tumour suppressors regulate growth remains a complex issue, with context 
dependent regulation of Hippo signalling through JNK and aPKC.  
In addition to the described basolateral and junctional proteins that regulate the 
Hippo pathway, the adhesion protein Echinoid (Ed), which is a component of the 
AJs, stimulates Hippo signalling (Yue et al., 2012). Ed interacts with Sav 
promoting its stability thus enhancing Hippo signalling and Yki inhibition. 
Moreover, the localisation of Ed appears to be important in forming a Hippo 
signalling complex at the border between AJs and the apical membrane, 
antagonising the more basal Jub (Sun et al., 2015).  
It is clear that polarity is a key regulator of Hippo signalling, with the basolateral 
membrane crucially modulating activity of Yki. The role of the apical domain, with 
a focus on the Crb complex will be thoroughly discussed below. 
1.3.12. The Crumbs Complex 
Crb was initially described as an apically localised protein responsible for the 
establishment and maintenance of cell polarity (Tepass et al., 1996; Tepass and 
Knust, 1993; Tepass et al., 1990; Wodarz et al., 1993). Mutant embryos for crb 
show multiple holes in the cuticle, which look like crumbs, hence the gene name 
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(Jurgens et al., 1984). Crb is expressed in almost all tissues, with the exception 
of the intestine (Tepass and Knust, 1990), and once polarity is established Crb is 
required for its maintenance in most epithelial tissues, with the exception of late 
embryonic epidermis, larval imaginal discs and early malpighian tubule 
development (Campbell et al., 2009; Pellikka et al., 2002; Tanentzapf and 
Tepass, 2003; Tepass, 2012). Crb forms a complex with Sdt (Bachmann et al., 
2001; Hong et al., 2001), Veli (also known as Lin7) (Bachmann et al., 2008b; 
Bachmann et al., 2004) and Patj (formerly Discs Lost) (Bhat et al., 1999). 
Mutations in sdt are smiliar to that of crb and cause severe polarity defects in the 
embryo (Bachmann et al., 2001; Hong et al., 2001), whereas mutations in veli do 
not have obvious polarity defects (Bachmann et al., 2008a) and null mutations in 
patj do not display embroyic polarity defects, rather cause polarity defects in 
specific tissues, such as the follicular epithelia (Penalva and Mirouse, 2012; Zhou 
and Hong, 2012). 
Structurally, Crb consists of a large extracellular sequence containing epidermal 
growth factor (EGF)-like repeats and Lamin AG-like domains, a single-pass 
transmembrane domain, and a relatively short intracellular domain consisting of 
only thirty seven amino acids (Bulgakova and Knust, 2009). This intracellular 
region contains two conserved protein binding domains, a FERM-Binding Motif 
(FBM) and a PDZ-Binding Motif (PBM), which are responsible for many of the 
known functions of Crb (Figure 1-3B) (Tepass, 2012). Overexpression of a crb 
construct containing the transmembrane and intracellular domains (Crbi) is able 
to recover the lethality of crb mutant embryos, and cuticle patterning to the same 
extent as overexpression of full length Crb (Klebes and Knust, 2000; Wodarz et 
al., 1995). Rescue of the crb mutant relies on the function of both the FBM and 
the PBM motifs (Klebes and Knust, 2000). This small intracellular domain is 
responsible for a large number of binding interactions, including the Crb complex 
member Sdt, which acts as a scaffold for many interaction partners, and the other 
apical determinants aPKC and Par6 (Bachmann et al., 2001; Hong et al., 2001; 
Kempkens et al., 2006; Sotillos et al., 2004). The interaction with Par6 is crucial 
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in aiding the exclusion of Baz, a component of the AJs, from the apical region 
(Morais-de-Sa et al., 2010; Walther and Pichaud, 2010).  
While most of the known functions of Crb have been ascribed to the small 
intracellular domain, the function of the extracellular domain has remained 
relatively elusive. However, several pieces of evidence now suggest that the 
extracellular domain of Crb is more important than originally thought, and is 
involved in the formation of homophilic interactions in cis and trans (Thompson 
et al., 2013). When analysing Drosophila morphogenesis, neither the 
extracellular or intracellular domains of Crb were sufficient to rescue overgrowth 
induced by crb mutation, only a crb construct containing both of these sequences 
was able to recover this phenotype, alluding to a role for the extracellular domain 
of Crb (Richardson and Pichaud, 2010). Moreover, if Crbi is overexpressed in 
follicle cells, it is unable to localise apically, and rather localises in endosomes 
(Fletcher et al., 2012). Moreover, a Crb construct consisting of wildtype 
extracellular Crb, but where the intracellular domain has been replaced with 
Green Fluorescent Protein (GFP), is able to localise to the apical membrane only 
in the presence of wildtype Crb, but not in the context to crb mutations. These 
data suggest the extracellular domain of Crb is vital to the stabilisation of Crb at 
the apical surface, and forms Crb-Crb homophilic interactions in cis (Fletcher et 
al., 2012; Letizia et al., 2013).  
Evidence for homophilic interactions in trans comes through analysis of Crb, and 
Crb complex members at crb mutant clone boundaries. Crb protein is lost in the 
cell membrane directly in contact with crb mutant clone tissue, but remains on the 
cell membrane when in contact with surrounding wildtype cells (Hafezi et al., 
2012; Pellikka et al., 2002), which is also true for the Crb binding partners Ex and 
Patj (Chen et al., 2010). These data suggest that Crb interactions in trans are 
essential for its correct localisation. This conclusion is also supported by data 
obtained in zebrafish, where the crb orthologues crb2a and crb2b form trans-
dimers to function as cell adhesion molecules (Zou et al., 2012).  
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In addition to its role in polarity, crb is also involved in regulation of tissue growth. 
This was originally described to be the result of Notch regulation, with Crb acting 
in a negative feedback loop to repress the γ–Secretase complex, which activates 
Notch signalling (Herranz et al., 2006), or through regulation of Notch (N) and/or 
Delta (Dl) endocytosis, thereby inhibiting the pathway (Richardson and Pichaud, 
2010). More recently, endocytosis of Notch has been described to be inhibited by 
extracellular interaction between Notch and Crb, therefore limiting ligand-
independent Notch activity (Nemetschke and Knust, 2016).  
Crb also regulates growth through Hippo signalling by regulating Ex. The FBM of 
Crb is able to interact with the FERM domain of Ex, and is essential in regulating 
the apical localisation of Ex (Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 
2010; Robinson et al., 2010). The localisation of Ex appears to be important for 
stimulating Hippo signalling, as many members of the Hippo pathway are apically 
localised, forming a hub of signalling culminating in the inhibition of Yki (Genevet 
and Tapon, 2011; Sun et al., 2015). Indeed, the core Hippo kinases Hpo and Wts 
have been proposed to actively relocalise upon Hippo pathway stimulation, to 
Crb-positive regions within the wing disc epithelia, triggering Yki inhibition (Sun 
et al., 2015). In tissues mutant for crb, the Yki target genes diap1, ex and cycE 
are upregulated, coinciding with excess proliferation and overgrowth. Moreover, 
in crb mutant tissue, Ex is incorrectly localised away from the apical membrane, 
and is dispersed throughout the cytosol (Chen et al., 2010; Grzeschik et al., 2010; 
Ling et al., 2010; Robinson et al., 2010). These data are consistent with the model 
whereby Crb regulates the Hippo pathway by regulating the apical localisation of 
Ex, aiding the formation of an apically active Hippo signalling hub, inhibiting Yki 
through Wts-dependent and -independent means (Chen et al., 2010; Grzeschik 




Figure 1-3 Ex and Crb protein architecture 
Schematic representation of the domains and motifs within Ex (A) and Crb intracellular domain 
(B). Ex contains a FERM domain, two Slmb Binding Domains (SBD), three PPxY motifs and 
the circled P representing a Wts phosphorylation site at S1116 (Badouel et al., 2009; Ribeiro 
et al., 2014; Zhang et al., 2015a) (A). Architecture of Crb shows the transmembrane domain 
(TM) and the 37 intracellular amino acids, which includes the FERM Binding Motif (FBM) and 
the PDZ Binding Motif (PDM) both highlighted (Tepass, 2012) (B). 
 
In addition to the regulation of Ex localisation to promote Hippo signalling, Crb 
also has a role in negatively regulating the Hippo pathway. Overexpression of 
Crbi results in tissue overgrowth, and this effect is dependent on the FBM, but not 
on the PBM of Crb (Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; 
Robinson et al., 2010). This Crbi-mediated overgrowth is also associated with an 
increase in Yki target gene expression, and is dependent on the Hippo pathway 
components sav and yki. This initially puzzling discovery, in direct contrast to crb 
mutant phenotypes, lead to the identification that Ex is highly sensitive to levels 
of Crb, with excess Crb promoting Ex degradation (Chen et al., 2010; Grzeschik 
et al., 2010; Ling et al., 2010; Robinson et al., 2010). Interestingly, Crb 
overexpression induces Ex phosphorylation through an undefined kinase (Ling et 
al., 2010). The Crb-mediated phosphorylation of Ex stimulates recognition of an 
N-terminal phosphodegron sequence by the E3 ligase Slmb, which ubiquitylates 
Ex resulting in its proteasomal degradation (Ribeiro et al., 2014). The 
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identification of the kinase responsible for the degradation of Ex, and the potential 
reversal of Ex ubiquitylation provide the main focus of this thesis (Figure 1-4). A 
recent study shows that slmb regulates ex in multiple ways, and that, as well as 
recognising an N-terminal phosphodegron sequence of Ex, Slmb also recognises 
a C-terminal degron sequence (Zhang et al., 2015a). This study proposes that 
the C-terminal Slmb degron of Ex is inhibited by Wts phosphorylation, which 
stabilises Ex. However, this Wts-dependent mechanism of Ex regulation appears 
to be independent of Crb-mediated Ex degradation and, in fact, seems to be 
superseded by it, as Wts overexpression is unable to rescue Crb-mediated Ex 
degradation (Zhang et al., 2015a).  
Therefore, it seems that Crb activity acts as a rheostat for Hippo signalling. Crb 
is involved in Hippo pathway activation through the control of Ex localisation, but, 
it is simultaneously involved in switching off the pathway, through the regulation 
of Ex stability. This potentially acts as a highly precise mechanism for regulating 
tissue growth, although the physiological conditions whereby Crb stimulates Ex 
degradation remain to be determined. 
The complexity of Crb-mediated regulation of Hippo pathway has been increased 
through a recent study analysing the localisation of Hippo pathway components. 
Su et al. suggest that, in addition to inhibiting the Hippo pathway through 
promoting Ex degradation, Crb can also block Hippo signalling by inhibiting Kib 
and Mer (Su et al., 2017). This study suggests that Kib and Mer activate the Hippo 
pathway at the medial cell cortex independently of Ex, rather than at the cell 
junctions as previously assumed, although the authors suggest this may be tissue 
or context dependent. At this medial cortex, Kib promotes formation of a 
Kib/Mer/Sav/Hpo/Wts complex promoting Hippo signalling (Su et al., 2017).  
Although evidence for the functionality of this complex is somewhat lacking, 
overexpression of Kib in the presence of RNAi-mediated depletion of crb results 
in wing undergrowth. This is in contrast to crb depletion alone, which causes wing 
overgrowth, and kib overexpression alone, which causes only a mild wing 
undergrowth. This suggests that Crb is able to repress the full functionality of Kib 
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with regards to Hippo signalling, however more work needs to be done to 
ascertain the importance of this medial cortex signalling platform (Su et al., 2017). 
The regulation of Ex localisation and stability by Crb, as well as the regulation of 
Kib activity, appears to provide a very intricate and subtle means for dynamic 
regulation of the Hippo pathway. 
Interestingly, the most highly homologous crb orthologue in mammals CRB3 
(Karp et al., 2008) also regulates Hippo signalling. CRB3 is able to sense cellular 
density, and modulates YAP activity accordingly, through indirect interaction with 
AMOT (Varelas et al., 2010). The interaction of CRB3 with AMOT facilitates 
inhibition of YAP at cellular junctions through PPxY:WW domain interactions, 
siRNA mediated knockdown of CRB3 resulting in activation of YAP/TAZ (Varelas 
et al., 2010). In this context, regulation of YAP/TAZ physically interact with 
SMAD2/3, CRB3-mediated inhibition of YAP/TAZ therefore also inhibiting 
SMAD2/3 nuclear translocation (Narimatsu et al., 2015; Varelas et al., 2010). 
CRB3 also has a role in promoting differentiation in airway epithelia, which is 
dependent on LATS1/2 phosphorylation and inhibition of YAP (Szymaniak et al., 
2015). The most likely regulatory mechanism employed by CRB3 to regulate 
Hippo signalling is through AMOT, which is functionally analogous to Ex.  
The regulation of Hippo signalling by the apical polarity determinant Crb is 
becoming increasingly complex, both activating and repressing Yki-mediated 
transcription. The focus of this thesis will be the further characterisation of these 
intricate biochemical mechanisms.  
1.3.13. The Physiological Relevance of Hippo Signalling 
The initial discovery of Hippo signalling as a growth suppressive pathway led 
many of its mechanisms and components to be analysed in this context, as 
regulators of growth. In this capacity, it is increasingly apparent that the Hippo 
pathway is involved in cancer. Initial transgenic expression of YAP in the mouse 
liver resulted in tumourigenesis highlighting the potential for the Hippo pathway 
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to regulate cancer (Dong et al., 2007). Moreover, enrichment of nuclear YAP/TAZ 
is associated with a wide variety of human cancers in including lung, colorectal, 
liver, gastric, pancreatic and glioma (Harvey et al., 2013; Yu et al., 2015b; 
Zanconato et al., 2016). Intriguingly, despite a vast amount of evidence 
suggesting LATS1/2 are the major regulators of YAP activity, there are very few 
cancers that contain inactivating mutations in these genes, which is inconsistent 
with the idea that these kinases are the dominant regulators of YAP activity 
(Harvey et al., 2013; Zanconato et al., 2016). Indeed, LATS has even been shown 
to promote tumourigenesis by inhibiting the immune system from targeting 
tumour cells (Moroishi et al., 2016). It therefore seems likely that in cancer, Hippo 
pathway/LATS-independent mechanisms may contribute to the activity of YAP 
and thus tumourigenesis (Harvey et al., 2013; Zanconato et al., 2016). 
It is becoming increasingly apparent that, as well as regulating growth during 
development, the Hippo pathway is also important in the regulation of 
differentiation, and in response to numerous stress signals. The upstream 
pathway members described, such as polarity, mechanical sensing and 
metabolic inputs all facilitate the response of Hippo signalling in normal 
physiology.  
Hippo signalling regulates stem cell maintenance in numerous tissues, such as 
the intestine, liver, the nervous system and even human embryonic stem cells 
(Camargo et al., 2007; Cao et al., 2008; Imajo et al., 2015; Varelas et al., 2008; 
Yimlamai et al., 2014). In general terms, YAP/TAZ are expressed in 
progenitor/stem cell populations, and are important in regulating the proliferation 
and differentiation of these cells. In this context, the Hippo pathway appears to 
be important in inactivating YAP/TAZ in differentiated cells to maintain 
quiescence (Yu et al., 2015a; Zhou et al., 2009). The sensitivity of 
progenitor/stem cells to YAP activity is crucially important in response to injury, 
and highlights a key role of physiological Hippo signalling in promoting 
regeneration (Cai et al., 2010; Gregorieff et al., 2015; Taniguchi et al., 2015).  
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The role of Hippo signalling in regeneration is conserved from Drosophila to 
mammals. In the wing imaginal discs, Yki is hyperactivated upon injury, and is 
necessary for regeneration of the tissue (Grusche et al., 2011; Sun and Irvine, 
2011), which is also true in the Drosophila intestine, where Yki regulates intestinal 
stem cell proliferation to replace dead or damaged cells (Karpowicz et al., 2010; 
Ren et al., 2010a; Shaw et al., 2010; Staley and Irvine, 2010). In mammalian cell 
culture, wounding drives YAP activation, which leads to the induction of a 
transcription programme stimulating expression of genes such as Connective 
Tissue Growth Factor (CTGF) that promote wound healing (Lee et al., 2014; 
Sisco et al., 2008; Zhao et al., 2007; Zhao et al., 2008).  
In addition to responding to injury, Hippo signalling is important in responding to 
other situations of cellular stress. Studies of MST1/2 prior to the delineation of 
Hippo signalling showed these kinases are activated in response to toxic sodium 
arsenite or heat shock (Taylor et al., 1996). Some early studies also suggested 
MST1/2 were cleaved by caspases to promote apoptosis (Graves et al., 2001; 
Lee et al., 2001). Moreover, oxidative stress promotes MST activation, inducing 
apoptosis (Lehtinen et al., 2006) and stress induced by extra chromosomes 
stimulates LATS activity (Ganem et al., 2014). In Drosophila, the MST orthologue 
Hpo is activated by p53 in response to DNA damage (Colombani et al., 2006) 
highlighting the conservation of Hippo pathway responses to stress.  
As previously discussed, the Hippo pathway responds to metabolic inputs, with 
low energy states stimulating Hippo signalling. This suggests that upon metabolic 
stress, Hippo signalling may be activated to limit proliferation and growth (DeRan 
et al., 2014; Mo et al., 2015; Wang et al., 2015b). In contrast to oxidative and 
metabolic stress, hypoxia appears to activate YAP/TAZ, stimulating the E3 ligase 
SIAH2 to degrade LATS, in a process that seems to involve the junctional protein 
Zyxin (Ma et al., 2015; Ma et al., 2016). It has also recently been reported that 
Hippo signalling in the Drosophila fat body is important for the response to 
infection by Gram-positive bacteria. In this instance, the Toll-pathway activates 
Hpo, thus inhibiting Yki. This limits the transcription of the Toll-response inhibitor 
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Cactus (Cact), thus promoting the Toll-pathway to produce antimicrobial peptides 
(Liu et al., 2016).  
1.3.14. Aim – To Study the Relationship Between Crumbs and Expanded 
in the Regulation of Hippo Signalling 
The Hippo pathway is a critical regulator of development, and is increasingly 
associated with tumourigenesis (Harvey et al., 2013; Yu et al., 2015b; Zanconato 
et al., 2016). However, many of the detailed interactions that define this complex 
signalling network remain undefined. This study aimed to address the precise 
mechanism by which the apical polarity determinant Crb acts as an upstream 
regulator of Hippo signalling to control the localisation and stability of Ex, a critical 
regulator of growth in Drosophila. This work has predominantly focused on the 
identification of a kinase (see ‘Results 2 – Candidate Kinase Screen to Identify 
Regulators of Expanded Stability’), and to a lesser degree a DUB (see ‘Results 4 
– The Reversibility of Expanded Degradation’) responsible for regulating Ex 
stability downstream of Crb (Figure 1-4). Furthermore, this study has attempted 
to define DUBs that control growth through interaction with ex, and could 
therefore act as novel members of the Hippo pathway (see ‘Results 5 – A Screen 




Figure 1-4 A model of Crb-mediated regulation of Ex 
During homeostasis, Crb regulates Ex localisation at the apical membrane, but 
can also stimulate Ex phosphorylation and degradation. Crb-mediated 
phosphorylation occurs through an unidentified kinase, triggering recognition 
by the E3 ligase Slmb. Subsequent ubiquitylation should be reversible through 




 Materials and Methods 
 Molecular Biology 
2.1.1. Polymerase Chain Reaction 
DNA fragments were amplified from plasmid DNA, genomic DNA or cDNA 
templates using oligonucleotide primers flanking the region of interest. Typically, 
Polymerase Chain Reaction (PCR) reactions were carried out in 20-50 µL 
reaction volumes and the Pwo Master-mix® (Roche) was used as DNA 
polymerase cocktail. PCR reactions were typically carried out as follows: (1) Initial 
denaturing - 95oC for 2 minutes (mins); (2) Melting – 95oC for 30 seconds (s); (3) 
Annealing –usually between 55-65oC for 30 s, at a temperature typically 5oC 
below the theoretical Tm of the primers used; (4) Extension - 72oC for 1min/kb 
amplicon. PCR reactions were performed with 30 cycles of steps (2)-(4) and were 
kept at 4oC for immediate use, or at -20oC. See below for a list of the 
oligonucleotide primers used for PCR: 
 
Table 2-1 List of PCR oligonucleotides
 
Primer name Primer sequence
pENTR cloning primers – Primers contain BP recombinase recognition sequence:
F: GGGGACAAGTTTGTACAAAAAAGCAGGCTCTACC 
R: GGGGACAAGTTTGTACAAAAAAGCAGGCTCTACC  
CG2577 F GAACGACTGCGCTCCTCCCAA 
CG2577 R CGGCCAGAAGTTGCACTTCTCA 
CG7094 F GCAAAACAAGAAGCAACAAATGGG 
CG7094 R CTTTCGCTTGCTAATGCCTCCATC 
CG9962 F AACGACTACGAACTGGAAACCATG 
CG9962 R GACGACCTTTTTCACCACCACCC 
CG12147 F GCGGAACGGGAAAAGGGGCG 
CG12147 R AAGACAGGGCATCTGAGGGGA 
Dnt F ATGGAATCTGTGAATAAATGCGGTAAAAG 
Dnt R GACATAGCGCGTGATTTGTGAATAG 
Sax F GAGCTCTCCTCCGCCTCATC 
Sax R AACGCAGACCTCGTCGAAGTCCAGGC 
Tkv F GCGCCGAAATCCAGAAAGAAG 







Ex F ATGCGAGCATTTTGCACCGTCAGCGC 
Ex1-450 CAAX R 
TTTCGAGCTCATGCAGCCAGGACCACTCTCATCGGGTGGGT
TCAGTTTGTTGGAGCTGGTACTCGAGATAAC 
GishisoF F ATGCGAGCATTTTGCACCGTCAGCGC 











2.1.2. Agarose Gel Electrophoresis 
DNA was analysed and/or purified by electrophoresis in 0.8-1% agarose gels in 
40 mM Tris Acetate, 1 mM EDTA (TAE) solution (Sigma) containing 1% GelRed 
(Biotium) for 45 mins at 100 V. QIAquick Gel Extraction KitTM (Qiagen) was used 
according to the manufacturer’s protocol to extract and purify DNA from agarose 
gels. Gels were visualised using an Amersham Imager 600 (GE Healthcare) 
chemiluminescence imager.  
2.1.3. dsRNA Synthesis and Purification 
DNA templates for double stranded (ds)-RNA synthesis were generated by PCR 
using specific oligonucleotide primers with a 5’ T7 RNA polymerase recognition 
sequence: TAATACGACTCACTATAGGG. Synthesis of dsRNA was performed 
using the Megascript T7 kit® (Ambion) according to the manufacturer’s protocol. 
Briefly, reaction mixtures containing manufacturer defined volumes of PCR 
product as a DNA template, reaction buffer, ATP, CTP (Cytidine Triphosphate), 
GTP (Guanosine Triphosphate), UTP (Uridine Triphosphate), T7 enzyme and 
water were incubated at 37oC 12 hours (h). Reaction mixture was then treated 
with DNase I for 15 mins at 37oC to degrade unwanted DNA, and subjected to an 
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annealing step as follow: (1) 70oC for 10 mins (2) Ramp temperature down to 
25oC at 2.50C /s (3) hold at 25oC for 25 s (4) Maintain at 10oC for 5 mins (5) repeat 
steps (1)-(4). Precipitation and purification of dsRNA was performed using the 
LiCl2 method (Barlow et al., 1963): After addition of 2x volume of RNase-free 
water, 0.1x volume of 5M LiCl2 (Sigma) was added to the dsRNA product. 
Precipitation of the dsRNA was performed by adding 3x volume of 100% ethanol 
and incubating at -20oC for 20 minutes, before centrifugation at 13000 revolutions 
per minute (rpm) for 10 mins. After removal of the supernatant, 0.5 mL of 80% 
ethanol was added to the pellet and spun down at 13000 rpm for 5 mins. The 
dsRNA pellet was then air dried and dissolved in RNase-free water. See below 
for a list of the oligonucleotide primers used for dsRNA synthesis: 
 
Table 2-2 List of dsRNA synthesis oligonucleotides
 
Primer name Primer sequence
dsRNA synthesis primers – Primers contain T7 5’ recombinase recognition sequence: 
TAATACGACTCACTATAGGG  
 
aPKC F GCGTGCTTTCTGTGCCTACTG 
aPKC R GTTGATCACCTTCATGGCGTA 
dnt F  GAGGACTTCGAGCTTTCAGAGACTA 
dnt R AGAACATCCTGAGTGTCGTTGTAG 
eph F GATTTTAAACTGGACCCACAAACAC 
eph R TAATGACATTCTCGAAACAATTTGA 
gish F TGGCCAAAGAATACATTGATTTAGA 
gish R GGCAGTGAACCCCTTAAGAAATAC
gprk21 F ACATCAATCACAAGAAGCTGGAC 
gprk21 R AAAATACATAGAGCTCTCAAACTCCC 
gprk22 F AGCGTTGGACGATAGATGTTCTAGT 
gprk22 R GAACCTTCGGCAACTTAAACTTAG 
hpo F CTGTGTGGCAGACATATGGT 
hpo R CTCATCCACACCTTGCTCT 
hppy F GCGAAACGAATACAGAGCAA 
hppy R CACATGTACGCGATCTGGAC 
lacZ F TTGCCGGGAAGCTAGAGTAA 
lacZ R CCTTCCTGTTTTTGCTCAC 
mnb5_1 F GTCACTGGGCTGCATCTTG 
mnb5_1 R GATCCTGGCGGCTTGTACT 
mnb11_1 F CAAATTGGCTGCCAGCAT 
mnb11_1 R GAACCATCAGCACATTGCC 
msn11_1 F GATCGGGAAGTGCTAGTGGTAG 
msn11_1 R ATAAATGCTGTTCCTTTGGTACACT 
msn13_1 F TTACTAATCTCTTGCACAAATCTGCT 
msn13_1 R GATCTAGCAGCATTAAGCCATTCT 
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put F TTTATACGAAAGAAGTCGTGTAAGATG 
put R AGGGCAAAACAAATTGTACGTTAT 
pvr F TTCTGTCCAATCGGTTCTCC 
pvr R CAACGATATCCGACAGGGAT 
sax F CACCATATTGCTACGACATGAAAAT 
sax R GTTCGAGGTGACCAGTATATTCTTT 
slmb F GCACAGGCCTTCACAACCACTATG 
slmb R TGCAGACCAGCTCGGATGATTT 
tkv F CGCTCCCTAACCTGCTACTG 
tkv R AAAACCACCGTTGTCTTCGG 
wts F CACAAAGTGGGACTGCC 
wts R GCAGGGTTTTCATCGCATAC 
  
 
2.1.4. Gateway® Cloning 
Plasmid constructs for cell transfection were generated using the Gateway® 
technology cloning system (Invitrogen). DNA coding sequences were amplified 
by PCR with oligonucleotide primers flanked by 5’ BP Clonase® recombination 
recognition sequences. Amplified coding PCR product was incubated with BP 
Clonase® as per manufacturer’s protocol to generate pENTR® (Invitrogen) 
plasmids. Entry clone plasmids were used in LR Clonase® reactions (Invitrogen) 
to move coding DNA into an expression vector (pDEST) containing a desired 
peptide tag for antibody recognition. The correct integration of coding DNA was 
initially confirmed by DNA restriction digest analysis (see below), followed by 
DNA sequencing. The insert sequence was confirmed by Sanger sequencing 
(Source Bioscience) using pENTR® specific primers (M13F and M13R), pDEST 
specific primers (ActF and SV40R) and gene specific primers. All pENTR and 
DEST vectors contain antibiotic resistance genes for selection. See below for a 
list of the expression plasmids used: 
Table 2-3 List of expression plasmids
 
Plasmid name Gene name
Drosophila actin5C-driven expression
pAHW aPKC aPKC 
pAHW aPKCCAAX aPKC – CAAX sequence 
pAHW aPKCK293W aPKC – kinase dead 
pAHW aPKC293W CAAX aPKC – CAAX sequence / kinase dead 
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pAFW CG10889 CG10889 
pAHW CG10889 CG10889 
pAFW CG10889C154A CG10889 – catalytic mutant 
pAHW CG10889D138N CG10889 – catalytic mutant 
pAFW CG10889Y413A CG10889 – PPxY mutant 
pAHW CG10889 Y413A CG10889 – PPxY mutant 
pAHW CG2577 CG2577 
pAHW CG7094 CG7094 
pAHW CG9962 CG9962 
pAHW CG12147 CG12147 
pAHW CK1α CK1α 
pAHW CK1αK49R CK1α – kinase dead 
pUAS CrbFL Crb – full length - inducible 
pAMW Crbi Crb – intracellular domain 
pAMW CrbiΔFBM Crb – intracellular domain / FBM mutant 
pAHW D D 
pAHW Dco Dco 
pAHW DcoK38R Dco  kinase dead 
pAWV DntisoA Dnt 
pAWF Ex Ex – full length 
pAWV Ex Ex – full length 
pAFW Ex1-468 CAAX Ex1-450 – CAAX sequence 
pAWF Ex1-468 Ex1-468 
pAWV Ex1-468 Ex1-468 
pAFW Ex1-468 CAAX Ex1-468 – CAAX sequence 
pAVW Ex1-468 CAAX Ex1-468 – CAAX sequence 
pAHW FtICD Ft – intracellular domain 
pAW Gal4 Gal4 
pAWH GFP GFP 
pAWF GFP GFP 
pAWM GFP GFP 
pAWV GFP GFP 
pAWH GishisoF GishisoF 
pAWH GishisoF CAAX GishisoF – CAAX sequence 
pAWF GishisoI Gishisoi 
pAWH GishisoI Gishisoi 
pAWH GishisoI K91R Gishisoi – kinase dead 
pAHW Hpo Hpo 
pAHW Mats Mats 
pAWF NTAN NTAN 
pAWV SaxisoB SaxisoB 
pAHW Sgg Sgg 
pAHW SggS9A Sgg – constitutively active 
pAHW SggA81T Sgg – kinase dead 
pAWF Slmb Slmb 
pAWV TkvisoD TkvisoD 
pAHW Ub Ub 
pAFW Usp2isoA Usp2isoA 
pAFW Usp2isoA C540A Usp2isoA – catalytic mutant 
pAFW Usp2isoC Usp2isoC 
pAFW Usp2isoC C622A Usp2isoC –catalytic mutant 
pAWF Wts Wts
pAWH Wts Wts 
pAFW Yki Yki 
pAHW Yki Yki
pAFW Yki1-140 Yki1-140 
pAFW Yki1-300 Yki1-300 
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pAFW Yki1-369 Yki1-369 
pAFW YkiΔWW2 YkiWW2 – WW2 domain mutant 
pAFW Yki ΔWW1+2 YkiWW1+2 – WW 1 and 2 domain mutant 
   
 
2.1.5. DNA Restriction Enzyme Digestion 
Correct integration of desired DNA into pENTR or pDEST vectors was first tested 
by DNA restriction enzyme digest reaction using defined restriction enzyme 
recognition sequences flanking the Gateway® integration sites. 5 µL reactions of 
0.5 µL plasmid DNA, 1 µL appropriate restriction enzyme buffer, 0.3 µL Bovine 
Serum Albumin (BSA, Sigma) and 1 µL total restriction enzyme topped up with 
RNase-free water and incubated at 37oC for 1 h. Double DNA digest contained 
0.5 µL of each restriction enzyme. Agarose gel electrophoresis was performed 
on digested DNA to confirm correct DNA insertion.   
2.1.6. Site-Directed Mutagenesis 
Point mutations were generated using the QuikChange® Multi Site-Directed 
Mutagenesis Kit (Stratagene) according to the manufacturer’s instructions. In 
brief, a reaction mixture containing manufacturer defined volumes of two 
complimentary oligonucleotides containing the relevant point mutation, plasmid 
DNA template and Pwo Master-mix® (Roche) were submitted to the following 
thermocycler programme: (1) Initial denaturing - 95oC for 30 s (2) Melting – 95oC 
for 30 s (3) Annealing – 55oC for 1 min  (4) Extension - 70oC for 1min/kb of plasmid 
length. PCR reactions were performed with 16 cycles of steps (2)-(4) and held at 
10oC. Methylated DNA template was then digested through treatment of 1 µL of 
Dpn I at 37oC for 1 h. Typically, mutagenesis was performed in existing pENTR® 
vectors. Mutagenesis was confirmed by Sanger sequencing. 
2.1.7. Production of Transformation Competent Bacteria 
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Calcium competent bacteria capable of incorporating plasmid DNA were 
amplified from Top10 stock (Thermo Fisher). Top10 stock bacteria were plated 
on an antibiotic free Lysogeny Broth (LB)-agar plate and incubated overnight at 
37oC. A single colony was selected and inoculated with 10 mL LB media and 
incubated overnight at 37oC.  Next, 2 L of LB media was inoculated with 10 mL 
of the started culture and grown at 37oC until the absorbance at 600 nm was 
measured between 0.35 and 0.4 Absorbance Units (AU). Culture was chilled on 
ice for 30 mins and harvested by centrifugation at 3000 g for 15 mins at 4oC. 
Bacterial pellets were resuspended in 200 mL of 4oC MgCl2 (100 mM Sigma) and 
harvested by centrifugation at 2000 g for 15 mins at 4oC. Pellet was resuspended 
in 400 mL of 4oC CaCl2 (100 mM Sigma) and incubated at 4oC for 20 mins. 
Bacteria were harvested by centrifugation at 2000 g for 15 mins at 4oC and 
resuspended in 100 mL of 4oC CaCl2 (85 mM), 15% glycerol. Bacteria were 
harvested by centrifugation at 1000 g for 15 mins at 4oC and resuspended in 4 
mL of 4oC CaCl2 (85 mM), 15% glycerol (Sigma). Bacteria were then aliquoted 
and snap frozen in liquid nitrogen and stored at -80oC.  
2.1.8. Transformation of Competent Bacteria 
Amplification of cloned plasmid DNA was performed through transformation of 
competent bacteria. 0.2-0.5 µL DNA was gently mixed with 5-20 µL competent 
bacteria on ice and incubated for 20 mins, followed by 45 s heat-shock at 42oC 
and 2 min incubation on ice. Transformed bacteria were then incubated with 400 
µL of LB for 1 h at 37oC under shaking, and plated on LB-agar plates overnight 
at 37oC. Plasmids with antibiotic resistance genes were selected in LB-agar 
plates laced with the appropriate antibiotic.  
2.1.9. Plasmid DNA Purification 
Plasmid DNA from transformed bacterial colonies was purified using the 
QIAprep® miniprep (Qiagen) or NucleoBond® midiprep (Macherey-Nagel) kits 
according to the manufacturer’s instructions. 
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2.1.10. Nucleic Acid Quantification 
Nucleic acid concentration was quantified using a Nanodrop 1000 
Spectrophotometer (Thermo Fisher). Quantification in ng/µL uses the Beer-
Lambert equation based on absorbance at 260 nm and the defined extinction 
coefficients for nucleic acids. The purity of the sample was assessed by the ratio 
of sample absorbance at 260 nm and 280 nm. A ratio of approximately 1.8 or 2 
was deemed pure for DNA or RNA respectively.  
2.1.11. Preparation of Protein Lysates 
Drosophila S2 cells were isolated by centrifugation at 1200 rpm for 3 mins and 
lysed in Triton X-100 lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-
100, 10% glycerol and 1 mM EDTA, Sigma) supplemented with phosphatase 
inhibitor cocktails 2 and 3 (Sigma) and protease inhibitor cocktail (Roche) at 4oC. 
Cell lysates were cleared by centrifugation at 13,000 rpm for 12 mins at 4oC. Total 
protein concentration was determined by Bradford assay (Bio-Rad), whereby the 
absorption shift of Coomassie Brilliant Blue upon protein binding was visualised 
at 595 nm, and compared to a BSA protein standard. Lysates were next treated 
with 1:10 sample reducing buffer® (Invitrogen) and 1:4 LDS sample buffer® 
(Invitrogen) and either frozen at -20ºC or -80oC (for short term or long term 
storage, respectively) or denatured at 95oC for 5 mins for Western Blot analysis.  
2.1.12. Protein Co-Immunoprecipitation 
Agarose M2-FLAG beads (Sigma) were pre-washed with lysis buffer described 
in ‘Preparation of Protein Lysates’ and S2 cell lysates were incubated with 30 µL 
of M2-FLAG beads for 1-2 h at 4oC on a rotating wheel, and recovered by 
centrifugation at 4000 rpm. Beads were then washed 3 times for 5 mins in lysis 
buffer and eluted by addition of 80 µL of 150 ng/µL 3xFLAG peptide for 40 mins 
at 4oC on a rotating wheel. FLAG immunoprecipitates were recovered by 
centrifugation at 13000 rpm for 1min, and a mixture of 1:10 sample reducing 
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buffer® (Invitrogen) and 1:4 LDS sample buffer® (Invitrogen) was added to 
samples. Lysates were either frozen at -20ºC or -80oC, or denatured at 95oC for 
5 mins for Western Blot analysis. 
2.1.13. Ubiquitylation Assays 
Ubiquitylation assays were performed on lysates previously transfected with HA-
ubiquitin. Ubiquitylated proteins were isolated via HA-immunoprecipitation. Cells 
were harvested by centrifugation at 1200 rpm for 3 mins and washed with ice-
cold Phosphate Buffered Saline (PBS). 10% of cell material was lysed as 
described in ‘Preparation of Protein Lysates’. The remaining 90% was lysed in 
boiling 1% SDS-PBS for 5 mins at 100oC, vortexed and incubated for a further 5 
mins at 100oC, and lysates were diluted fivefold with 0.5% BSA-1% Triton X-100 
PBS. DNA was sheared by sonication and cell extracts were cleared by 
centrifugation at 13000 rpm for 10 mins at 4oC. HA-agarose beads (Sigma) were 
pre-washed in PBS and incubated with samples diluted twofold with 0.5% BSA-
1% Triton X-100 PBS using Bio-Spin Columns (Bio-Rad) overnight at 4oC on a 
rotating wheel. Subsequently, columns were washed twice with 0.5% BSA-1% 
Triton X-100–PBS and twice with 1% Triton X-100–PBS. HA immunoprecipitates 
were eluted using 75 L 0.2 M glycine pH 2.5 for 30 min at room temperature 
(RT) and the pH of the eluates was adjusted with 7 µL 1 M NH4HCO3 (Sigma). 
Samples were prepared for immunoblot analysis by addition of 1:10 sample 
reducing buffer® (Invitrogen) and 1:4 LDS sample buffer® (Invitrogen) and 
denaturing at 95oC for 5 mins. 
2.1.14. Immunoblotting 
30-40 µg of total protein from cell lysates or 10-15 µL of immunoprecipitated 
sample was loaded into NuPAGE®Novex® 10% or 4-12% Bis-Tris gels 
(Invitrogen) and separated by electrophoresis as per manufacturer’s 
recommendation. Typically, electrophoresis was performed at 4oC for 20 mins at 
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100 V to concentrate the protein at the border between the stacking and resolving 
gel, and subsequently for 1 h at 195 V. 
Proteins were transferred from gels onto Amersham Hybond-P® PVDF 
membranes (GE Healthcare). For the analysis of proteins whose size was less 
than 200 kDa, the transfer took place at 4oC for 100-120 mins at 100 V using 
transfer buffer (25 mM Tris, pH 8, 192 mM glycine and 20% methanol, Sigma). If 
proteins of interest were greater than 200 kDa, transfer took place at 4oC for 14-
16 h at 18 V using transfer buffer (25 mM Tris, pH 8, 192 mM glycine and 10% 
methanol).  
Membranes were then blocked for 30-60 mins in 5% milk in Tris buffered saline 
with 0.1% Tween (TBST) and subsequently incubated with primary antibody 
diluted in 5 mL 5% milk in TBST overnight, or for 1-2 h at RT. Membranes were 
then washed 3 times for 10 mins in 0.1%-TBST before incubation for 1h at RT 
with 5 mL horseradish peroxidase-conjugated secondary antibodies diluted in 5% 
milk in TBST. Membranes were developed by chemiluminescence using ECL 
PLUS® HRP substrate (Pierce). See below for a list of the antibodies used for 
immunoblot analysis: 
 
Table 2-4 List of immunoblot antibodies
 
Primary Antibody  Species Dilution Source 
aPKCsc-216 Rabbit 1:5000 Santa-Cruz 
CrbCq4 Mouse 1:1000 DSHB 
FLAGM2 Mouse 1:5000 Sigma 
HA3F10 Rat 1:2500 Roche 
c-MYC9E10 Mouse 1:2500 Santa-Cruz 
αTubE7 Mouse 1:5000 DSHB 
V5Novex Mouse 1:5000 Invitrogen 
Secondary Antibody  Species Dilution Source 
MouseHRP Sheep 1:5000 Amersham 
RabbitHRP Donkey 1:5000 Amersham 
RatHRP Goat 1:5000 Amersham 




2.1.15. Quantification of Immunoblots 
Densitometric quantification of immunoblots was performed on x-ray films 
scanned using an ‘Epson Perfection V700’ flatbed scanner using the ‘Gel 
Analyzer’ function within ImageJ software. For experiments involving dsRNA 
treatment of S2 cells, quantified Ex levels and Crb levels were normalised to the 
tubulin loading control. The ratio of these normalised values was then calculated 
to account for variablilty in Crb levels. These values were then normalised to the 
mean Ex level for the CrbFBM negative control, which was set to 1 to gain a 
relative level of Ex compared to this negative control. For experiments involving 
kinase overexpression, Ex levels normalised against the tubulin loading control 
were normalised directly against the mean Ex level from CrbFBM negative control, 
which was set to 1 to gain a relative level of Ex compared to this negative control. 
 Cell Culture 
2.2.1. Drosophila S2 Cell Culture 
The Drosophila Schneider S2 cell line used throughout this study is composed of 
semi-adherent cells derived from late stage (20-24 h) embryos and represents a 
macrophage-like lineage (Schneider, 1972). S2 cells were maintained in 
Schneider’s medium® (Invitrogen) supplemented with 10% foetal bovine serum 
(FBS, Invitrogen) and 1% Penicillin/Streptomycin (Sigma). Cells were passaged 
in T75cm2 flasks (Corning) every 2-3 days to a 1:10 dilution. Prior to splitting, cells 
were collected by centrifugation for 3 mins at 1200 rpm and washed with PBS or 
media to remove debris. Frozen cell stocks were stored in liquid nitrogen in a 
7.5% DMSO, FBS or 10% DMSO, FBS solution.  
2.2.2. Transient Transfection of S2 Cells 
For plasmid DNA transfections, cells were seeded in 6-well plates 20 minutes 
prior to transfection at a concentration of 2.0 x106 cells/mL/well. Mini- or Midi-
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prep purified plasmid DNA was diluted in 100 µL EC buffer with Effectene 
Enhancer® and Effectene Transfection Reagent® (Qiagen) as per the 
manufacturer’s protocol, and added to plated cells in a dropwise manner. 
Typically, 3.2 µL of Effectene Enhancer® and 10 µL Effectene Transfection 
Reagent® were used. Unless otherwise stated, cells were harvested 48 h after 
transfection. 
2.2.3. Drosophila S2 Cell dsRNA Treatment 
For dsRNA treatment, cells were seeded in 6-well plates at 1.5 x106 cells/mL/well 
and left to adhere for 20 minutes. After removing media, cells were incubated with 
1 mL/well serum-free media and treated with 20 µg dsRNA for 1 h, before addition 
of 2 mL/well of complete media. Subsequent DNA transfections occurred 24 h 
after dsRNA treatment. Cells were harvested between 48-72 h after initial dsRNA 
treatment.  
 Fly Genetics 
2.3.1. Fly Husbandry 
Drosophila stocks and crosses were maintained in vials containing fly food made 
in-house according to the following recipe: 
For 3 L H20: 240 g maize powder, 54 g yeast extract, 30 g soya powder, 240 g 
malt, 120 g molasses, 26 g agar, 18.6 mL propionic acid, 1.2 mL phosphoric acid 
and 36 mL of 10% Nipagin in 70% ethanol (Sigma).  
All crosses were carried out at 25oC unless specified.  
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2.3.2. Maintenance of Stable Stocks 
Drosophila homozygous lethal genotypes were maintained using balancer 
chromosomes. Balancer chromosomes contain multiple, overlapping inversions 
to suppress meiotic recombination, as well as carrying dominant phenotypic 
markers and recessive lethal or recessive sterile mutations. This prevents 
homozygous lethal genotypes being segregated through meiotic recombination, 
or loss of desired genotype due to dominant deleterious effects, thus facilitating 
the maintenance of stable transgenic lines.  
2.3.3. Enhancer Trap-Gene Expression Analysis 
Enhancer traps are genetic constructs that allow for analysis of gene specific 
expression patterns. Enhancer trap constructs contain a reporter, typically the 
lacZ gene from Escherichia coli (E. coli) encoding the β–Galactosidase (β–Gal) 
protein, fused to the transposase promoter within a P-element. As P-element 
integration frequently occurs in close proximity to gene promoters (Spradling et 
al., 1995), the transposase promoter, and thus the reporter gene may come under 
the spatial and temporal control of specific genes (Bier et al., 1989) and can be 
used to study gene specific expression patterns.   
Many defined enhancer traps have been generated, and the following were used 
in this study: P{lacW}diap1j5C8 (diap1-lacZ) (Spradling et al., 1999) and 
P{lacW}ex697 (ex-lacZ) (Boedigheimer and Laughon, 1993). 
2.3.4. The UAS-Gal4 System – Spatiotemporal Control of Gene 
Expression 
The Gal4 protein is a transcription factor responsible for the regulation of 
galactose metabolism genes in Saccharomyces cerevisiae by binding the 
upstream activation sequence (UAS) and stimulating transcription (Hashimoto et 
al., 1983). High level of conservation between eukaryotic transcription 
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machineries means the Gal4-UAS system can activate transcription in other 
species, such as Drosophila, and the development of this technique has 
transformed Drosophila genetics (Brand and Perrimon, 1993).  
Many Drosophila enhancer traps have been generated using the Gal4 
transcription factor as a reporter, which will therefore come under the specific 
control of genes close to the site of Gal4 P-element insertion. Experimental 
combination of these Gal4 enhancer traps with transgenes containing UAS 
sequences results in transgenic expression within the specific spatial and 
temporal Gal4 expression pattern (Brand and Perrimon, 1993). This technique is 
therefore used ubiquitously to drive expression of transgenes in known spatial 
and temporal patterns (Figure 2-1A). 
The following Gal4 enhancer traps were used: P{ap-Gal4.VNC} (apterous-Gal4, 
ap>) (Rincon-Limas et al., 1999) to drive expression in the dorsal compartment 
of the wing, P{en2.4-Agl4}e16E (engrailed-Gal4, en>) (Brand and Perrimon, 
1993) and P{Gal4}hhGal4 (hedgehog-Gal4, hh>) (Tanimoto et al., 2000) to drive 
expression in the posterior compartment of the wing, P{GawB}BxMS1096 (MS1096-
Gal4, MS1096>) to drive expression in the whole wing (Capdevila and Guerrero, 
1994), P{GawB}nubbin-Gal4, nub>) to drive expression in the wing pouch 
(Azpiazu and Morata, 2000), and P{GawB}ptc559.1 (patched-Gal4, ptc>) to drive 
expression along the wing anterior-posterior boundary (Brand and Perrimon, 
1993).  
See below for a list of the UAS overexpression lines used: 
Table 2-5 List of UAS overexpression lines
 
UAS-line Chromosome
CK1αHA III  
Crbi III  
D2D II  
DV5 II  
Dco III  
Ds(II) II  
Ds(L14) II  
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Ex II  
ExS453A II  
FtHA II  
GFP::CD8 II  
GishisoB II  
GishisoB Kinase Dead II  
GishisoF  III  
SggisoB II  
SggisoB A81T II  
Usp2(II) II  
Usp2(III) III  
 
2.3.5. Interference RNA 
Interference RNA (RNAi) guides the sequence specific degradation of messenger 
(m)-RNA to control gene expression. Specific RNAi sequences encode dsRNA 
which is processed by the enzyme Dicer creating a guide RNA strand, which is 
incorporated into the RNA-induced silencing complex (RISC), where sequence 
specificity of the RNA targets mRNA, commonly for degradation thus silencing 
the target gene (Wilson and Doudna, 2013). Several Drosophila stock centres 
and large laboratory consortia have systematically generated genome-wide RNAi 
transgene libraries under the control of UAS elements (Perrimon et al., 2010), 
which enable the rapid and efficient study of gene function.  
See below for a list of the RNAi lines used, with the exception of RNAi lines used 
for the DUB modifier screen. See Table 7-1 for list of RNAi lines used in the DUB 
modifier screen.  
 
Table 2-6 List of UAS-RNAi lines
 
Gene RNAi line Chromosome 
CG2577 105471 KK II  
CG7094 108273 KK II  
CG9962 108721 KK II  
CG10889 10889R-3 II  
CG12147 101875 KK II  
d 102550 KK II  
ds - II  
eph TRIP HMS01986 II  
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ft - II  
gckIII 107158 KK II  
gckIII TRIP HMS04487 II  
gish 108680 KK II  
gprk2 TRIP HMS02330 II  
hpo 104169 KK II  
lacZ n/a II  
mnb 107066 KK II  
msn 101517 KK II  
patj 31620 GD III  
put TRIP HMS01944 II  
sax TRIP HMS04520 II  
sdt 23822 GD III  
sgg 101538 KK II  
tkv TRIP HMS02185 II  
usp2 14619R-1 III  
usp2 14619R-3 III  
usp2 104382 KK II  
wts 12072R-1 III  
For RNAi lines used in nub>DUBIR screen, see Table 7-1 
 
 
2.3.6. The FLP/FRT System 
Generation of genetic mosaics is a useful tool for phenotypic analysis of specific 
mutations. Tissue containing mutant clones can be achieved by generating 
mitotic recombination between homologous chromosomes using the Flippase 
Recombinase (FLP) isolated from yeast 2µ plasmid, which mediates highly 
efficient site-specific recombination between specific Flippase Recombination 
Target (FRT) DNA sequences (Golic and Lindquist, 1989; Senecoff et al., 1985). 
During mitosis, activity of the FLP recombinase can catalyse recombination 
between non-sister chromatids, which results in a high frequency of recombinant 
mitotic clones. If a heterozygous mutant gene is located within the chromosome 
arm that is recombined, homozygous mutant clones will be generated and can 
be phenotypically analysed. This technique will also generate homozygous wild-
type tissue and heterozygous mutant/wild-type tissue. If the wild-type FRT 
chromatid contains a marker such as GFP, the mutant tissue will be marked by 




Figure 2-1 The Gal4-UAS and the FLP-FRT systems 
Schematic representation of the Gal4-UAS system whereby the Gal4 transcription factor under 
the control of a genomic enhancer drives the expression of any gene downstream of the UAS 
sequence (A). See ‘The UAS-Gal4 System – Spatiotemporal Control of Gene Expression’ for 
details. Representation of the FLP-FRT system to induce negatively labelled homozygous 
mitotic clones, where GFP is used as a fluorescent marker (B). See ‘The FLP/FRT System’ for 
details.   
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stocks containing a FLP transgene driven, typically under the control of the heat-
shock promoter (hsFLP) are combined with P-element transformed 
chromosomes containing FRT sites in close proximity to the centromeres. If 
hsFLP provides the FLP source, the heat-shock promoter drives expression of 
FLP at 37oC, and one hour incubation during larval development is normally 
sufficient to efficiently induce recombination (Xu and Rubin, 1993).  
2.3.7. Immunofluorescence Analysis 
Drosophila wing imaginal discs from third instar larvae were dissected in PBS 
and fixed in 4% paraformaldehyde in PBS, 0.1% Triton X-100 for 25 mins at room 
temperature. Samples were washed in 0.1% Triton X-100, PBS, and blocked for 
1 h at room temperature in 5% Normal Donkey Serum (NDS)-PBS, 0.1% Triton 
X-100. Primary antibody diluted in 5% NDS-PBS, 0.3% Triton X-100 were 
incubated overnight at 4oC. After washing for 1 h in 0.1% Triton X-100, PBS, 
samples were incubated with secondary antibody diluted in 5% NDS NDS-PBS, 
0.3% Triton X-100 for 1 h at room temperature and washed in 0.1% Triton X-100, 
PBS for 3 h, the penultimate wash step was supplemented with 1:1000 DAPI for 
DNA visualisation. Samples were mounted in Mowiol media (84 mL stock – 9.6 g 
Mowiol 4-88, 12 ml glycerol, 24 ml H2O, 48 ml 0.2 M TrisHCL, pH 8.5, Sigma)  on 
glass slides (VWR) sealed with cover slips (WVR) and stored at 4oC for at least 
24 h prior to imaging. See below for a list of the antibodies used for 
immunofluorescent analysis: 
Table 2-7 List of immunofluorescence antibodies
 
Primary Antibody  Species Dilution Source 
β-Galactosidase  Mouse 1:500 Promega 
Ci2A1 Rat 1:100 DSHB 
CrbCq4 Mouse 1:10 DSHB 
CrbICD Rat 1:200 F. Pichaud  
GFPab13970 Chicken 1:1000 Abcam 
GFP::FITC - ab6662 Goat 1:1000 Abcam 
HA3F10 Rat 1:100 Roche 
c-MYC9E10 Mouse 1:100 Santa-Cruz 
V5Novex Mouse 1:250 Invitrogen 
Secondary Antibody / Fluorophore Species Dilution Source 
Chickenab150169 /Alexa 488 Goat 1:1000 Abcam 
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Mouse / Alexa 647 Donkey 1:1000 Jackson Immuno 
Mouse / FITC Donkey 1:500 Jackson Immuno 
Mouse RRX Donkey 1:250 Jackson Immuno 
Ratab175710 /Alexa 568 Goat 1:1000 Abcam 
Rat / RRX Donkey 1:500 Jackson Immuno 
    
2.3.8. Confocal Microscopy 
Images of imaginal wing discs were obtained using an LSM 510 or LSM 710 laser 
scanning confocal microscope (Zeiss) using a 40x oil immersion lens. Images 
were analysed using the LSM Image Browser (Zeiss), ImageJ and Photoshop 
software. Image colours, brightness and contrast were adjusted in Photoshop 
(Adobe).   
2.3.9. Adult Wing Analysis 
Adult Drosophila of the appropriate genotype were collected and stored in 70% 
ethanol prior to wing dissection. Adult wings were dissected in isopropanol and 
mounted in Euparal (Anglian Lepidopterist Supplies, UK) on glass slides (VWR) 
sealed with cover slips (VWR) and baked at 65oC for 5 h.  
Adult wing images were captured using a Panoramic 250 High Throughput 
Scanner, and wing area was quantified using the ImageJ software. For 
quantification of the posterior wing area / total wing area ratio, the posterior wing 
was measured to include the entire wing below the longitudinal vein 4.  
Wing area data were transformed using Excel (Microsoft) and graphs were 
constructed using GraphPad Prism 5. Statistical analysis was performed in 
GraphPad Prism 5 using the Student’s t-test, or by one-way ANOVA, with either 
the Dunnett’s post hoc test or the Turkey’s range post hoc test depending on the 
data. Analysis is defined within the specific figure legends.   
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 Results 1 – Polarity Proteins as Regulators 
of Expanded Stability 
 A Novel Tool to Study the Regulation of Expanded Protein 
Stability In Vivo 
One of the technical difficulties in observing Ex protein levels in vivo is that 
depletion of Ex activates a Yki-dependent transcriptional programme, which in 
turn increases Ex protein levels as a result of Yki-mediated ex expression. This 
axis of Hpo signalling results in a negative feedback loop limiting excessive Yki 
activity (Figure 1-2). As a consequence of this feedback loop, assessing Ex 
protein levels using an Ex-specific antibody reflects not only post-translational, 
but also transcription-dependent regulation of Ex. Therefore, directly regulating 
Ex post-translational stability will affect ex transcription. To avoid this feedback 
loop, a transgenic Drosophila line was generated (Paulo Ribeiro – Barts Cancer 
Institute) containing a GFP-tagged Ex1-468 truncation under the control of the 
ubiquitin promoter (ubi-ex1-468::GFP). This N-terminal fragment of Ex includes the 
FERM domain, and has been previously identified as the minimal region of Ex 
required to be degraded in response to Crb (Ribeiro et al., 2014). The ubiquitin 
promoter drives the expression of the ubi-ex1-468::GFP reporter constitutively in 
all tissues and, unlike endogenous ex, is refractory to Yki-mediated transcription. 
Thus, by analysing changes in GFP levels, changes in exogenous Ex levels can 
be directly assessed while avoiding the confounding effect of the Yki feedback 
loop. Unfortunately, a full length version of this reporter could not be recovered, 
possibly due to the pro-apoptotic and anti-proliferative functions of full length Ex, 
even when expressed at low levels under the ubi promoter. The function of the 
N-terminal fragment of Ex appears to be in regulating its correct localisation, 
which is dependent on the FERM domain of Ex, and the FBM of Crb, rather than 
explicitly regulating growth (Badouel et al., 2009). As correct localisation of Ex is 
vital to its regulation of the Hippo pathway (Chen et al., 2010; Grzeschik et al., 
2010; Ling et al., 2010; Ribeiro et al., 2014; Robinson et al., 2010; Sun et al., 
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2015), the study of the Ex1-468 N-terminal fragment is still valid as a tool for 
understanding of its overall function. 
Figure 3-1 Validation of ubi-ex1-468::GFP as a tool for analysing Ex protein levels in vivo 
Third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-B) and ubi-ex1-468 
S453A::GFP (C-D) were dissected and processed for immunofluorescence analysis. Confocal 
micrographs of GFP staining (A, B, C, D - green in merged image) in maximum intensity projection 
of the apical domain (A, A’, B, B’, C, C’, D, D’), a basal plane (A’’, B’’, C’’, D’’) and transverse xz 
sections (A’’’, B’’’, C’’’, D’’’) of wing imaginal discs. Nuclei are marked by DAPI staining (blue) and 
the posterior hh>Gal4 expression domain marked by the absence of Ci staining (red). 
Overexpression of hh>lacZIR has no effect on ubi-ex1-468::GFP levels (A-A’’’) or ubi-ex1-468 
S453A::GFP (C-C’’’). Expression of hh>crbi causes loss of ubi-ex1-468::GFP (B-B’’’). Expression of 




To validate that the ubi-ex1-468::GFP reporter behaved as expected and 
accurately reported modulation of Ex protein levels, wing imaginal discs were 
analysed for GFP, in combination with hh-Gal4  to drive UAS-mediated 
overexpression in the posterior compartment (Tanimoto et al., 2000). Anti-Ci 
staining was used as a marker of the anterior compartment (Eaton and Kornberg, 
1990; Orenic et al., 1990). While the ubi-ex1-468::GFP is expressed universally 
throughout the wing disc, specific transgenes were expressed only in the 
posterior compartment. Therefore, in these experiments, the anterior 
compartment serves as an internal control, where the expression of the ubi-ex1-
468::GFP reporter should not be affected by transgene expression. This allows for 
accurate identification of genotypes that impact upon Ex levels in the posterior 
compared to the anterior compartment. 
In control discs overexpressing UAS-lacZIR, the ubi-ex1-468::GFP reporter was 
localised at the apical junctions of cells, similar to wildtype endogenous Ex 
(Figure 3-1A) (Boedigheimer et al., 1997; McCartney et al., 2000). When ubi-ex1-
468::GFP levels were analysed in a cross-section of a single plane of the wing 
disc, the GFP signal was predominantly localised to the apical membrane 
surface. This suggests that Ex1-468::GFP localisation accurately reflects that of 
endogenous Ex. Overexpression of crbintracellular-domain (crbi) is known to stimulate 
Ex degradation (Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; 
Robinson et al., 2010) and was therefore used as a positive control to validate 
the ubi-ex1-468::GFP reporter. This crbi fragment contains the thirty seven amino 
acid intracellular tail of Crb, as well as the transmembrane region, but no 
extracellular domain (Figure 1-3B) (Ling et al., 2010). In the presence of UAS-
crbi, ubi-ex1-468::GFP appears to be almost entirely lost from the apical surface of 
the tissue (Figure 3-1B), without a concurrent increase in basal levels of Ex. This 
suggests the ubi-ex1-468::GFP reporter is responsive to Crb-mediated degradation 
similar to endogenous Ex.   
An additional ubi-ex1-468::GFP reporter line was also generated containing a 
S453A (ubi-ex1-468 S453A::GFP) point mutation. This serine residue closely 
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conforms to the canonical Slmb phosphodegron consensus 452TSGIVS457 and, 
accordingly, the ExS453A point mutant is unable to bind to Slmb, and is refractory 
to Crb-mediated degradation in S2 cells (Ribeiro et al., 2014). Similar to the 
wildtype ubi-ex1-468::GFP reporter and endogenous Ex, ubi-ex1-468 S453A::GFP was 
apically localised (Figure 3-1C) as seen through XY and XZ sections. However 
upon crbi overexpression, apical ubi-ex1-468 S453A::GFP is predominantly lost, 
coupled with a dramatic increase in basal levels of the reporter (Figure 3-1D), 
which is not observed in the wildtype reporter (Figure 3-1A). This reflects the 
inability of crbi to stimulate degradation of Ex with a mutation at S453. Crb is an 
apically localised polarity determinant, however overexpressed Crbi has been 
reported to localise on all plasma membranes  (Klebes and Knust, 2000). 
Consistent with this, in collaboration with Maxine Holder of the Francis Crick 
Institute  staining for the intracellular domain of Crb (CrbICD) (Walther et al., 2016) 
revealed that wildtype Crb localises to the apical membrane, whereas in addition 
to being apically localised, crbi is also localised throughout the basal membranes 
of the wing imaginal disc (collaborator data not shown). Therefore it is likely that 
the increase in basal ubi-ex1-468 S453A::GFP (Figure 3-1D) is the result of physical 
interaction between Ex and Crb, and thus as Crb is localised throughout the 
plasma membrane of the wing disc, so too is Ex. It would be interesting to assess 
the localisation of the ubi-ex1-468 S453A::GFP reporter on expression of full-length 
Crb, which only localises to the apical region of the wing disc due to the stabilising 
effect of homophilic cis- and trans-interactions (Fletcher et al., 2012; Thompson 
et al., 2013).  
In order to further characterise these reporter lines, their ability to regulate tissue 
size was analysed, as the overexpression of Ex should result in reduced growth 
through inhibition of Yki. Adult wings from control flies expressing GFP under the 
control of hh-Gal4 were dissected and their size was measured. The average size 
of wildtype wings was compared to adult wings from the hh>GFP, ubi-ex1-
468::GFP reporter lines. No statistical difference was observed in adult wing size 
between the controls or the reporter lines, suggesting either the ubiquitin 
promoter is too weak to drive sufficient Ex expression to inhibit Yki, or the Ex1-
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468 truncation itself is insufficient to significantly inhibit Yki, perhaps because the 
main growth inhibitory region of Ex is the C-terminus PPxY motif-containing 
portion, which is absent from Ex1-468 (Figure 3-2). 
 
Figure 3-2 Expression of ubi-ex::GFP reporters does not alter adult wing size 
Adult wings expressing GFP as a control (A), GFP; ubi-ex1-468::GFP (B) or GFP; ubi-ex1-468 
S453A::GFP (C) under the control of the hh-Gal4 driver. Wing area was quantified using ImageJ 
and normalised to the average area of GFP expressing control wings (D). Individual data points 
are shown as well as average ± Standard Deviation (SD) for each genotype. Quantification 
shows no statistical difference in size between any of the groups analysed. Groups were 
compared by a one-way ANOVA with a Turkey’s range post hoc test. 
 
 Expanded Protein Turnover as a Contributing Factor to 
Tissue Growth 
The ExS453A residue is important for the stability of Ex and, unlike wildtype Ex 1-
468, Ex1-468 S453A is not efficiently degraded by Crbi (Ribeiro et al., 2014). However, 
the contribution of this point mutation on growth control is unclear. Therefore, 
adult wings were analysed using full-length, wildtype Ex (exWT) or full-length 
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mutant ExS453A (exS453A) UAS-overexpression constructs (see 2.3.4 for details). 
These were compared to UAS-GFP control wings, and UAS-crbi wings, which 
increase adult tissue size through degradation of Ex and activation of Yki (Chen 
et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010)  
 
Figure 3-3 ExS453A regulates tissue growth in a Crbi refractory manner 
Adult wings from Drosophila raised at 18oC expressing GFP as a control (A), crbi (B), exWT (C), 
exWT, crbi (D), exS453A (E), or exS453A, crbi (F) under the control of en-Gal4. Wing area was 
quantified using ImageJ and normalised to the average area of GFP expressing control wings 
(G). The ratio of the area of the posterior compartment of the wing and the total wing area was 
also calculated (H). Individual data points are shown as well as average ± SD for each 
genotype. Results show a statistical difference (*** = P < 0.0001) between all genotypes with 
the exception of the pairwise comparisons en>GFP and en>crbi (G), and en>exWT, crbi and 
en>exS453A, crbi (G, H). Groups were compared by a one-way ANOVA with a Turkey’s range 
post hoc test. 
  
The en-Gal4 driver was used to overexpress constructs only in the posterior 
compartment of the wing (Brand and Perrimon, 1993; Morata and Lawrence, 
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1975), and the ratio of posterior wing area to total wing area was used to analyse 
the ability of these transgenes to modulate tissue growth within this compartment. 
Compared to the en>GFP control, wings expressing en>crbi had an increased 
posterior to whole wing area ratio, with a defect in the posterior cross-vein (PCV) 
(Figure 3-3A-B, G-H). Surprisingly, the whole wing area of en>crbi wings is not 
statistically larger than the en>GFP control wings, despite an increase in the 
posterior area, perhaps due to the number of wings analysed being too low, due 
to a compensatory decrease in the anterior compartment size, or because 
development occurred at 18oC resulting in lower levels of Crb expression 
compared to development at 25oC (Figure 3-3A-B, G-H). Wings overexpressing 
en>exWT were significantly undergrown, with a reduced posterior to whole wing 
ratio compared to control (Figure 3-3C, G-H) consistent with the known function 
of Ex in controlling Yki activity. Interestingly, there was a significant suppression 
of en>exWT undergrowth in wings overexpressing both en>exWT and en>crbi 
(Figure 3-3D, G-H). This is presumably the result of Crbi-mediated degradation 
of Ex resulting in a reduced ability of Ex protein to activate the Hpo pathway, and 
de-repress of Yki and tissue growth.  
Wings overexpressing en>exS453A were undergrown compared to both en>GFP 
and en>exWT (Figure 3-3E, G-H). Moreover, unlike in the en>exWT case, 
en>exS453A;crbi wings were the same size as wings expressing en>exS453A alone 
(Figure 3-3F, G-H), reflected in the posterior to whole wing area ratios and relative 
wing area. Firstly, this shows that the ExS453A has a stronger effect on tissue 
growth than ExWT, and secondly, that overexpression of crbi could not suppress 
the undergrowth caused by en>exS453A expression. These data are consistent 
with the model whereby a mutation at S453 in Ex results in the inability of Crb to 
stimulate Ex degradation, thus enhancing the effective function of Ex protein in 
inhibiting Yki. Moreover, despite overexpression of crbi resulting in basal 
redistribution of ubi-ex1-468 S453A::GFP (Figure 3-1D), it appears enough Ex is 
available at the apical membrane to sufficiently stimulate Hippo signalling and 
inhibit growth. This is perhaps due to the fact that crbi overexpression, whilst 
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localising throughout the plasma membrane, still exhibits strong localisation to 
the apical membrane (collaborator data not shown). 
 The role of the Crumbs Complex in Regulating Expanded 
Stability 
Crb regulates cell polarity as part of a complex of proteins that localises at the 
apical surface of cells (Tepass, 2012). Whilst Crb is a known regulator of Ex 
localisation and stability (Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 
2010; Ribeiro et al., 2014; Robinson et al., 2010), little is known about the role of 
the other members of the Crb complex in the regulation of Ex localisation and 
stability. To this end, the role of patj and sdt, two key members of the apical Crb 
complex, were tested by RNAi-mediated depletion in the developing wing. Ex 
levels were assessed using the ubi-ex1-468::GFP reporter, therefore analysing 
their involvement in Crb-mediated regulation of Ex protein stability.  
 Depletion of patj using the hh>Gal4 posterior compartment driver resulted in no 
change in the ubi-ex1-468::GFP reporter (Figure 3-4A). However, depletion of sdt 
resulted in loss of apical ubi-ex1-468::GFP (Figure 3-4B) alluding to a potential role 
in regulating the stability or localisation of Ex. Sdt is a vital member of the Crb 
complex, and helps stabilise Crb protein at the apical membrane. Loss of sdt 
results in internalisation and mislocalisation of Crb (Hong et al., 2001; Tepass 
and Knust, 1993). Therefore, the localisation of Crb was analysed in the 
background of sdt depletion, resulting in the loss of Crb from the apical membrane 
(Figure 3-4C). As apical localisation of Ex is dependent on Crb, and Sdt controls 
Crb localisation (Chen et al., 2010; Grzeschik et al., 2010; Hong et al., 2001; Ling 
et al., 2010; Ribeiro et al., 2014; Robinson et al., 2010; Tepass and Knust, 1993), 
the loss of apical Ex upon RNAi-mediated depletion of sdt, is most likely the result 




Figure 3-4 Regulation of Ex protein stability by the Crb complex members Sdt and Patj 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
B’ - green in merged images) or stained for Crb (C-C’ – green in merged image). Single channel 
images show maximum intensity projection staining in the apical domain region. Nuclei are 
marked by DAPI staining (blue) and the posterior hh-Gal4 expression domain is marked by the 
absence of Ci staining (red). Depletion of patj by expression of patjIR under the control of hh-
Gal4 has no effect on ubi-ex1-468::GFP levels (A), whereas sdtIR causes loss of GFP (B). Crb 
apical staining is also lost in hh>sdtIR tissue (C). 
 
 The Role of Fat Signalling in the Regulation of Expanded 
Stability 
The link between Hpo signalling and PCP has been known for many years, with 
initial reports suggesting that Ex acted as a downstream effector of Ft in the 
regulation of tissue growth (Reddy and Irvine, 2008), and has been discussed 
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more generally in the introduction to this thesis (see 1.3.10). However, the precise 
involvement of Ex in Fat-Hippo signalling has yet to be sufficiently elucidated.  
Initial results showed elevated ex mRNA in ft mutant tissue, however this mRNA 
increase did not correlate with an increase in Ex protein levels in eye and wing 
discs. This effect was in sharp contrast to wts mutant tissue, which showed a 
dramatic increase in Ex protein due to enhanced Yki activity (Bennett and Harvey, 
2006). Mutant clones for wts also showed enhanced apical localisation of Ex, 
consistent with the increase in protein levels. However, in ft mutant clones, the 
apical localisation of Ex was reduced, despite no impact on Ex protein 
concentration (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 
2006). This reduction but not complete loss in apical Ex protein in ft mutant tissue 
was later confirmed by immunofluorescence (Feng and Irvine, 2007), presumably 
due to residual Ex localised to the membrane by Crb. This suggested that Ft may 
be involved in regulating Ex translation, localisation and/or the stability of Ex 
(Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006). Moreover, 
in ds overexpression or fj mutant clones, Ex levels are non-autonomously 
decreased at the clonal boundaries, a phenotype that is dependent on Fat, 
suggesting Ds may also act through Fat to regulate localisation and stability of 
Ex (Willecke et al., 2008).  
D also appears to influence Ex localisation, as in d,ft double mutant clones, Ex 
localised normally to the apical surface of cells, unlike in ft tissue where apical Ex 
levels were partially reduced (Feng and Irvine, 2007). These data potentially 
allude to a role of Ft-D in the regulation of Ex stability. In ft mutant clones, apical 
D levels are increased and Ex levels are decreased, whereas in d,ft mutant 
clones, Ex apical localisation and levels appear normal (Feng and Irvine, 2007). 
This could suggest that D stimulates Ex degradation or loss from the apical 
membrane in ft mutant clones, and this degradation would not occur in the ft,d 
double mutant clones, hence Ex levels and localisation would be unaffected.  
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Overexpression of d or RNAi-mediated depletion of crb in the wing results in only 
mild overgrowth phenotypes. However, d overexpression in combination with 
RNAi-mediated crb depletion results in a dramatically enhanced overgrowth 
phenotype (Chen et al., 2010). This suggests that crb and d act in parallel to 
regulate growth through the Hpo pathway, presumably with D regulating Wts 
activity, and Crb regulating Ex localisation in this context (Chen et al., 2010). 
However, the possibility of D and Crb acting synergistically to regulate Ex 
localisation or stability has not been formally investigated.   
Therefore, the interaction between the Fat pathway and Crb-dependent 
regulation of Ex protein stability was analysed. This was initially performed by 
assessing Ex stability in Drosophila S2 cells overexpressing Crbi or a FERM-
binding mutant of Crb, CrbintraΔFBM (CrbiΔF), which does not induce Ex degradation, 
presumably due to its inability to interact with Ex (Ling et al., 2010). The stability 
of Ex was then assessed by overexpression of either the intracellular domain of 
Ft (FtICD), which is sufficient to regulate growth via the Hippo pathway (Matakatsu 
and Blair, 2006; Pan et al., 2013) or D, in combination with Crbi. As expected, 
Crb effectively degraded either the Ex1-468 truncation or ExFull-length (ExFL) (Figure 
3-5A-B lanes 1), with CrbiΔF unable to stimulate their degradation (Figure 3-5A-B 
lanes 2). Crb stimulates phosphorylation of Ex priming it for degradation. This 
phosphorylation means Ex cannot migrate as effectively during SDS-
Polyacrylamide gel electrophoresis (PAGE) resulting in a band shift when 
compared to the un-phosphorylated state. It is possible to see this mobility 
retardation of ExFL as a result of Crb-induced phosphorylation, in addition to 
depletion (Figure 3-5B lanes 1, 4, 6) (Ling et al., 2010; Ribeiro et al., 2014). 
Overexpression of FtICD did not appear to alter the stability of Ex compared with 
the CrbiΔF control, and did not affect the ability of Crbi to degrade Ex (Figure 3-5A-
B lanes 1-4). In contrast, D appeared to mildly stabilise Ex1-468 but not ExFL, 
although expression levels of D were very low so are perhaps not responsible for 
this effect, particularly as overexpressing D did not affect the ability of Crbi to 
degrade Ex in vivo (Figure 3-5A-B lanes 1-2, 5-6, E). 
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Figure 3-5 Fat pathway components have no effect on Ex stability 




(Continued from previous page) Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-
468 (A) or ExFL (B). Expression of Myc-tagged Crbi but not of CrbiΔF causes degradation of Ex1-
468 (A – lanes 1, 2, 4, 6) and ExFL (B – lanes 1, 2, 4, 6). Compared to Crbi or CrbiΔF controls, 
expression of HA-tagged FtICD or D does not alter the stability of Ex1-468 (A - lanes 3-6) or ExFL 
(B - lanes 3-6). Lysates were probed with the indicated antibodies. Tubulin (Tub) was used as 
a loading control (A-B). Confocal micrographs of third instar larvae wing imaginal discs 
expressing ubi-ex1-468::GFP (C-J’). Single channel images show GFP staining in maximum 
intensity projection of the apical domain. Nuclei are marked by DAPI staining (blue) and the 
posterior compartment where hh-Gal4 is expressed is marked by the absence of Ci staining 
(red) (C’, F’, G’, H’), the presence of V5 staining (D’, E’) or HA staining (I’, J’). Overexpression 
of d2D (C), d::V5 (D), ds(II) (F), ds(L14) (G) or ft::HA (I) using hh-Gal4 had no effect on ubi-ex1-468::GFP 
levels. Co-expression of crbi with d::V5 (E), ds(L14) (H) or ft::HA (J) failed to modify the phenotype 
seen with expression of crbi alone with regards to the levels of ubi-ex1-468::GFP (see Figure 
3-1B). 
The role of the Ft pathway was also interrogated in vivo using the constitutively 
expressed ubi-ex1-468::GFP reporter with hh-Gal4 to drive transgene 
overexpression. Consistent with previous work, overexpression of d, particularly 
d::V5 resulted in overgrown discs, presumably as a result of Wts inhibition (Figure 
3-5C-D) (Cho et al., 2006; Mao et al., 2006). However, despite overgrowth, the 
discs showed no change in ubi-ex1-468::GFP reporter levels compared to the 
anterior compartment internal control (Figure 3-5C-D). Moreover, when d and crbi 
were co-expressed, ubi-ex1-468::GFP was completely lost from the posterior 
compartment, suggesting that d does not influence Ex stability (Figure 3-5E). 
There also appeared to be an enhanced growth phenotype when both d and crbi 
were co-expressed, compared to that of d or crbi alone suggesting these proteins 
work in parallel to regulate growth, and that D does not regulate growth directly 
via Ex stability (Figure 3-5E). Furthermore, overexpression of the tumour 
suppressors ds or ft does not influence ubi-ex1-468::GFP reporter levels (Figure 
3-5F-G, I), and nor does overexpression of either of these proteins influence the 
ability of Crb to stimulate degradation of Ex as ubi-ex1-468::GFP was still lost from 
cells when ds or ft were co-expressed with crbi (Figure 3-5H, J).  
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Loss of function phenotypes of Fat pathway genes were also analysed. The 
kinase Mnb acts downstream of Ds, along with its adaptor protein Riq to 
phosphorylate and inhibit Wts, therefore activating Yki (Degoutin et al., 2013). 
This inhibition of Wts is independent of D-mediated Wts inhibition, which is 
downstream of Ft but not Ds (Degoutin et al., 2013). dsRNA-mediated depletion 
of mnb in S2 cells had no influence on the ability of Crb to regulate Ex stability or 
electrophoretic mobility (corresponding to phosphorylation) (Figure 3-6A). Other 
Fat pathway genes, such as d, ds and ft were not assessed in S2 cells because 
these polarity proteins are not sufficiently expressed in unpolarised S2 cells to 
warrant dsRNA treatment. In addition to cell data, RNAi-mediated depletion of 
mnb in vivo showed no change in ubi-ex1-468::GFP reporter levels. When crbi was 
co-expressed with mnbIR, there was complete loss of ubi-ex1-468::GFP suggesting 
that mnbIR has no influence on Ex stability (Figure 3-6B-C). Depletion of d 
resulted in posterior compartment undergrowth consistent with published data 
suggesting D inhibits Wts (Figure 3-6D) (Mao et al., 2006). Interestingly, ubi-ex1-
468::GFP reporter levels were decreased in the posterior compartment, 
particularly at the posterior/anterior boundary edge suggesting D may stabilise 
Ex (Figure 3-6D), which is in complete contrast to our hypothesis proposing that 
D may destabilise Ex. However, as overexpression of D did not seem to influence 
ubi-ex1-468::GFP reporter levels, these data are difficult to interpret. Moreover, as 
dIR caused a decreased ubi-ex1-468::GFP levels, co-expression with crbi resulted 
in complete loss of ubi-ex1-468::GFP in the posterior compartment similar to that 
of crbi alone (Figure 3-6E).  
RNAi-mediated depletion of ds or ft resulted in overgrowth of the posterior 
compartment, consistent with their well-known roles as tumour suppressors 
(Figure 3-6F, H) (Bryant et al., 1988; Clark et al., 1995), althought the overgrowth 
in the case of ft knockdown is very weak when compared to the ft mutant 
phenotypes, possible due to the inefficiency of the RNAi line. In Figure 3-6F it 
appears that the ubi-ex1-468::GFP reporter levels are increased at the anterior-
posterior boundary, however this is likely to be due to local tissue folding as the 
two compartments seem to be rejecting each other, concentrating membrane-
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localised proteins such as Ex. However, ubi-ex1-468::GFP levels away from the 
boundary interface appear to be consistent with the internal anterior control. 
Depletion of ft does also not appear to change the levels of ubi-ex1-468::GFP 
(Figure 3-6H). The complete loss of ubi-ex1-468::GFP observed upon crbi 
overexpression is not altered by either ds or ft RNAi-mediated depletion (Figure 
3-6G, I). However, combination of crbi overexpression with either dsIR or ftIR led 
to an enhancement of the overgrowth phenotype (Figure 3-6G, I), similar to the 
situation seen with crbi plus d overexpression. This suggests that tissue growth 
regulation downstream of Ft and Crb likely act in parallel. Moreover, these data 
do not support a role for the Ft pathway in the regulation of Ex levels.   
 Concluding Remarks 
In this chapter, the use of a novel tool for the analysis of Ex stability in vivo has 
been established and validated. Importantly, as the newly generated Ex protein 
level reporter is under the control of the ubiquitin promoter, it facilitates the 
analysis of levels and localisation of Ex that are only influenced by post-
translational mechanisms, and does not reflect the transcriptional control of 
endogenous ex by Yki, which has previously been a severe limitation in the 
analysis of Ex protein. However, it is important to state that the reporter lines 
generated are only a truncated version of Ex, encompassing amino acids 1-468 
rather than the full 1427 amino acid protein. Whilst this is useful in the study of 
Crb-mediated Ex stability, as this N-terminal region is still sensitive to Crb-
mediated degradation, there will be further post-translational regulation of Ex at 
the C-terminus which cannot be assessed using these truncated Ex reporters.  
Moreover, the role of the previously identified ExS453A point mutation has been 
confirmed in vivo (Figure 3-3). The S453A mutation results in enhanced stability 
of Ex, making it refractory to the action of Crb (Ribeiro et al., 2014). This 
culminates in increased activity of Ex, which leads to a more severe tissue 
undergrowth phenotype when compared with the wildtype counterpart providing 
evidence to the functional relevance of Ex turnover by Slmb. 
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The ability of the Crb complex and Fat pathway to influence Ex stability has also 
been assessed, with the confirmation that Crb localisation by Sdt is vital to the 
localisation of Ex in vivo (Figure 3-4). This is interesting as there is limited data 
regarding the function of Sdt in regulating growth (Bachmann et al., 2001; Hong 
et al., 2001; Tepass and Knust, 1993). The only report suggesting that other 
members of the complex besides Crb can regulate growth, describes a genetic 
interaction between activated RasV12 and loss of sdt, which results in extremely 
large tumours, with metastatic properties compared to RasV12 or sdt mutations 
alone (Pagliarini and Xu, 2003). As Ex is a potent regulator of tissue growth, it is 
intriguing that loss of sdt causes a significant loss of apical Ex, presumably 
through regulating the stability of the Crb complex (Figure 3-4). It would be 
expected that, if Sdt regulates Crb complex stability (Bachmann et al., 2001; 
Hong et al., 2001), and apical levels of Ex, loss of sdt would result in overgrowth 
phenotypes similar to crb mutation. Whilst this was not formally investigated in 
this thesis, it would be an interesting area for follow-up.  
Furthermore, previous evidence pointed to a potential role of the Ft pathway in 
the regulation of Ex stability (Staley and Irvine, 2012). However analysis of ft, ds, 
d and mnb provides limited evidence that the Fat pathway directly regulates Ex 
stability, with only knockdown of d causing a reduction in Ex reporter (Figure 
3-6D). This result is still preliminary and needs further validation as, while d 
depletion causes a loss of ubi-ex1-468::GFP staining, the converse is not true, and 
D overexpression does not cause enhanced Ex stability (Figure 3-5). More 
recently the genes App, Dlish/Vam and FbxL7 have been proposed to regulate 
levels, localisation and activities of D and Ft at the membrane (Bosch et al., 2014; 
Matakatsu et al., 2017; Misra and Irvine, 2016; Rodrigues-Campos and 
Thompson, 2014; Zhang et al., 2016). Perhaps analysis of these members of the 
Fat pathway may help in describing how Ft is able to regulate Ex localisation and 
stability (Bennett and Harvey, 2006; Silva et al., 2006).   
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Figure 3-6 Depletion of Fat pathway components has modest effects on Ex stability 
(Continued on next page) 
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(Continued from previous page) Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-
468 (A) treated with dsRNA against lacZ as a control (A – lanes 1-2) or a pool of two independent 
dsRNA against mnb (A – lane 3). Expression of Myc-tagged Crbi but not CrbiΔF caused an 
electrophoretic shift in Ex1-468 (A – lanes 1-2), which is not affected by mnb dsRNA treatment 
(A – lane 3). Lysates were probed with the indicated antibodies and Tub used as a loading 
control (A). Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-
468::GFP (B-I’). Single channel images show GFP staining in maximum intensity projection of 
the apical domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment 
where hh-Gal4 is expressed is marked by the absence of Ci staining (red). Expression of mnbIR 
(B), dsIR (F), or ftIR (H) under the control of hh-Gal4 had no effect on ubi-ex1-468::GFP levels. 
Expression of dIR caused a reduction in ubi-ex1-468::GFP levels (D). Co-expression of crbi with 
mnbIR (C), dIR (E), dsIR (G), or ftIR (I) had no effect on ubi-ex1-468::GFP levels compared to 











 Results 2 – Candidate Kinase Screen to 
Identify Regulators of Expanded Stability 
 Candidate Kinases Identified as Expanded Interacting 
Partners through Mass Spectrometry 
As discussed in ‘1.3.12 - The Crumbs Complex’, Crb acts as a dual regulator of 
Hpo signalling through the regulation of Ex protein localisation and stability (Chen 
et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; Ribeiro et al., 2014; 
Robinson et al., 2010). Overexpression of crbi drives tissue overgrowth via Yki, 
and also induces Ex phosphorylation and depletion through ubiquitin conjugation, 
and proteasomal degradation (Chen et al., 2010; Grzeschik et al., 2010; Ling et 
al., 2010; Ribeiro et al., 2014; Robinson et al., 2010). While the E3 ligase 
responsible for Ex degradation has been recently described (Ribeiro et al., 2014), 
the identity of the kinase(s) responsible for phosphorylating Ex is still unknown. 
This section will describe the work performed to identify a kinase(s) that is directly 
involved in the Crb-mediated phosphorylation and degradation of Ex. 
To identify potential regulators of Ex protein stability, mass spectrometry (MS) 
was performed to identify proteins that specifically interact with Ex upon Crbi 
overexpression. For these experiments, a FLAG-tagged Ex truncation spanning 
amino acids 1-468 was used, as Ex1-468 had previously been identified as the 
minimal region of Ex that is sensitive to Crb-mediated degradation (Ribeiro et al., 
2014). Ex1-468 was isolated from Drosophila S2 cells by performing 
immunoprecipitation (IP) with FLAG beads, and purified Ex and associated 
complexes were analysed via MS. These data led to the identification of the 
SCFSlmb/β-TrCP E3 ligase complex as a crucial regulator of Ex stability, Ex requiring 




Ex-interacting kinases were also detected within the same MS data set used to 
identify Slmb as a regulator of Ex stability. These were used as the starting point 
for investigations into potential kinases involved in Ex degradation (Table 4-1 – 
performed by (Ribeiro et al., 2014)). Despite the fact that several kinases were 
identified in this MS experiment, due to the transient nature of kinase-substrate 
interactions, they are often difficult to capture by MS. Therefore, these 
experiments can only provide a snapshot of the total protein interaction network 
within a cell, and thus unfortunately, this list is unlikely to be exhaustive (Amano 
et al., 2010). 
Table 4-1 Summary of MS Ex binding partners
Summary of MS results including protein name, protein name abbreviation and CG number 
(CG#). Unique and total denote the number of unique and total peptides detected in the 
MS analysis for each specific protein, respectively. S2 cell lysates were processed for MS 
analysis after co-immunoprecipitation of FLAG-tagged GFP as a negative binding control 
or FLAG-tagged Ex1-468 in the presence of Myc-tagged Crbi or CrbiΔF. Experiment was 
performed by Paulo Ribeiro and this MS data has previously been used in the identification 
















Unique Total Unique Total Unique Total
Expanded Ex CG4114 0 0 27 601 26 423 
Hippo Hpo CG11228 0 0 10 12 10 12 
Germinal Centre Kinase 
III 
GckIII CG5169 0 0 4 4 0 0 
Gilgamesh Gish CG6963 0 0 3 3 0 0 
Doughnut on 2 Dnt CG17559 0 0 2 3 0 0 
Eph Receptor Tyrosine 
Kinase 
Eph CG1511 0 0 2 2 0 0 
PDGF- and VEFG-
Receptor Related 
Pvr CG8222 0 0 12 18 0 0 
G Protein-Coupled 
Receptor Kinase 2 
Gprk2 CG17998 0 0 9 9 0 0 
Saxophone Sax CG1891 0 0 2 2 0 0 
Thickveins Tkv CG14026 0 0 11 12 0 0 




Figure 4-1 Functional screen of MS candidate kinases and their effect on Ex stability in 
S2 cells 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 (A-B) and treated with dsRNA 
targeting lacZ (control dsRNA treatment; A, B – lanes 1-2), dnt (A – lane 3), gprk2IR#1 (A – lane 
4), gprk2IR#2 (B – lane 3) and pvr (B – lane 4). Expression of Myc-tagged Crbi (A, B - lanes 1, 
3-4) but not of CrbiΔF (A, B – lanes 2) caused an electrophoretic shift and depletion in Ex1-468, 
which was not abrogated by any dsRNA treatment. A box and whiskers, min to max plot 
showing immunoblot quantification of Ex levels relative to the CrbFBM negative control (C) 
(protocol outlined in ‘2.1.15’). Groups were compared to the CrbFBM negative control group by 
a one-way ANOVA with a Dunnet’s multiple comparison post hoc test.  Expression of Myc-
tagged Crbi (C – lane 1) or HA-tagged GishisoI (C – lane 3) but not of Myc-tagged CrbiΔF (C – 
lane 2) or HA-tagged Dnt (C – lane 4) caused degradation and electrophoretic shift of V5-
tagged Ex1-468 CAAX. Lysates were analysed using the indicated antibodies and Tub was used 
as a loading control (A-B, D). 
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Several of these initial candidate kinases were then screened in Drosophila S2 
cells by RNAi-mediated depletion, in combination with Crbi overexpression to 
assess levels of Ex protein. Immunoblots were quantified using ImageJ as 
described in section ‘2.1.15’ and levels of Ex were normalised to the loading 
control tubulin, and the levels of Crb expression, itself normalised to tubulin. 
Quantified levels of Ex were then normalised to the negative control condition of 
Ex levels in the presence of the CrbFBM (set to 1). Candidate kinase(s) that could 
recover Crb-mediated Ex electrophoretic mobility shift (corresponding to 
phosphorylation) or degradation were taken forward for further analysis. RNAi-
mediated depletion of the kinases doughnut on 2 (dnt) and G protein-coupled 
receptor kinase 2 (gprk2) showed no stabilisation of Ex relative to the Crbi positive 
control, although the variability of results and number of repeats was too low to 
obtain statistical significance, even in the positive control (Figure 4-1A lanes 3-4 
and C). Indeed, Ex protein was still electrophoretically shifted due to Crb-
mediated Ex phosphorylation suggesting that neither Dnt nor Gprk2 influenced 
phosphorylation and therefore Ex stability. An additional gprk2 dsRNA was also 
assessed, which also failed to modulate Crb-mediated Ex degradation (Figure 
4-1B lane 3). Moreover, when Ex levels were analysed in vivo using the ubi-ex1-
468::GFP reporter, gprk2 RNAi-mediated depletion showed no effect on GFP 
levels, suggesting this protein is not involved in the regulation of Ex stability 
(Figure 4-2A). A Dnt overexpression construct was generated, and its ability to 
phosphorylate and promote degradation of Ex in S2 cells was assessed. This 
was performed using an Ex construct containing a C-terminal CAAX 
palmitoylation site (Ex1-468 CAAX), thereby promoting its localisation to the cellular 
membranes where Crb-mediated regulation of Ex occurs, therefore promoting 
maximal interactions between Ex and the putative kinases tested (Genevet and 
Tapon, 2011; Hancock et al., 1990; Sun et al., 2015). Neither a mobility shift nor 
depletion of Ex was observed upon overexpression of Dnt in S2 cells compared 




depletion in the Ex construct (the role of Gish will be discussed later in ‘Chapter 
5 - Results 3’) (Figure 4-1D – lane 4). 
Figure 4-2 In vivo functional screen of MS candidate kinases and their effect on Ex 
stability 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
B’). Single channel images show GFP staining in maximum intensity projection of the apical 
domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment where hh-
Gal4 is expressed domain is marked by the absence of Ci staining (red). Depletion of gprk2 or 
eph using respectively hh>gprk2IR (A) or hh>ephIR (B) had no effect on the levels of ubi-ex1-
468::GFP. 
 
In addition, the receptor tyrosine kinase PDGF and VEGF-Receptor Related 
Receptor Tyrosine Kinase (Pvr), was assessed in S2 cells.  Despite the 
appearance that depletion of this kinase is able to increase levels of Ex (Figure 
4-1B – lane 4), quantification of levels of Ex in combination with pvr knockdown 
suggest this kinase does not influence the ability of Crb to stimulate Ex 
degradation (Figure 4-1C). However, it is important to note that in this context, 
the number of experiments assessed, and the variablilty of results did not result 
in a statistical significance between Ex levels in the Crbi positive control and the 
CrbFBM negative control, or the kinases tested (Figure 4-1C). Rather, the 
conclusion were based on a trend towards a decrease in Ex levels upon 
Crbi overexpression, which was not abrogated by knockdown of the kinases 




Figure 4-3 Effect of depletion of BMP pathway kinases on Ex protein stability in S2 cells
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 (A, B) and treated with dsRNA 
against lacZ as a control (A – lanes 1-2, B – lanes 1), put (A – lane 3), sax (A – lane 4, B – lane 
3) and tkv (A – lane 5, B – lane 2) or tkv + sax (B – lane 4). Expression of Myc-tagged Crbi (A 
– lanes 1, 3-5 and B - lanes 1-4), but not CrbiΔF (A – lane 2) caused depletion and 
electrophoretic shift in Ex1-468, which was mildy abrogated by BMP kinase dsRNA treatment. 
Lysates were probed with the indicated antibodies and Tub was used as a loading control (A-
B). A box and whiskers, min to max plot showing immunoblot quantification of Ex levels relative 
to the CrbFBM negative control (C) (protocol outlined in ‘2.1.15’). Groups were compared to the 
CrbFBM negative control group by a one-way ANOVA with a Dunnet’s multiple comparison post 
hoc test (* = P < 0.05).   
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Receptor Tyrosine Kinase (eph) by combining hh>Gal4, UAS-RNAi-mediated 
depletion with the ubi-ex1-468::GFP reporter showed no change in Ex levels in the 
posterior compartment (Figure 4-2B).These data suggest none of these kinases 
tested are able to modulate the ability of Crb to stimulate Ex degradation. 
Within the MS data set were three receptor tyrosine kinases of the Bone 
Morphogenetic Protein (BMP) pathway, a Tissue Growth Factor (TGF) β-like 
pathway stimulated by ligands such as Dpp, which controls a whole host of 
biological functions throughout development including growth and patterning 
(Hamaratoglu et al., 2014). This signalling cascade is initiated by ligand dimers 
binding to receptor heterodimers comprised of a type I receptor Thickveins (Tkv) 
or Saxophone (Sax), and the type II receptor Put. Activated Put phosphorylates 
the type I receptor, which in turn phosphorylates Mad, activating the Dpp 
transcriptional response (Hamaratoglu et al., 2014). Given the fact that several 
proteins from this pathway were recovered in the MS experiments, their role in 
the regulation of Ex was tested. As with the previous kinases tested, the ability of 
Crbi to phosphorylate and degrade Ex1-468 was assessed in cells treated with 
dsRNA targeting tkv, sax or put. Depletion of any of each of these kinases had 
no effect on the abilty of Crbi to stimulate phosphorylation of Ex1-468 as measured 
by electrophoretic mobility shift (Figure 4-3A). Interestingly, knockdown of these 
BMP kinases may cause a mild stabilisation of Ex1-468, despite the persistence of 
the phosphorylation induced by Crb (Figure 4-3A-C). In this instance, 
quantification of Ex1-468 levels led to a significant difference between Ex in 
combination with Crbi compared to CrbFBM however, variability in results, or too 
few repeats did not result in a statistically significant difference between Ex1-468 
upon treatment with depleted BMP kinases compared to the CrbFBM control, 





Figure 4-4 Effect of depletion of BMP pathway kinases on Ex stability in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
C’). Single channel images show GFP staining in maximum intensity projection of the apical 
domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment where hh-
Gal4 is expressed is marked by the absence of Ci staining (red). Depletion of sax (A), tkv (B) 
or put (C) in the hh-Gal4-expressing compartment using saxIR, tkvIR or putIR had no effect on 
ubi-ex1-468::GFP levels. 
In addition, these receptors work as dimers, potentially masking the effect of 
depleting individual kinases in the pathway, as alternative receptor dimers may 
form, allowing signalling to persist. Therefore, co-depletion of sax and tkv, both 
type I receptors was performed, however the stability of Ex-468 was not enhanced 
compared to single dsRNA treatments (Figure 4-3B-C). 
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Unfortunately, when the ubi-ex1-468::GFP reporter was analysed in vivo, 
knockdown of either sax, tkv or put had no effect on GFP levels when UAS-RNAi 
was driven in the posterior compartment by hh>Gal4 (Figure 4-4).  
Overexpression constructs of the type I receptors Sax and Tkv were generated 
and transfected into S2 cells in an attempt to see Ex phosphorylation and 
depletion. When tested with Ex1-468, neither of these constructs caused a 
depletion of Ex unlike the positive controls Crbi or Gish (Figure 4-5A-B), althought 
the number of repeats was too low to statistically confirm this. Interestingly, when 
Tkv was overexpressed with the Ex1-468 CAAX, which should be localised to cell 
membranes, an electrophoretic mobility shift but not a depletion of Ex was 
observed, similar to that caused by overexpression of the positive controls Crbi 
and Gish (Figure 4-5C lane 5 and D) suggestive of a potential phosphorylation of 
Ex not involved in regulating Ex stability.  
 Core Hippo Kinases as Potential Regulators of Expanded 
Ex is one of the most important upstream inputs of the Hippo pathway in 
Drosophila and can associate with Hpo and Wts in an apically localised activated 
kinase complex (Genevet and Tapon, 2011; Sun et al., 2015). Indeed, Hpo kinase 
was detected as an Ex interacting partner through the MS analysis from 
whichpotential Ex kinases were selected (Table 4-1), although there was no 
difference in binding preference depending on whether Crbi or CrbiΔF was 
expressed consistent with previous reports (Reddy and Irvine, 2011; Yu et al., 
2010). It is therefore attractive to speculate that within this complex there is 
phosphorylation of Ex allowing tight regulation of pathway activity. Indeed, it has 
been reported that Wts can phosphorylate the C-terminus of Ex inhibiting 
degradation through Slmb, reinforcing the activity of the Hpo pathway by 
preventing excessive activity of Yki (Zhang et al., 2015a). It is therefore possible  
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Figure 4-5 Effect of overexpression of BMP pathway kinases on Ex protein stability in 
S2 cells 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 (A) or Ex1-468 CAAX (C), and 
concurrent  box and whiskers, min to max plot showing immunoblot quantification of Ex levels 
relative to the CrbFBM negative control (B and D) (protocol outlined in ‘2.1.15’). Groups were 
compared to the CrbFBM negative control group by a one-way ANOVA with a Dunnet’s multiple 
comparison post hoc test. Expression of Myc-tagged Crbi and HA-tagged GishisoI but not Myc-
tagged CrbiΔF caused degradation (A lanes 1-3, B) or an electrophoretic shift but no degradation 
(C lanes 1-3, D) of Ex. Expression of  V5-tagged SaxisoB caused neither degradation or an 
electrophoretic mobility shift in Ex (A-D), whereas V5-tagged TkvisoD had no effect on Ex1-468 (A 
– lane 5, B), but caused an electrophoretic shift in Ex1-468 CAAX (B – lane 5). Lysates were 




that the converse mechanism of Hpo regulation could exist, whereby under 
certain conditions Ex is phosphorylated within the Hpo kinase complex, and 
degraded to deactivate Hpo signalling switching on a Yki transcriptional 
programme. 
To test this hypothesis, the core Hpo kinases were depleted through dsRNA 
treatment in S2 cells, and Crb-dependent Ex stability was assessed. The Crb-
sensitive N-terminal fragment Ex1-468 was used, which does not contain the C-
terminal Wts phosphorylation site, therefore ruling out the stabilising effect of Wts 
on Ex (Zhang et al., 2015a). Depletion of the core kinases hpo or wts did not 
impact the stability of the Ex1-468, confirmed upon quantification (Figure 4-6A 
lanes 3-4 and E). RNAi-mediated depletion in vivo suggests the ubi-ex1-468::GFP 
reporter was mildly stabilised by hpoIR, however when co-expressed with crbi, 
ubi-ex1-468::GFP was totally lost from the apical membrane (Figure 4-7A-B). The 
apparent upregulation of ubi-ex1-468::GFP in hpoIR may be the result of a Yki-
dependent upregulation of apical proteins (Genevet et al., 2009). Depletion of wts 
had no effect on the ubi-ex1-468::GFP reporter (Figure 4-7C). According to 
published reports, if the reporter was full length Ex, we would expect that 
depletion of wts would result in loss of Ex protein due to decreased levels of C-
terminal Ex phosphorylation, and concomitant degradation (Zhang et al., 2015a). 
The effect of overexpression of Hpo and Wts, along with the Wts adaptor protein 
Mats on Ex1-468 CAAX was also assessed, which resulted in a mobility shift but no 
degradation of Ex compared to the Crbi control (Figure 4-6B). The significance of 
this phosphorylation is still unclear. The mobility shift could be a technical artefact 
due to the use of Ex1-468 CAAX, which is forced to cellular membranes, or there 
could be an unknown regulatory mechanism of these kinases on Ex alluded to in 
the introduction to this section.  
To confirm that the ability of Wts to stabilise Ex had no effect on Crb-mediated 
Ex degradation, stability of ExFL was analysed with overexpression of Wts and 
Crb (full length and intra). Consistent with published work, Wts overexpression 




Figure 4-6 Effect of Hippo pathway kinases on Ex protein stability in S2 cells 
(Continued on next page) 
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(Continued from previous page) Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 
(A, D) and treated with dsRNA against lacZ as a control (A, D – lanes 1-2), hpo (A – lane 3), wts 
(A – lane 4) a pool of two independent dsRNA against msn (D – lane 3) or hppy (D – lane 4). 
Expression of Myc-tagged Crbi (A – lanes 1, 3-4, D – lanes 1, 3-4), but not CrbiΔF (A, D – lanes 2) 
caused depletion and/or electrophoretic shift in Ex1-468, which was not affected by any dsRNA 
treatment. Box and whiskers, min to max plot showing immunoblot quantification of Ex levels 
relative to the CrbFBM negative control (E) (protocol outlined in ‘2.1.15’). Groups were compared 
to the CrbFBM negative control group by a one-way ANOVA with a Dunnet’s multiple comparison 
post hoc test (** = P < 0.01, * = P < 0.05). Expression of Myc-tagged Crbi (B – lane 1), HA-tagged 
Hpo (B – lane 3) or HA-tagged Wts and Mats (B – lane 4), but not of Myc-tagged CrbiΔF (B – lane 
2) caused degradation and/or electrophoretic shift of V5-tagged Ex1-468 CAAX (B). Compared to 
empty control (C – lanes 1, 5), expression of FLAG-tagged Wts stabilised ExFL (C – lanes 2, 6). 
Expression of CrbFL (C – lane 3-4) or Myc-tagged Crbi (C – lane 7-8) caused degradation of ExFL, 
irrespective of the presence or absence of FLAG-tagged Wts coexpression (C – lanes 4, 8). 
Lysates were probed with the indicated antibodies and Tub was used as a loading control (A-D). 
 
(Figure 4-6C lanes 1-2, 5-6). However, when Wts was co-expressed with CrbFL 
or Crbi, Ex was completely degraded suggesting Crb is the dominant factor in the 
regulation of Ex stability (Figure 4-6C lanes 3-4, 7-8).  
Additional proteins acting on the core kinase cascade have recently been 
identified including Msn and Hppy (Li et al., 2014a; Meng et al., 2015), which 
were analysed as potential regulators of Ex stability. In S2 cells, depletion of 
these kinases appeared to have little effect on the abiliy for Crb to stimulate Ex 
degradation, despite the lack of statistical significance for msn  upon immunoblot 
quantification  (Figure 4-6D and E). Depletion of msn in vivo appeared to have no 
effect on stabilising the ubi-ex1-468::GFP reporter, whilst co-expression with crbi 
resulted in no change from Crb-phenotype of Ex degradation, corroborating the 
data obtained in S2 cells suggesting msn has no effect on regulating Ex stability 
(Figure 4-7G-H). As well as Hppy and Msn, another Germinal Center Kinase, 
Germinal Center Kinase III (GckIII) exists which has been speculated to be 
involved in Hpo signalling (Ribeiro et al., 2010; Zheng et al., 2015). Depletion of 
this kinase was tested in vivo, with two independent RNAi lines showing mild 
increase in ubi-ex1-468::GFP intensity suggesting this kinase is perhaps involved 
in regulating Ex stability (Figure 4-7D-E). When combined with co-expression of 
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crbi however, depletion of the kinase did not recover ubi-ex1-468::GFP as would 
be expected if this kinase initiated Crb-dependent Ex phosphorylation and 
degradation (Figure 4-7F). Indeed, in Drosophila there have been no reports of 
gckIII regulating growth, and there is limited evidence for any functional 
significance of the effect of GckIII on Ex. 
Despite preliminary data suggesting Hpo and Wts can phosphorylate the N-
terminus of Ex (Figure 4-6B), the impact of this phosphorylation remains unclear, 
and, collectively, these data suggest none of the core Hpo kinases are involved 
in priming Ex for degradation upon Crb-mediated stimulus. 
 Additional Candidate Kinases and their Role in Regulating 
Expanded Stability 
In addition to the kinases identified by MS, or kinases that are obviously closely 
localised with Ex, there were two other kinases that were prioritised for analysis: 
the apical kinase aPKC, and Shaggy (Sgg), the Drosophila orthologue of 
Glycogen Synthase Kinase-3β (Gsk3β).  
aPKC has a critical role in determining apical polarity in epithelial cells and is 
regulated by the adaptor proteins Par6 and Baz, the Drosophila orthologue of 
Par3, which control the positioning and activity of aPKC, forming the apical Par 
complex (Tepass, 2012). The Par complex is involved in excluding basal polarity 
complexes from the apical domain thus helping to determine and maintain the 
apical domain, and the kinase activity of aPKC plays a crucial role in these 
processes (Tepass, 2012). In addition, aPKC has been reported to directly 
phosphorylate the intra-cellular region of Crb (Sotillos et al., 2004). This 
phosphorylation is necessary to maintain apical localisation of Crb, and is thought 
to be involved in regulating FERM-dependent Crb interactions (Sotillos et al., 
2004; Tepass, 2012). As the interaction between Ex and Crb is dependent on the 
FERM domain of Ex, and due to the apical localisation of both Ex and aPKC, this 
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kinase has been speculated to be an Ex kinase (Genevet and Tapon, 2011; 
Ribeiro et al., 2014).  
Figure 4-7 Effect of Hippo pathway kinases on Ex protein stability in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
H’). Single channel images show GFP staining in maximum intensity projection of the apical 
domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment where hh-
Gal4 is expressed is marked by the absence of Ci staining (red). Expression of hpoIR (A), wtsIR 
(C) or msnIR (G) under the control of hh-Gal4 had no effect on ubi-ex1-468::GFP levels. 
Expression of RNAi transgenes targeting gckIII (respectively gckIIITRIP and gckIIIKK in D and E) 
caused a mild increase in the levels of the ubi-ex1-468::GFP reporter. Coexpression of crbi with 
hpoIR (B), gckIIIKK (F) or msnIR (H) did not abrogate the depletion in ubi-ex1-468::GFP levels 
caused by expression of crbi alone (see Figure 3-1B). 
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However, when aPKC was tested in cells, there was no evidence to suggest it 
has a role in the regulation of Ex stability. When S2 cells were treated with dsRNA 
against aPKC, along with an inhibitor of aPKC CRT0668 (a kind gift from Dr 
Philippe Riou and Dr Peter Parker - The Francis Crick Institute), Ex stability 
remained unchanged when compared to the Crbi control (Figure 4-8A). Moreover, 
when different versions of aPKC were expressed in cells, there was no depletion 
or electrophoretic mobility shift in Ex, unlike in Crbi expressing cells. Wildtype and 
kinase dead (KD) aPKC, either with or without a CAAX palmitoylation sequence 
to promote its membrane localisation (Hancock et al., 1990) (where canonical 
aPKC activity occurs) were used in these experiments (Figure 4-8B). In vivo 
expression of a constitutively active truncated form of aPKC (aPKCΔN) that lacks 
the C-terminal pseudosubstrate region of full-length aPKC, and that cannot bind 
to Par6 so is no longer apically restricted (Betschinger et al., 2003; Drier et al., 
2002), causes lethality before the L3 larval stage when under the control of hh-
Gal4, and therefore was not possible to assess its effect on Ex stability.  
Sgg has an important role in priming substrates for Slmb/β-TrCP-mediated 
degradation through phosphorylation of substrate phosphodegron sequences 
(Skaar et al., 2013), which is discussed more thoroughly in ‘1.2.3 - F-box E3 
Ligases’. Sgg is involved in regulating the stability of the Hh effector Ci (Price and 
Kalderon, 2002), the circadian clock regulators Timeless (Tim) and Per (Martinek 
et al., 2001; Top et al., 2016) and the Wingless effector Arm (Peifer et al., 1994) 
among others. As Sgg often primes Slmb substrates for degradation, the potential 
effect of Sgg in the regulation of Ex stability was tested. In S2 cells, 
overexpression of wildtype, constitutively active, or kinase dead versions of Sgg 
had no effect on the mobility or stability of Ex1-468 or Ex1-468 CAAX (Figure 4-9A). 
Overexpression the B isoform of Sgg in vivo had no effect on the ubi-ex1-468::GFP 
reporter (Figure 4-9B). However, overexpression of SggA81T, a kinase dead form 
of Sgg (Bourouis, 2002) resulted in very disrupted morphology of the posterior 
compartment compared to the anterior internal control, this folding of the tissue 
could explain the apparent increased intensity of ubi-ex1-468::GFP (Figure 4-9C). 




Figure 4-8 aPKC has no effect on Ex protein stability in S2 cells 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 CAAX (A) treated with mock drug 
(H2O) (A – lane 1) , DMSO (A – lanes 2,3) or CRT0668 (A – lane 4) and with dsRNA targeting 
lacZ as a control (A – lanes 2,3) or aPKC (A – lane 4). Expression of Myc-tagged Crbi (A – lane 
2,4) caused depletion and/or electrophoretic shift in FLAG-tagged Ex1-468 CAAX when compared 
to GFP (A – lane 1) or Myc-tagged CrbiΔF (A – lane 3) controls, which was not influenced by 
treatment with the aPKC inhibitor CRT0668 and aPKC dsRNA treatment (A – lane 4). Expression 
of Myc-tagged Crbi (B – lane 1) but not CrbiΔF (B – lane 2), HA-tagged aPKCWT (B – lane 3), 
aPKCKD (B – lane 4), aPKCWT CAAX (B – lane 5) or aPKCKD CAAX (B – lane 6) caused depletion 
and electrophoretic mobility shift of Ex1-468. S2 cell lysates were probed with the indicated 




the SggA81T construct sequestering endogenous Sgg substrates through 
physically interaction. However, this was in stark contrast to sgg knockdown in 
S2 cells (Figure 4-9A) and RNAi-mediated depletion of sgg in vivo, which showed 
no change in ubi-ex1-468::GFP levels (Figure 4-9D). When sggIR was combined 
with crbi overexpression, ubi-ex1-468::GFP was totally lost from the posterior 
compartment, similar to the crbi  alone phenotype (Figure 4-9E). These data 
suggest that, at least in the conditions tested, Sgg is not involved in the regulation 
of Ex stability in vitro or in vivo. 
 Concluding Remarks 
This chapter has attempted to identify a potential Ex degradative kinase using a 
candidate based approach with MS data, and current literature as the basis for 
candidate selection. Of the kinases tested, the BMP pathway seems to be the 
most promising as a potential regulator of Ex and Hippo signalling, because, at 
least in S2 cells, kinase depletion appears to result in mild stabilisation of Ex, and 
overexpression of Tkv causes an electrophoretic mobility shift in Ex1-468 CAAX.  
However, the discrepancy between analysis performed in S2 cells and in vivo 
needs to be rectified. Interestingly, the Hippo and BMP pathways interact in 
Drosophila (Oh and Irvine, 2011) and mammals, CRB3 regulating the localisation 
of both YAP and SMAD (Varelas et al., 2010). Therefore it would be interesting 
to discover whether in Drosophila these pathways regulate, and are regulated by 
Ex.  
In addition, the ability of the core Hippo kianses Hpo and Wts to stimulate Ex N-
terminal phosphorylation warrants further investigation, althought this signalling 
event is unlikely to act downstream of Crb, or influence Ex stability. Interestingly, 
Wts has been reported to phosphorylate Ex at S1116 within the C-terminus to 
promote Ex function by inhibiting degradation by Slmb (Zhang et al., 2015a).  
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Analysis of the Ex protein sequence revealed only one Wts HXRXXS consensus 
sequence at the ExS1116 site, suggesting that the mobility shift seen in Ex1-468 upon 
Wts overexpression (Figure 4-6C) may not be a result of direct phosphorylation. 
As no clear Hpo or MST1/2 consensus has been established, it is difficult to 
assess whether Hpo directly phosphorylates Ex, or whether this effect is indirect 
(Figure 4-6C). Interestingly, LATS reportedly phosphorylates AMOT in mammal 
(Adler et al., 2013; Chan et al., 2013; Dai et al., 2013; Hirate et al., 2013), which 
alters its ability to regulate YAP (Moleirinho et al., 2014; Ragni et al., 2017). 
Perhaps the phosphorylation of Ex induced by Hpo and Wts influences Ex activity 




Figure 4-9 Sgg has no effect on Ex in S2 cells or in vivo 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 (A – lanes 1-5) or Ex1-468 CAAX (A 
– lane 6-10). Expression of Myc-tagged Crbi (A – lanes 1, 6) but not CrbiΔF (A – lanes 2, 7), HA-
tagged SggWT (A - lanes 3, 8), constitutively active SggS9A (A – lanes 4, 9) or kinase-deficient 
SggKD (A – lanes 5, 10) caused electrophoretic shift/depletion of Ex1-468 (A - lanes 1-5) and 
FLAGEx1-468 CAAX (A – lanes 6-10). Lysates were analysed with the indicated antibodies and Tub 
was used a loading control (A-B). Confocal micrographs of third instar larvae wing imaginal 
discs expressing ubi-ex1-468::GFP (B-E’). Single channel images show GFP staining in 
maximum intensity projection of the apical domain. Nuclei are marked by DAPI staining (blue) 
and the posterior compartment expressing hh-Gal4 is marked by the absence of Ci staining 
(red). hh-Gal4-mediated expression of sggisoB (B) or of a sgg RNAi transgene (D, sggIR) had no 
effect on ubi-ex1-468::GFP levels. Expression of a kinase dead version of sgg (C, sggisoB A81T) 
disrupted the morphology of the posterior compartment and increased ubi-ex1-468::GFP levels. 
Coexpression of crbi with sggIR (E) had no effect on ubi-ex1-468::GFP levels compared to 




 Results 3 – The Role of Casein Kinase 1 
Family Kinases in the Regulation of Expanded 
 An Introduction to the CK1 Family Kinases 
The MS experiments described in the previous chapter also revealed Gilgamesh 
(Gish) as a potential Ex binding partner (Table 4-1). Gish is a member of the 
Casein Kinase 1 (CK1) family of kinases and the Drosophila orthologue of CK1γ, 
Therefore, the ability of Gish, and related kinases to regulate Ex stability was 
assessed.  
CK1s are highly conserved, serine/threonine (S/T) kinases (Figure 5-1A) that are 
ubiquitously expressed among eukaryotes and involved in a wide array of 
biological processes (Knippschild et al., 2005; Schittek and Sinnberg, 2014). Of 
particular interest is the fact that CK1 kinases are commonly involved in the 
phospho-dependent targeting of their substrates for degradation, often through 
interactions with F-box proteins such as Slmb (Skaar et al., 2013). Prominent 
substrates of the CK1s include Arm (Liu et al., 2002; Yanagawa et al., 2002), Ci 
(Jia et al., 2005), and Per (Price et al., 1998), CK1 phosphorylation stimulating 
ubiquitylation. Interestingly, the CK1s also regulate Hippo signalling by 
phosphorylating and activating Ft in Drosophila (Feng and Irvine, 2009; Sopko et 
al., 2009), and YAP in mammals (Zhao et al., 2010). There are seven family 
members, ck1α (Drosophila ck1α), ck1β (which is only found in bovine species) 
(Cheong and Virshup, 2011), ck1δ and ck1ε (orthologues of Drosophila discs 
overgrown (dco)) and ck1γ1-3 (Drosophila gish), along with numerous splice 
variants (Figure 5-1A).  
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Figure 5-1 CK1 family and Gish interaction with Ex 
Phylogenetic analysis of the CK1 family kinases complied using PhyML and DrawTree tools in 
the Phylogeny online tool (http://www.phylogeny.fr/simple_phylogeny.cgi) (Dereeper et al., 2008). 
CK1α and orthologues in red, CK1δ/ε and orthologues in green, CK1γ and orthologues in blue, 
and uncharacterised Drosophila CK1s in black (A). CK1 kinase sequence alignment using 
MUSCLE (Edgar, 2004) showing only the kinase domain, and putative palmitoylation motif 
(Davidson et al., 2005) of GishisoI, GishisoF and human (Hs) CK1γ1-3 (B). Immunoblot of S2 cell 
lysates after co-immunoprecipitation of FLAG-tagged NTAN as a negative binding control (C – 
lanes 1, 2, D – lane 1), FLAG-tagged Ex1-468 (A – lanes 3-6) or FLAG-tagged GishisoI (B – lanes 2, 
3). Myc-tagged Crbi expression but not CrbiΔF stimulated the association between Ex1-468 and HA-
tagged GishisoI (C – lanes 3, 5). Neither Crbi nor CrbiΔF induced the interaction between Ex1-468 and 
HA-tagged GishisoF (C – lanes 4, 6). Crbi expression but not CrbiΔF stimulated the association 
between GishisoI and V5-tagged Ex1-468 CAAX (D – lanes 2, 3). Lysates and FLAG 
immunoprecipitates were analysed with the indicated antibodies and Tub was used as a loading 




 Gilgamesh Interacts with Expanded 
To confirm the initial interaction between Ex and Gish defined in the MS data set 
(Table 4-1), immunoprecipitation of FLAG-tagged Ex was performed in S2 cells. 
Two different isoforms of Gish were co-expressed with Ex, isoform (iso) I (GishisoI) 
and F (GishisoF). These are two different products of gish, with the isoI variant 
containing a C-terminal palmitoylation site that presumably allow it to localise at 
the membrane. In contrast, the isoF of Gish lacks the putative palmitoylation site 
(Figure 5-1B). Crb and Ex both localise at the apical membrane, which is 
presumably where Crb stimulates Ex degradation. Therefore, as GishisoI localises 
to the membranes through its palmitoylation sequence, it was one of the 
predominant isoforms analysed. Upon Crbi stimulation, purified Ex and 
associated interacting complexes were also found to contain GishisoI (Figure 5-1C 
lane 4). However, no Gish was identified when Ex was purified in the presence 
of CrbiΔF, suggesting the kinase-substrate is dependent on the FERM domain of 
Crb and the ability of Crb to stimulate Ex degradation (Figure 5-1C lanes 5-6). 
Unlike GishisoI, GishisoF was not identified in Ex-purified immunoprecipitates, 
suggesting that this kinase isoform does not interact with Ex, and that perhaps 
the difference in localisation of these kinases is important for their interaction and 
substrate specificity. The interaction between Ex and Gish was also confirmed by 
reciprocal immunoprecipitation, purifying FLAG-GishisoI. Similarly to previous 
results, Ex was identified as a Gish-interacting protein only when co-expressed 
with Crbi and not CrbiΔF (Figure 5-1D).  
 Stimulation of Expanded Phosphorylation and 
Degradation by Overexpression of CK1 Family Kinases 
As Ex and CK1 family members appear to interact in a Crb-dependent manner, 
and phosphorylation stimulated by Crb induces Ex degradation, the role of CK1s 
in regulating Ex phosphorylation and degradation was assessed. CK1 family 




Figure 5-2 Overexpression of CK1 family kinases in S2 cells regulates Ex protein levels 




(Continued from previous page) Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-
468 CAAX (A-B) or V5-tagged Ex1-468 CAAX (C, D). Expression of Myc-tagged Crbi (A, B, C - lanes 1) 
but not CrbiΔF (A, B, C – lanes 2) as controls caused electrophoretic mobility shift and Ex protein 
depletion. Expression of HA-tagged CK1α (A – lane 3), HA-tagged Dco (A – lane 5) and HA-
tagged GishisoI (A – lane 7) but not the respective kinase dead constructs (A – lanes 4, 6, 8) 
caused electrophoretic mobility shift and depletion of FLAG-tagged Ex1-468 CAAX. Expression of 
HA-tagged GishisoI (B – lane 3) and HA-tagged GishisoF CAAX (B – lane 6), but not of HA-tagged 
GishisoI KD (B – lane 4) or HA-tagged GishisoF (B – lane 5), caused electrophoretic mobility shift 
and depletion of FLAG-tagged Ex1-468. Expression of HA-tagged CG7094 (C – lane 4), but not 
of HA-tagged CG2577, CG9962 or CG12147 (C – lanes 3, 5, 6), caused electrophoretic mobility 
shift and depletion of V5-tagged Ex1-468 CAAX. Co-expression of HA-tagged CK1α, Dco and 
GishisoI (D – lane 4) increased the electrophoretic mobility shift of V5-tagged Ex1-468 CAAX 
compared to expression of individual kinases (D – lanes 1-3). Lysates were probed with the 
indicated antibodies and Tub served as loading control (A-D). Box and whiskers, min to max 
plot showing immunoblot quantification of Ex levels relative to the CrbFBM negative control (E) 
(protocol outlined in ‘2.1.15’). Groups were compared to the CrbFBM negative control group by 
a one-way ANOVA with a Dunnet’s multiple comparison post hoc test (*** = P < 0.001). 
 
electrophoretic shift, corresponding to Ex phosphorylation and depletion in Ex1-
468 CAAX, although the mobility shift induced by Dco expression is far weaker than 
either CK1α or Gish(Figure 5-2A and E). Point mutations within the conserved 
kinase were introduced to render the kinases inactive (CK1αK49R, DcoK38R and 
GishisoI K91R). The kinase dead CK1s were also overexpressed in S2 cells and 
induced no mobility shift in Ex1-468 CAAX suggesting the mobility shift and depletion 
of Ex stimulated by the CK1 family kinases is dependent on their enzymatic 
activity (Figure 5-2A). Immunoblot quantification revealed that of these three 
kinases, only Gish overexpression resulted in a statistically significant reduction 
in Ex levels when comared to the CrbFBM negative control, although CK1α and 
Dco both show a trend to induce a reduction in Ex levels, and it is likely that with 
an increased number of repeats, these data would become statistically significant 
(Figure 5-2E). Interestingly immunoblot quantification also reveals that the kinase 
dead CK1s are also statistically indistinct from the CrbFBM negative control  
providing further evidence that the kinase activity of the CK1s is important in the 
regulation of Ex1-468 CAAX stability in S2 cells (Figure 5-2E). Ex1-468 CAAX was used 
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in these experiments because S2 cells do not express Crbi, which means Ex may 
not localise correctly to the site of initial phosphorylation or degradation. 
Therefore, Ex was forced to the membrane in order to simulate its localisation 
when Crb is expressed.  
Protein subcellular localisation is critical in regulating cellular processes. Gish is 
known to associate with cellular membranes in vivo through analysis of a GFP-
fused Gish protein trap within the endogenous locus (known as Spider-GFP) 
(Martin et al., 2009; Morin et al., 2001). Indeed, GishisoF which is the only Gish 
isoform not to contain a putative palmitoylation sequence (Figure 5-1B), does not 
interact with Ex upon Crbi overexpression (Figure 5-1C). Therefore, the ability of 
these Gish isoforms to regulate Ex phosphorylation and degradation was 
assessed. As described, GishisoI was able to stimulate an electrophoretic mobility 
in Ex, unlike the kinase dead version of the protein (Figure 5-2A). When GishisoF 
was overexpressed, there was a much less dramatic shift in Ex, and Ex levels 
were not reduced when compared to the CrbFBM negative control (Figure 5-2B 
lane 5 and E) suggesting that this isoform was much less potent at 
phosphorylating Ex. A palmitoylation CAAX sequence was then cloned onto 
GishisoF in order to localise this kinase to the cellular membranes. GishisoF CAAX 
could readily induce a dramatic mobility shift in Ex, implying that this kinase can 
phosphorylate Ex (Figure 5-2B – lane 6). However, unlike Crb or GishisoI 
overexpression, Ex was not degraded upon GishisoF CAAX overexpression (Figure 
5-2B and E). This result was somewhat unexpected and perhaps the CAAX-tag 
limits the ability of GishisoF to stimulate Ex degradation, or it is possible that forcing 
the localisation of GishisoF CAAX to the membrane can induce Ex phosphorylation 
without stimulating its degradation.  
The ability of several uncharacterised CK1-like kinases, CG2577, CG7094, 
CG9962 and CG12147 to regulate Ex was also tested by overexpression in S2 
cells. CG7094, CG9962 and CG12147 all appeared to induce a mobility shift in 
Ex (Figure 5-2C lane 4-6). Of these kinases CG7094 appeared to induce the most  
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Figure 5-3 Overexpression of CK1 family kinases regulates Ex in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
H’). Single channel images show GFP staining in maximum intensity projection of the apical 
domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment where hh-
Gal4 is expressed is marked by the absence of Ci staining (red in A’ and C’), the presence of HA 
staining (red in B’) or MYC staining (red in D’-F’). Image depicting expression of the control lacZIR 
in the hh-Gal4 domain (A) is the same as in ‘Figure 3-1A’, and does not affect ubi-ex1-468::GFP 
levels. Unlike gishisoB KD (E), expression of ck1α (B), dco (C), gishisoB (D), or gishisoF (F) under the 
control of hh-Gal4 caused depletion of ubi-ex1-468::GFP levels. 
 
dramatic mobility shift in Ex, which also results in statistically significant depletion 
of Ex when compared to the CrbFBM negative control (Figure 5-2C lane 4 and E). 
The fact that so many members of the CK1 family appear to be able to induce Ex 
phosphorylation suggests there may be overlapping substrate specificity between 
these kinases. To test whether this was indeed the case, multiple CK1s, CK1α, 
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Dco and GishisoI were expressed alone, or in combination. CK1s expressed alone 
resulted in electrophoretic shift as previously discussed. Interestingly, when all 
three kinases were overexpressed, a higher proportion of Ex1-468 CAAX was shifted, 
with the lower, un-phosphorylated band almost undetectable (Figure 5-2D). This 
data is in agreement with a potential synergistic action of CK1 kinases in the 
regulation of Ex function, although it cannot be ruled out that simply expressing 
three times as much of any single kinase would yield the same result.  
The role of the CK1s was also tested in vivo by hh-Gal4 controlled overexpression 
of UAS-CK1s, in combination with the ubi-ex1-468::GFP reporter. Overexpression 
of kinase active CK1α, Dco and GishisoB, an isoform closely related to GishisoI that 
contains the C-terminal palmitoylation site, and GishisoF all induced depletion of 
the ubi-ex1-468::GFP reporter (Figure 5-3B-D, F). A kinase dead form of GishisoB 
was also overexpressed and did not result in depletion of ubi-ex1-468::GFP in the 
hh-positive posterior compartment (Figure 5-3E). These data support the results 
obtained in S2 cells suggesting that the CK1 family of kinases can regulate Ex 
stability through phosphorylation. Interestingly, in vivo, even GishisoF was able to 
induce a depletion in the ubi-ex1-468::GFP reporter in contrast to cell experiments. 
This could be due to differential localisation of GishisoF in vivo compared to in S2 
cells, although this remains unclear. Moreover, the CK1 family kinase are able to 
phosphorylate apically localised substrates such as Ft, Arrow (Arr) and 
Smoothened (Smo) (Chen et al., 2011; Davidson et al., 2005; Feng and Irvine, 
2009; Sopko et al., 2009; Zhang et al., 2006), suggesting that despite not 
possessing a palmitoylation sequence, these kinases are able to stimulate 
depletion of Ex, at least upon overexpression.  
Ex1-468 was identified as the minimal region of Ex that is required for Crb-induced 
degradation, whereas Ex1-450, only eighteen amino acids shorter is no longer 
phosphorylated and degraded upon expression of Crb (Ribeiro et al., 2014). In 
order to determine whether the CK1s also induced Ex phosphorylation in a similar 
manner, either Crbi, CrbiΔF, which does not induce Ex phosphorylation, or GishisoI 
were overexpressed with either Ex1-450 CAAX or Ex1-468 CAAX. As previously reported, 
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Crbi could only induce a mobility shift in Ex1-468, whereas CrbiΔF failed to induce a 
shift in either Ex construct (Figure 5-4A lanes 1-2, 4-5) (Ribeiro et al., 2014). 
GishisoI behaved similarly to Crbi, and was only able to induce a mobility shift in 
Ex1-468 CAAX, but not in Ex1-450 CAAX (Figure 5-4A lanes 3, 6). This suggests that 
Gish, and perhaps the other CK1s, stimulate phosphorylation of Ex within the 
same region that is phosphorylated upon expression of Crb. However, it cannot 
be ruled out that the region between Ex450 and Ex468 is only responsible for the 
interaction between the kinase and Ex, and not the site of phosphorylation per 
se. Within this region, there are several serine and threonine residues, which are 
potential candidates for the CK1 phosphorylation site (Figure 5-4B), in addition to 
several other S/T residues present directly N-terminal to this region of Ex. The 
most obvious candidate for CK1 phosphorylation is S453, which has been shown 
previously, and in this report, to be essential for regulating Ex stability (Ribeiro et 
al., 2014).  
As phosphorylation of Ex results in Slmb-mediated binding and degradation, the 
ability of the CK1 kinases to stimulate Ex:Slmb interaction was assessed. 
Overexpression of Ck1α, Dco or Gish, followed by Slmb-immunopurification, 
stimulated the interaction between Slmb and Ex1-468 CAAX (Figure 5-4C). 
Therefore, in S2 cells, kinase overexpression is sufficient to induce Ex:Slmb 
interactions independently of Crbi, providing further evidence that these kinases 
are important in the regulation of Ex phosphorylation and stability. Interestingly, 
in addition to the isolation of Ex, immunopurification of Slmb also pulled-down 
CK1α and not Dco or Gish, so perhaps CK1α constitutively associates closely 
with Slmb due to the number of substrates it targets for degradation (Figure 5-4C 
lane 2). 
 Loss of Function Analysis of CK1 Family Kinases and 
Expanded Stability 
In addition to gain of function experiments, loss of function assays were also 




Figure 5-4 CK1 kinases regulate the Ex Slmb phosphodegron region and binding to Slmb
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-450 CAAX (A – lanes 1-3) and FLAG-
tagged Ex1-468 CAAX (A – lanes 4-6). Expression of Myc-tagged Crbi (A - lanes 1, 4) and HA-
tagged Gishisoi (A – 3, 6) caused an electrophoretic shift in FLAG-tagged Ex1-468 CAAX but not on 
Ex1-450 CAAX, whereas expression of Myc-tagged CrbiΔF did not cause an electrophoretic shift in 
either (A – lanes 2, 5). A cartoon depiction of the Ex450-468 region highlighting the canonical β-
TrCP consensus sequence, the S453 residue (red), which is important for regulating Ex 
stability, and the S/T residues (green) included in this part of Ex (B). S2 cell lysates expressing 
V5-tagged Ex1-468 CAAX after co-immunoprecipitation of FLAG-tagged GFP as a negative binding 
control (C – lane 1) or FLAG-tagged Slmb (C – lanes 2-4). Expression of HA-tagged CK1α, Dco 
or Gishisoi induced the interaction between V5-tagged Ex1-468 CAAX and Slmb (C – lanes 2-4). 
Note that HA-tagged CK1α also associated with Slmb (C – lane 2). Lysates and FLAG 
immunoprecipitates were probed with the indicated antibodies and Tub was used as loading 
control (A, C). 
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dramatic stabilisation of Ex1-468 despite overexpression of Crbi (Figure 5-5A).  
Also, it is important to note that unlike in the cases of Crb or kinase 
overexpression where a doublet of Ex is visible, with one band corresponding to 
phosphorylated and one band corresponding to un-phosphorylated Ex, when gish 
is depleted the Ex upper band is nearly undetectable and the un-phosphorylated 
lower band completely dominates (Figure 5-5A). This suggests that knocking 
down gish creates a situation whereby Crb can no longer stimulate Ex 
phosphorylation, thus the electrophoretic mobility of Ex is impeded. In addition to 
gish depletion stabilising Ex1-468 even in the presence of Crb, gish depletion could 
also block Crb-mediated degradation of ExFL, which suggests that the 
mechanisms identified in relation to the N-terminal truncation used throughout 
this thesis are also applicable to full-length Ex (Figure 5-5B). Unfortunately, 
dsRNA efficiently targeting dco or ck1α in cells could not be generated, therefore 
limiting the analysis of these kinases. In addition, the alternative, uncharacterised 
CK1 family kinases are not sufficiently expressed in S2 cells to warrant analysis 
of their loss of function phenotypes in this system. In order to confirm that the 
dsRNA use to target gish efficiently knocked down the desired kinase, GishisoI 
was overexpressed in S2 cells treated with dsRNA targeting lacZ as a negative 
control, and dsRNA targeting gish. Overexpressed GishisoI was undetectable in 
cells treated with gish dsRNA confirming the effectiveness of this reagent (Figure 
5-5C). Loss of function phenotypes were also analysed in vivo. RNAi-mediated 
knockdown of gish resulted in an increase in the ubi-ex1-468::GFP reporter in the 
hh-positive posterior compartment (Figure 5-5D). In combination with crbi 
overexpression, gish depletion caused severe morphological disruption with 
enhanced cell death, judged by the presence of pyknotic nuclei in DAPI nuclear 
staining (Figure 5-5E’). Despite this phenotype, there was a recovery of ubi-ex1-
468::GFP in the crbi overexpression domain (Figure 5-5E). These data suggest 
that gish may regulate the stability of Ex in vivo, thereby corroborating the data 
obtained in S2 cells. Regrettably, expression of UAS-ck1αIR under the control of 
hh-Gal4 resulted in the complete absence of any imaginal disc tissue due to the 
strength of the RNAi line, so the effect on Ex stability could not be analysed in 
this context.  
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Figure 5-5 Depletion of gish stabilises Ex in S2 cells and in vivo 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 CAAX (A), V5-tagged ExFL (B) or 
FLAG-tagged GishisoI (C) treated with dsRNA against lacZ as a control (A, B– lanes 1, 2, C – 
lane 1) or gish (A, B – lanes 3, C – lane 2). Expression of Myc-tagged Crbi, but not CrbiΔF, 
caused an electrophoretic shift and depletion in FLAG-tagged Ex1-468 CAAX (A lanes 1, 2) and V5-
tagged ExFL (B – lanes 1, 2), which was abrogated by depletion of gish (A, B – lanes 3). 
Expression of FLAG-tagged GishisoI was abrogated by depletion of gish (C – lane 2). Lysates 
were analysed using the indicated antibodies and Tub was used as a loading control (A, B). 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (D-
E’). Single channel images show GFP staining in maximum intensity projection of the apical 
domain. Nuclei are marked by DAPI staining (blue) and the posterior compartment where hh-
Gal4 is expressed is marked by the absence of Ci staining (red). Expression of gishIR under the 
control of hh-Gal4 increased the levels of the ubi-ex1-468::GFP reporter (D). Co-expression of 
crbi and gishIR (E) prevented crbi from depleting ubi-ex1-468::GFP when compared to crbi alone 
(see Figure 3-1B), albeit leading to a disruption in tissue morphology (E). 
 
In collaboration with Maxine Holder, Francis Crick Institute, RNAi-mediated 
depletion of the uncharacterised CK1-like kinases was carried out in wing 
imaginal discs. RNAi targeting CG2577, CG7094, CG9962 or CG12147 alone 
had no effect on the levels of the ubi-ex1-468::GFP reporter (collaborator data not 
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shown). However, in combination with crbi overexpression, depletion of CG2577, 
CG9962 and, in particular, CG7094 resulted in mild stabilisation of the ubi-ex1-
468::GFP reporter specifically along the dorsal-ventral compartment boundary 
(collaborator data not shown). Depletion of CG12147 did not result in stabilisation 
of ubi-ex1-468::GFP in the presence of crbi (collaborator data not shown). These 
data are in agreement with the overexpression data in S2 cells, which suggested 
that CG7094 may be able to phosphorylate and deplete Ex protein. Interestingly, 
the RNAi line used for depletion of CG2577 had one predicted off-target hit 
against CG7094, which may explain why depletion of CG2577 in combination 
with crbi resulted in mild stabilisation of the ubi-ex1-468::GFP reporter, as this may 
be the influence of the off-target effect of the RNAi-line. Why the ubi-ex1-468::GFP 
reporter is only stabilised along the dorsal-ventral compartment boundary 
remains unknown.  
Following on from RNAi experiments, the ubi-ex1-468::GFP reporter was analysed 
in homozygous mutant clones for CK1 family kinases, which were generated in 
wing imaginal discs. Note that this in vivo analysis was performed in collaboration 
with Maxine Holder (Francis Crick Institute). See ‘2.3.6 - The FLP/FRT System’ 
(Figure 2-1B) for details. Homozygous mutant clones for dco3, a hypomorphic 
dco allele that causes dramatic overgrowth phenotypes through the inhibition of 
Fat signalling (Feng and Irvine, 2009; Sopko et al., 2009; Zilian et al., 1999), or 
gishKG03891, a P-element insertion in the third exon of gish, which causes 
penetrant recessive lethality (Bellen et al., 2004; Tan et al., 2010) had no effect 
on the levels of the ubi-ex1-468::GFP reporter (collaborator data not shown). To 
assess whether the gish allele initially used was null, an additional gish mutant 
allele was generated my Maxine Holder (Francis Crick Insitute) using CRISPR-
Cas9 mediated double strand DNA breaks (Port et al., 2014), which created a 
frameshift, followed by a stop codon at amino acid 96 targeting all gish isoforms. 
This new allele, gish17 is recessive lethal and deemed to be null. Clones for this 
new, null gish allele also did not result in any overt changes in the levels of ubi-
ex1-468::GFP compared to surrounding wildtype tissue (collaborator data not 
shown) corroborating the result from the published gish allele. However, ck1α 
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mutant clones did induce an increase in the ubi-ex1-468::GFP reporter but only in 
the wing pouch and not in the notum (collaborator data not shown), consistent 
with previous results describing slmb regulation Ex degradation only in the pouch 
(Ribeiro et al., 2014). No ck1α null mutants currently exist and the ck1α8B12 allele 
used in these experiments contains a G43D point mutation, which is unable to 
stimulate Arm degradation (Legent et al., 2012). These data seem to suggest that 
in vivo, ck1α is the most important kinase in the regulation of Ex stability, and not 
gish. 
To confirm that ck1α mutant clones specifically up-regulate Ex protein, rather 
than simply increasing the apical domain, ck1α clones were analysed for the 
apical markers Crb and Spider-GFP. In ck1α clones within the pouch, the levels 
of both Crb and Spider-GFP (Gish) were increased, which was not the case with 
Crb staining in gish mutant clones (collaborator data not shown). This suggests 
there is a broad increase in apical abundance in ck1α clones, potentially limiting 
the significance of the increase in ubi-ex1-468::GFP reporter (collaborator data not 
shown). However, it is interesting to note that Gish increases in ck1α mutant 
clones. As potential redundancy appears to be an issue with the CK1s, perhaps 
loss of ck1α results in the compensatory up-regulation of other CK1 members, in 
this case gish, thereby limiting the potential damage to tissue homeostasis 
caused by loss of ck1α (collaborator data not shown). 
In cells, overexpression of the CK1 family kinases is sufficient to induce 
interaction with Slmb (Figure 5-4C). Therefore, whether loss of function of gish 
could block the interaction of Ex with Slmb was analysed. Immunoprecipitated 
FLAG-Slmb interacts with Ex upon Crbi overexpression, and this interaction is 
dependent on an intact FBM within Crb (Figure 5-6A lanes 2-3). However, when 
cells were also treated with dsRNA against gish, the Crbi induced Ex:Slmb 
interaction was abolished (Figure 5-6A lane 4). This suggests that the 
phosphorylation of Ex by Gish is vital to its recognition by Slmb, and its 
subsequent degradation in S2 cells. To further assess this, the ubiquitylation 




Figure 5-6 Depletion of gish inhibits Ex:Slmb binding and Ex ubiquitylation 
Immunoblots of S2 cell lysates expressing V5-tagged Ex1-468 after treatment with dsRNA 
against lacZ as a control (A - lanes 1-3) or gish (A – lane 4) and co-immunoprecipitation of 
FLAG-tagged NTAN as a negative binding control (C – lanes 1) or FLAG-tagged Slmb (A – 
lanes 2-4). Myc-tagged Crbi expression but not expression of CrbiΔF stimulated association 
between Slmb and Ex1-468 (A – lanes 2, 3), which was abrogated by treatment with gish dsRNA 
(A – lane 4). S2 cell lysates expressing V5-tagged Ex1-468 CAAX after treatment with dsRNA 
against lacZ as a control (B - lanes 1-4), slmb (B – lane 5) or gish (B – lane 6) and co-
immunoprecipitation of HA-tagged Ub. Myc-tagged Crbi expression (B – lane 3), but not 
expression of Ub alone (B – lane 2) or of Myc-tagged CrbiΔF (B – lane 4), induced V5-tagged 
Ex1-468 ubiquitylation, which is abrogated by slmb (B – lane 5) or gish (B – lane 6) dsRNA-
mediated depletion. Lysates and purified immunoprecipitates were probed with the indicated 
antibodies and Tub was used as a loading control (A, B). 
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HA-tagged ubiquitin was isolated from S2 cells by HA-specific 
immunoprecipitation. Proteins that have been tagged by ubiquitin will produce a 
smear when immunoblotted after SDS-PAGE. Using this method, Crbi 
overexpression, but not CrbiΔF induced ubiquitylation of Ex (Figure 5-6B lanes 3-
4), consistent with the role of these constructs in the regulation of Ex stability. As 
previously described, when cells overexpressing Crbi were also treated with 
dsRNA against slmb, Ex was no longer ubiquitylated as the E3-ligase responsible 
for tagging Ex with Ubi had been depleted (Figure 5-6B lane 5) (Ribeiro et al., 
2014). Furthermore, when cells were treated with dsRNA against gish, Ex 
ubiquitylation was also lost (Figure 5-6B lane 6), suggesting that this kinase is 
essential in priming Ex for ubiquitylation and subsequent degradation. 
 
 The Role of CK1 Family Kinases in Regulating the Hippo 
Pathway 
Ex is a very potent regulator of Yki activity acting both in a Hpo core kinase-
dependent and independent manner (Badouel et al., 2009; Hamaratoglu et al., 
2006). Therefore, proteins that impinge on Ex function would be expected to 
influence the activity of Yki. This is indeed the case with Crb, where 
overexpression of Crbi results in Ex degradation and increased Yki activity (Chen 
et al., 2010; Grzeschik et al., 2010; Ling et al., 2010; Robinson et al., 2010). To 
test the ability of the CK1 kinases to regulate Yki activity, the Hippo pathway 
enhancer trap ex-lacZ was used as readout for Yki activity (Boedigheimer and 
Laughon, 1993). UAS-transgenes were expressed in wing imaginal discs under 
the control of hh-Gal4. GFP control discs showed no difference between β‐Gal 
staining in the posterior and anterior compartments. As expected, wing discs with 
RNAi-mediated depletion of hpo, or Crbi overexpression both caused an increase 
in β‐Gal staining as a result of Yki activation, althought the increase in  β‐Gal 
staining in the Crbi expressing control was very mild (Figure 5-7A-C). Of all the  
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Figure 5-7 Overexpression of CK1 family kinases regulates ex-lacZ in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing an ex-lacZ enhancer-
trap (A-H’) Single channel images show β-Gal staining in a planar section in line with the nuclei 
of the wing pouch. Nuclei are marked by DAPI staining (blue) and the posterior compartment 
expressing hh-Gal4 is marked by expression of GFP. Expression of GFP under the control of hh-
Gal4 (negative control) did not alter levels of β-Gal (A). Expression of the positive controls hpoIR 
(B) and crbi (C) using hh-Gal4 led to an increase in β-Gal levels in the posterior compartment. 
Expression of ck1α (D) and dco (E) increased levels of β-Gal, whereas expression of gishisoB (F), 




CK1 transgenes tested, only ck1α overexpression resulted in mild autonomous 
increase in  β‐Gal staining, suggesting this gene activates Yki (Figure 5-7D). 
Overexpression of dco, gishisoB, gishisoB KD and gishisoF had no effect on β‐Gal 
staining when compared to the anterior compartment internal control (Figure 
5-7E-H).  It would be expected that if these kinases promote degradation of Ex, 
there would be an increase in Yki activity through inactivation of Hippo signalling, 
Yki thus being free to enter the nucleus and initiate its transcriptional programme. 
Here only ck1α can regulate the Hippo pathway, consistent with its putative role 
in degrading Ex, and activating Yki. 
In addition, in collaboration with Maxine Holder of the Francis Crick Institute, to 
gain of function analysis of Hippo reporters, ck1α and gish mutant clones were 
analysed for Yki activity using the diap1-lacZ and ex-lacZ reporters respectively. 
In ck1α mutant tissue, levels of diap1-lacZ were dramatically decreased, whereas 
ex-lacZ remained unchanged in gish mutant tissue (collaborator data not show). 
This is consistent with ck1α appearing to be the prominent CK1 isoform in 
regulating Ex in vivo. Furthermore, a decrease in Yki reporter activity in ck1α 
clones is also consistent with an increase in Ex levels seen in ck1α clones 
(collaborator data not show), which should inhibit Yki. Interestingly ck1α clones 
also increase the apical proteins Crb and Gish , and produce large rounded 
clones (collaborator data not show), which are phenotypes common to core Hippo 
pathway mutants which all up-regulate Yki activity (Edgar, 2006; Genevet et al., 
2009; Xu et al., 1995). However, this is in direct contrast to the obvious down-
regulation of diap1-lacZ seen in ck1α mutant clones (collaborator data not show). 
Perhaps this suggests that despite an increase in the apical membrane, Ex levels 
are stabilised which results in Yki inhibition. More work needs to be carried out to 
confirm this hypothesis, and the phenotypes observed may be the result of the 




 Concluding Remarks 
This chapter establishes the CK1 family of kinases as important regulators of Ex 
stability and the Hippo pathway. In S2 cells the CK1 kinase Gish appears to be 
crucial in mediating the Crb-dependent degradation signal for Ex, whereas in vivo 
the kinase seems more likely to be CK1. Precise delineation of the CK1-Ex 
regulatory axis is complex due to potential synergistic action of the CK1 family 
members, and and discrepancies between the analyses in cells and in vivo is still 
required. However, despite these shortcomings, the results from this chapter 
suggest the CK1s are novel regulators of the Drosophila tumour suppressor Ex, 
and will be discussed in more detail in ‘8.1 - The Regulation of Ex Stabilty by 






 Results 4 – The Reversibility of Expanded 
Degradation 
Crb regulates Ex by stimulating its phosphorylation, ubiquitylation and 
degradation through the proteasome. However, phosphorylation and 
ubiquitylation are both reversible post-translational protein modifications. The 
subsequent chapter will deal with the identification of a potential DUB, that can 
stabilise Ex protein thus reversing the action of the Ex kinase, and E3-ligase 
stimulating Ex degradation upon Crb-mediated stimulus.  
 Usp2 – A Novel Regulator of Expanded Stability 
The Drosophila DUB CG14619 or Ubiquitin Specific Protease 2 (Usp2) has a high 
level of homology with the mammalian Usp2. However, Usp2 also has a low level 
of homology with the mammalian Ubiquitin Specific Protease 37 (Usp37), which 
in mammals can interact with the SCF components β-TrCP1 and 2, SKP1 and 
CUL1, and is itself targeted for SCF-mediated ubiquitylation and degradation 
(Burrows et al., 2012). As Ex stability is regulated by the SlmbSCF complex, the 
ability of Drosophila Usp2 as a potential regulator of Ex stability was assessed. 
Initial experiments were performed by my PhD supervisor, Paulo Ribeiro, these 
data being included in the appendix to this thesis.  
To this end, Usp2 isoform A overexpression was analysed in S2 cells in 
combination with CrbFL, which stimulates Ex phosphorylation and degradation. 
Interestingly, Usp2 overexpression robustly stabilises Ex1-468 protein, despite 
CrbFL expression (Figure 9-1A). Moreover, Usp2 overexpression does not inhibit 
the ability of CrbFL to induce Ex1-468 phosphorylation, seen clearly as the Crb-
induced Ex doublet still forms (Figure 9-1A lane 3). This suggests Usp2 may act 
downstream of the Crb-dependent Ex kinase, but upstream of Slmb and can 
therefore stabilise Ex protein even when it has been phosphorylated and targeted 
for degradation. DUB protease domains are highly conserved and contain amino 
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acid residues vital to their catalytic function, the USP family containing two 
conserved cysteine and histidine boxes, which contain the catalytic triad and 
active site residues (Amerik and Hochstrasser, 2004). Point mutations of these 
key residues can render DUBs catalytically inactive (Amerik and Hochstrasser, 
2004). In order to test whether the ability of Usp2 to stabilise Ex in cells is 
dependent on the DUB enzyme activity, Usp2 isoform A and C were rendered 
catalytically inactive by generating point mutations at C540A and C622A 
respectively, these cysteine residues being key to enzyme activity (Engel et al., 
2014). Wild-type Usp2 isoforms A and C are able to stabilise Ex upon CrbFL 
induced overexpression, with the Ex doublet remaining intact (corresponding to 
phosphorylated and un-phosphorylated) as described above (Figure 9-1B lanes 
3, 6). Compared to CrbFL expression, which completely degraded Ex1-468, catalytic 
mutants of Usp2 appeared to still be able to stabilise Ex protein (Figure 9-1B 
lanes 4, 7). This could be explained through Usp2 mutants retaining some DUB 
activity, Usp2 catalytic mutants promoting the interaction of the endogenous 
Usp2 with Ex or that Usp2 catalytic mutants interact with Ubi-Ex sterically 
inhibiting degradation. However, the Usp2 wild-type isoforms appeared much 
more efficient at stabilising Ex upon CrbFL overexpression than the catalytic 
mutants suggesting the catalytic DUB domain of Usp2 is important for regulating 
Ex protein stability (Figure 9-1B lanes 3-4, 6-7).  
As a putative regulator of Ex stability, usp2 should have a role in regulating tissue 
size. Therefore, adult wing size was assessed with weak UAS-usp2(III) 
overexpression (construct located on the third chromosome) and RNAi-mediated 
UAS-usp2 knockdown. This was also carried out in combination with weak ex 
overexpression to analyse genetic interactions with this gene. In this instance, 
nub-Gal4 was used to promote UAS-transgene expression in the whole wing 
pouch (Cifuentes and García-Bellido, 1997). Compared to control wings 
overexpressing GFP, wings overexpressing ex were smaller but maintained 
correct morphology and patterning as expected (Figure 9-2A-B, K-L). When usp2 
was overexpressed, wings were also significantly smaller than nub>GFP control 
with complete loss of the anterior cross vein (Figure 9-2C, K-L). Moreover, there 
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was a genetic interaction when usp2 overexpression was combined with ex 
overexpression, as adult wings were smaller than the UAS-GFP control, and the 
UAS-usp2(III) or UAS-ex alone (Figure 9-2D, K-L). This suggests usp2 and ex can 
work together in the regulation of adult tissue size. One possible explanation for 
this is that Usp2 can directly stabilise Ex through its DUB activity, blocking Ex 
proteasomal degradation and enhancing the ability of Ex to inhibit Yki, similarly 
to that of ExS453A (Figure 3-3F, Figure 9-2D, K-L). An alternative possibility is that 
usp2 and ex regulate growth in parallel, or that usp2 affects growth through a 
Hippo-independent mechanism. However, these in vivo results combined with the 
data generated in S2 cells suggest that Usp2 employs a possible Hippo pathway 
and Ex-specific mechanism of growth regulation. In contrast to usp2 
overexpression data, data obtained by RNAi-mediated depletion of usp2 does not 
fit with this proposed model. Three different RNAi lines targeting usp2 result in 
mild but significant undergrowth wings compared to the nub>GFP control (Figure 
9-2E, G, I, K-L). These RNAi lines also appear to interact with UAS-ex as the 
combination of ex overexpression and usp2 depletion results in mildly smaller 
wings than UAS-ex alone (Figure 9-2F, H, J, K-L). These sets of data are difficult 
to reconcile with one another as they provide the same phenotype with opposite 
predicted levels of Usp2. As Usp2 likely has many potential substrates, this result 
does not rule out the possibility that Usp2 regulates Ex. Indeed, the efficiency of 
the Usp2 RNAi lines needs to be established by Quantitative Real Time-PCR 
(qRT-PCR), or through combining Usp2 overexpression and knockdown in the 
same tissue to test whether the overexpression phenotypes can be rescued.  
In addition to analysing adult wing phenotypes, analysis of Ex levels using the 
ubi-ex1-468::GFP reporter in wing imaginal discs was also carried out using two 
UAS-usp2 overexpression lines obtained from Marie-Odile Fauvarque (Institut de 
Biosciences et Biotechnologies de Grenoble) (Engel et al., 2014). These two UAS 
lines present dramatically different phenotypes, which is presumably the result of 
varying degrees of usp2 overexpression, perhaps due to their different genomic 
insertion sites, resulting in a dramatic affect on expression levels (Figure 6-1). 
Overexpression of the stronger usp2 transgene (usp2(II)) under the control of hh- 
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Figure 6-1 Effect of Usp2 on Ex stability in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing ubi-ex1-468::GFP (A-
C’) or ubi-ex1-468 S453A::GFP (D-D’). Single channel images show GFP staining in maximum 
intensity projection of the apical domain. Nuclei are marked by DAPI staining (blue in C-D) and 
the posterior compartment expressing hh-Gal4 is marked by the absence of Ci staining (red in A-
D’). Experiments whereby expression of usp2(II) (A) or usp2(II); crbi (B) was induced by hh-Gal4 at 
18oC resulted in a severe disruption of tissue organisation and morphology (A-B), or the complete 
absence of the posterior compartment in the case of usp2 and crbi co-expression (B). Expression 
of usp2(III) under the control of hh-Gal4 at 25oC led to an increase in the levels of ubi-ex1-468::GFP 
(C) and ubi-ex1-468 S453A::GFP (D). 
 
Gal4 results in highly disrupted posterior and anterior compartments even when 
developing larvae were raised at 18oC making the analysis of the ubi-ex1-468::GFP 
reporter difficult, although there is a suggestion that GFP levels are increased 
when Usp2 is expressed (Figure 6-1A). When this strong transgenic Usp2 line 
was used in combination with crbi overexpression, there was complete exclusion 
of the posterior compartment (Figure 6-1B). 
In wing imaginal discs overexpressing a weaker usp2 transgene (usp2(III)), which 
survive when developing at 25oC, the ubi-ex1-468::GFP reporter increases in the 
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hh-positive posterior compartment, which suggests usp2 may regulate ex post-
translationally (Figure 6-1C). Moreover, usp2 overexpression also resulted in the 
mutant ubi-ex1-468 S453A::GFP reporter levels increasing (Figure 6-1D) which 
indicates that despite the ExS453A mutation being highly effective at stabilising Ex, 
this mutant version of Ex can still be degraded, alluding to additional regulatory 
sites in Ex, beyond that of S453. Alternatively, this result could imply that Usp2 
regulates basal levels of Crb-mediated Ex degradation if Crb regulates Ex beyond 
the S453 residue alone. One limitation of the experiments carried out using the 
weak usp2(III) overexpression construct is that due to experimental genetic 
limitations, this line cannot easily be tested with UAS-crbi overexpression, and so 
the ability of Usp2 to regulate Crb-mediated regulation of Ex specifically has not 
been assessed yet.   
As usp2 overexpression potentially regulates growth (Figure 9-2) by stabilising 
Ex (Figure 9-1, Figure 6-1), it would be expected that usp2 would also control the 
activity of Yki. Therefore, the ex-lacZ enhancer trap was used as a readout of Yki 
activity in combination with usp2 overexpression (Boedigheimer and Laughon, 
1993). As Yki regulates ex expression, activity of Yki can be inferred from 
analysing the activity of this promoter through β-Gal staining. Driving strong 
usp2(II) expression using ap-Gal4, which drives UAS-transgene expression in the 
dorsal compartment of the wing disc (Cohen et al., 1992; Rincon-Limas et al., 
1999), or weak usp2(III) expression by hh-Ga4 resulted in severely disrupted wing 
disc morphology associated with cell death as judged by pyknotic nuclei, and it 
was difficult to assess β-Gal staining (Figure 6-2A-D’). As an alternative ptc-Gal4 
was used, which drives expression along the anterior-posterior compartment 
boundary (Brand and Perrimon, 1993; Phillips et al., 1990). Staining of β-Gal, the 
translated product of the lacZ gene was first analysed in control wings 
overexpressing either GFP or hpoIR under the control of ptc. As expected, RNA-
mediated depletion of hpo resulted in an increase in β-Gal staining, as hpo 
depletion results in de-repressed Yki, as well as an expansion of the GFP-positive 
area, corresponding to an increase in proliferation and apoptosis-resistance 
(Figure 6-2E-F). In discs overexpressing the weak usp2(III) transgene, there  
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Figure 6-2 Usp2 overexpression regulates ex-lacZ in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing an ex-lacZ enhancer 
trap (A-H’). Single channel images show β-Gal staining in a planar section in line with the nuclei 
of the wing pouch. Nuclei are marked by DAPI staining (blue). The dorsal compartment 
expressing ap-Gal4 is marked by expression of GFP (A’, B’), and the posterior compartment 
expressing hh-Gal4 is marked by expression of GFP (C’, D’). The anterior-posterior compartment 
boundary where ptc-Gal4 is expressed is marked by the presence of GFP (E’-H’). ap-Gal4 (A), 
hh-Gal4 (C) or ptc-Gal4 (E)-mediated expression of GFP as a negative control had no overt effect 
on the levels of β-Gal. Expression of ptc>hpoIR was used as a positive control and resulted in an 
increase in the levels of β-Gal (F). Expression of ptc>usp2(III) decreased levels of β-Gal (G). 
Expression of  the weak Usp2 overexpression construct usp2(III) by hh-Gal4 (D) or the stronger 
Usp2 overexpression construct usp2(II) by ap-Gal4 (B) or ptc-Gal4 (H) severely disrupted tissue 
morphology and induced apoptosis, thereby making it difficult to assess its effect on β-Gal levels 
representative of ex expression. 
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appeared to be a slight decrease in β-Gal staining within the GFP-positive 
expression domain, suggesting Yki-activity was repressed (Figure 6-2G – see 
yellow arrows). Moreover, the size of the GFP-positive domain was reduced, 
suggesting limited proliferative potential or enhanced apoptosis (Figure 6-2G), 
consistent with the adult wing analysis (Figure 9-2). These data support the role 
of usp2 as a positive regulator of Ex, as Usp2 overexpression would result in 
increased Ex levels, and subsequent increased Hpo pathway activity and 
decreased Yki activity and, therefore, growth inhibition. However, overexpression 
of the strong usp2(II) transgene resulted in severely disrupted morphology making 
β-Gal staining difficult to interpret, as in the case of ap-Gal4 and hh-Gal4 driven 
usp2 expression (Figure 6-2H). There also appeared to be large areas where 
there was extensive cell death in discs overexpressing this strong usp2(II) 
transgene, judged by the DAPI nuclear staining and the appearance of pyknotic 
nuclei, which would conform to the model of increased Ex levels, and the 
promotion of apoptosis (Figure 6-2H’). Mammalian USP2 has been shown to 
regulate apoptosis through several mechanisms (Mahul-Mellier et al., 2012a; 
Mahul-Mellier et al., 2012b; Oh et al., 2011), so whether the cell death observed 
is the result of excessive Ex or due to other factors remains to be seen, and more 
needs to be done to confirm these observations, such as analysing additional Yki-
target genes, or through epistatic analysis with other Hippo pathway members.  
 Concluding Remarks 
Although the data obtained in this section are somewhat preliminary, there is 
evidence to suggest usp2 could regulate growth through the modulation of Ex 
stability, which will be discussed more thoroughly in ‘8.1 - The Regulation of Ex 
Stabilty by Phosphorylation and Deubiquitylation’. However, discrepancies 
between depletion and overexpression of usp2 need to be reconciled before a 
definite role of usp2 in the Hpo pathway is confirmed, analysis of mutant usp2, 




 Results 5 – A Screen to Identify 
Ubiquitylating Enzymes Involved in Regulating Tissue 
Growth 
There are approximately forty five putative DUBs that have been identified in 
Drosophila (Zhang et al., 2012), many of these proteins remaining 
uncharacterised. In order to assess which of these DUBs are important in 
regulating tissue growth, a library of DUB-RNAi lines, including deSUMOylases 
and deNEDDylases was expressed in the adult wing using the nub-Gal4 driver, 
and the total area of the wing in the different samples was used as the phenotypic 
readout. All DUB families are represented except the newly identified MINDY 
family, which has no known orthologues in Drosophila. Being interested in the 
mechanisms that regulate Hippo signalling, and in particular ex, these same RNAi 
lines were used to carry out a modifier screen, with the aim of discovering genetic 
interactions between DUB depletion and weak overexpression of full-length ex, 
which reduces overall wing size by 40% (Figure 7-1, Figure 7-2, Figure 7-3, 
Figure 7-4, Table 7-1).  
Crosses were carried out in batches, each with a nub>GFP and/or a nub>ex 
control. To be able to compare the results obtained from different crosses, rather 
than using the raw area measured in pixels, results were standardised to the 
nub>GFP control group, for which the average wing size area was set to 100%. 
Each sample, or group was then calculated as a fraction of this control group, 
giving the size as a percentage of the mean nub>GFP control. These normalised 
results were then plotted and, for simplicity, the results were organised by DUB 
family (Figure 7-1, Figure 7-2, Figure 7-3, Figure 7-4). Note that the results for 
the USP family of DUBs were split into three individual plots as this is the largest 
DUB family (Figure 7-1). Where possible, the data for an individual nub>DUBIR 
genotype was plotted adjacent to its concordant nub>ex, DUBIR genotype to aid 
analysis, however not all DUBs are represented in both arms of the screen 




Figure 7-1 Summary of the role of USP family DUBs in tissue growth 
Graphs summarising the results of the in vivo screen for the role of USP family members in the 
regulation of tissue growth. Shown are the results obtained with RNAi-mediated depletion of 
DUBs using nub-Gal4 or nub-Gal4, UAS-ex as drivers.  Results of the USP screen are shown 
in three graphs due to the large number of members of this DUB family. Quantification of wing 
area was performed using ImageJ according to the protocol detailed in the Materials and 
Methods and wing area was normalised to control wings expressing GFP under the control of 
nub-Gal4 (A-C).  Individual data points are shown as well as the average ± SD of each of the 
genotypes analysed. Dashed line at 100% represents the mean of nub-Gal4, UAS-GFP 
controls and the dashed line at 60% represents the average relative size of nub-Gal4, UAS-ex 
controls. Groups were compared by a one-way ANOVA with a Turkey’s range post hoc test. 




Figure 7-2 Summary of the role of JAMM, OTU and UCH family DUBs in tissue growth 
Graphs summarising the results of the in vivo screen for the role of JAMM (A), OTU (B) or UCH 
(C) DUB family members in the regulation of tissue growth. Shown are the results obtained 
with RNAi-mediated depletion of DUBs using nub-Gal4 or nub-Gal4, UAS-ex as drivers. 
Quantification of wing area was performed using ImageJ according to the protocol detailed in 
the Materials and Methods and wing area was normalised to control wings expressing GFP 
under the control of nub-Gal4 (A-C). Individual data points are shown as well as the average ± 
SD of each of the genotypes analysed. Dashed line at 100% represents the mean of nub-Gal4, 
UAS-GFP controls and the dashed line at 60% represents the average relative size of nub-
Gal4, UAS-ex controls. Groups were compared by a one-way ANOVA with a Turkey’s range 




Figure 7-3 Summary of the role of the Josephine DUB family and ULPs in tissue growth 
Graphs summarising the results of the in vivo screen for the role of the Josephine DUB family 
(A) or the role of different ULPs (B) in the regulation of tissue growth. Shown are the results 
obtained with RNAi-mediated depletion of DUBs using nub-Gal4 or nub-Gal4, UAS-ex as 
drivers. Quantification of wing area was performed using ImageJ according to the protocol 
detailed in the Materials and Methods and wing area was normalised to control wings 
expressing GFP under the control of nub-Gal4 (A-C). Individual data points are shown as well 
as the average ± SD of each of the genotypes analysed. Dashed line at 100% represents the 
mean of nub-Gal4, UAS-GFP controls and the dashed line at 60% represents the average 
relative size of nub-Gal4, UAS-ex controls. Groups were compared by a one-way ANOVA with 
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GFP n/a 144 100 n/a n/a n/a n/a n/a n/a 
ex n/a n/a n/a n/a 185 59.2 *** 100 n/a 
USP 
Family 
CG12082 NIG 12082-R2 20 6.3 *** 29 4.2 *** 7.0 *** 
CG1490 VDRC 110324 KK 13 25.3 *** 19 14.2 *** 23.9 *** 
CG14619 VDRC 104382 KK 34 96.7 *** 19 55.7 *** 94.1 *** 
CG14619 NIG-FLY 14619R-1 n/a n/a n/a 20 47.8 *** 80.8 *** 
CG14619 NIG-FLY 14619R-3 n/a n/a n/a 13 46.1 *** 77.9 *** 
CG15817 VDRC 100992 KK 34 100.7 ns 18 60.5 *** 102.2 ns 
CG1945  VDRC 107716 KK 31 91.8 *** 20 59.5 *** 100.6 ns 
CG2904  VDRC 106671 KK 24 15.7 *** 20 10.2 *** 17.2 *** 
CG3016 VDRC 7090 GD 11 56.5 *** 26 56.9 *** 96.2 ns 
CG30421 VDRC 103553 KK 22 14.7 *** 25 58.8 *** 99.3 ns 
CG32479 VDRC 37859 GD 20 33.5 *** 21 5.9 *** 10.0 *** 
CG4165 VDRC 110286 KK 24 93.8 *** 21 60.4 *** 102.0 ns 
CG4166 VDRC 45775 GD (GD5) n/a n/a n/a 1 0.8 n/a 1.3 n/a 
CG4166 VDRC 45776 GD (GD6) n/a n/a n/a 4 55.2 *** 93.2 ns 
CG5384 VDRC 110227 KK 20 98.0 ns 22 65.2 *** 110.1 *** 
CG5486 VDRC 103743 KK 20 95.5 ns 26 54.8 *** 92.6 *** 
CG5505 VDRC 105989 KK 5 43.6 *** 19 28.0 *** 47.4 *** 
CG5603 VDRC 101414 KK 26 102.9 ns 25 61.6 *** 104.2 ns 
CG5794 VDRC 106192 KK 20 20.8 *** 26 13.5 *** 22.7 *** 
CG5798 VDRC 107623 KK 23 12.9 *** 23 20.8 *** 35.1 *** 
CG7023 VDRC 100586 KK 34 91.4 *** 23 55.9 *** 94.4 *** 
CG7288 n/a n/a n/a n/a 11 2.3 *** 3.9 *** 
CG8232 NIG 8232R-1 26 96.4 ns 26 55.5 *** 93.8 *** 
CG8334 VDRC 18981 GD (GD1) 24 95.9 ns 25 57.2 *** 96.6 ns 
CG8334 VDRC 18982 GD (GD2) 6 101.7 ns 26 59.4 *** 100.4 ns 
CG8494 VDRC 42609 GD 21 89.7 *** 22 52.6 *** 88.9 *** 
CG8830 VDRC 28960 GD 21 101.4 ns 20 59.5 *** 100.6 ns 
UCH 
Family 
CG1950 NIG 1950R-1 16 100.7 ns 24 57.6 *** 97.4 ns 
CG3431 VDRC 103481 KK 26 19.6 *** 22 61.4 *** 103.7 ns 
CG4265  VDRC 103614 KK 27 96.5 ns 21 59.9 *** 101.3 ns 
CG8445 VDRC 107757 KK 28 94.1 *** 19 61.2 *** 103.5 ns 
JAMM 
Family 
CG14884 NIG 14884-R1 16 26.8 *** 27 13.5 *** 22.8 *** 
CG18174 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG2224 VRDC 108622 KK 16 99.7 ns n/a n/a n/a n/a n/a 
CG3416 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG4673 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG4751 VDRC 45530 GD 26 93.4 *** 22 44.5 *** 75.2 *** 
CG6932 105385 KK 29 39.6 *** 21 25.3 *** 42.8 *** 
CG8335  VDRC 108169 KK 32 96.5 ns 24 59.8 *** 101.1 ns 
CG8877 DRC 18565 GD 26 98.9 ns 14 54.9 *** 92.7 *** 
CG9124 VDRC 36087 GD n/a n/a n/a 1 70.0 n/a 118.3 n/a 
CG9769 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
OTU 
Family 
CG12743 VDRC 108845 KK 24 97.0 ns 24 58.5   98.9 ns 
CG3251 VDRC 100532 KK 2 33.5 *** 24 12.8 *** 21.5 *** 
CG4603 VDRC 21893 GD 19 96.3 ns 29 59.7 *** 100.9 ns 
CG4968 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG6091 VDRC 109912 KK 19 95.4 ns 24 51.8 *** 87.6 *** 
CG7857 VDRC 105469 KK 25 90.0 *** 25 47.5 *** 80.2 *** 
CG9448 VDRC 24030 GD 17 86.3 *** 31 42.2 *** 71.3 *** 
Jos 
Family 




CG10107 VDRC 103524 KK n/a n/a n/a 4 6.5 *** 11.0 *** 
CG11023 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG12359 VDRC 106625 KK 16 12.4 *** 7 6.3 *** 10.6 *** 
CG12717 VDRC 106239 KK 23 98.8 ns 23 59.0 *** 99.8 ns 
CG1503 110486 KK 33 98.6 ns 27 61.2 *** 103.3 ns 
CG32110 VDRC 107634 KK 31 95.8 * 33 58.7 *** 99.2 ns 
CG41423 n/a n/a n/a n/a n/a n/a n/a n/a n/a 
CG8493 VDRC 100591 KK 30 97.5 ns 25 56.8 *** 96.0 ns 
MCPIP 
Family 
CG10889 NIG 10889R-2 15 78.0 *** 23 3.0 *** 5.1 *** 
# DUBS Tested alone: 44/55    
% DUBS Tested alone: 80    
# DUBS Tested with ex: 47/55    
% DUBS Tested with ex: 85.5    
N.B. Significance Determined by a One Way ANOVA With A Turkey's 
Range Post Hoc Test in GraphPad Prism 
   
   
n/a - not/applicable     
ns - not significant     
* P 
value 
<0.05       
*** P value <0.0001     
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Table 7-1 Summary of in vivo wing area DUB RNAi  
(Continued from previous page) A table to summarise the entire dataset obtained 
during the in vivo DUB RNAi screen to identify DUB genes that regulate tissue growth. 
Stock number (column 3) corresponds to the code number attributed to RNAi lines by the 
RNAi stock repositories. KK and GD lines were obtained from the Vienna Drosophila 
RNAi Centre (VDRC, Austria) and NIG RNAi lines were sourced from the National 
Institute of Genetics (NIG-Fly, Japan). Gene names and CG numbers are according to 
Flybase. Wing area of individual genotypes was normalised to the average wing area of 
nub-Gal4, UAS-GFP controls (columns 5, 8) and to the average wing area of nub-Gal4, 
UAS-ex controls (column 10). Analysis of the statistical significance of the screen results 
was performed using one-way ANOVA with a Turkey’s range post hoc test (columns 6, 9, 
11). 
 
When compared to nub>GFP control wings, RNAi-mediated depletion of many 
DUBs caused a reduction in tissue size, whereas no genotype resulted in an 
increase in wing size (Figure 7-1, Figure 7-2, Figure 7-3, Figure 7-4, Table 7-1). 
Within the population of DUBs that significantly perturb tissue growth, there 
seems to be no trend within a particular DUB family. The DUB showing the most 
drastic disruption of wing growth is CG12082. RNAi-mediated depletion of 
CG12082 resulted in wings that were 6.3% the size of control nub>GFP wings 
(Figure 7-1 A). Overexpression of a weak ex construct causes a 40% reduction 
in wing size, with the wings appearing narrower that the nub>GFP controls 
(Figure 7-1, Figure 7-2, Figure 7-3, Figure 7-4, Table 7-1). When DUB-RNAi lines 
were expressed in combination with ex overexpression, the majority of lines 
tested phenocopied overexpression of ex alone and therefore did not genetically 
interact with ex (Figure 7-1, Figure 7-2, Figure 7-3, Figure 7-4, Table 7-1). 
As nub>ex alone causes a reduction in wing area, in addition to comparing the 
results to the nub>GFP control group, nub>ex, DUBIR were also compared to a 
standardised nub>ex control group, in order to present results as a percentage 
of the nub>ex control group, which for this analysis was set to 100%. Depletion 
of DUBs with a value statistically indistinct from 100 had no effect on the reduction 
of size caused by ex-overexpression alone. However, many genotypes were 
significantly smaller than the nub>ex control (Table 7-1), and therefore genetically 
interact with this tumour suppressor gene. To investigate the functional relevance 
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of the putative genetic interaction between the DUBs and ex, only the DUBs for 
which nub>DUBIR and nub>ex, DUBIR data was collected were taken forward for 
further analysis. To visualise how these results relate to each other more readily, 
the normalised nub>GFP control values for each nub>DUBIR/ nub>ex, DUBIR pair 
were sorted in descending order, in relation to the nub>DUBIR result, and plotted 
on the same axis (Figure 7-5A). These genotypes broadly followed the same 
trend, whereby DUBs that did not dramatically influence tissue size, did not 
influence the ability of ex overexpression nor reduced tissue size. Hence, most 
nub>DUBIR genotypes cluster close to the 100% value, i.e. the do not 
dramatically influence growth, with their concomitant nub>ex, DUBIR value 
clustering around 60% wing size, comparable to the nub>ex alone control (Figure 
7-5A). In cases where the depletion of DUBs resulted in a decrease in tissue size 
(i.e. relative wing values significantly less than 100%), concurrent overexpression 
of ex generally resulted in enhanced reduction in tissue size, with the reduction 
in size remaining at around 40%, mirroring the effect of the DUBIR alone and 
suggesting no genetic interaction (Figure 7-5A). In order to dissect the genetic 
interaction between each DUB and ex, the nub>DUBIR /nub>ex, DUBIR pairs were 
directly compared by calculating the percentage difference in wing size between 
them, and comparing this value to the percentage difference in size between the 
nub>GFP and nub>ex controls, which is 40% (Figure 7-5B). To obtain these 
values, the standardised nub>ex, DUBIR value was subtracted from the 
nub>DUBIR alone standardised value. These results were then sorted into 
descending order and plotted, with the difference between the controls being 
marked by a gridline at 40% (Figure 7-5B). Most of the values represented were 
in close proximity to the 40% mark, corroborating what was discussed earlier and 
that in general, DUBIR depletion did not enhance the tissue undergrowth caused 
by ex-overexpression. In cases where the value for an individual DUB is between 
40% and 0%, the difference between the nub>DUBIR and the nub>ex, DUBIR is 
less than between the controls, suggesting the UAS-ex phenotype has been 
suppressed. Values of approximately 0% are observed when there is no different 
between the nub>DUBIR and the nub>ex, DUBIR, UAS-ex having no influence 
over the UAS- DUBIR phenotype (Figure 7-5B). 
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Strikingly, upon analysis of these figures (Figure 7-5), three DUBs stand out as 
genetically interacting with ex. Depletion of either CG3431 or CG30421 caused 
a dramatic and significant decrease in tissue size compared to the nub>GFP 
control, an 80% and 85% size reduction respectively (Table 7-1). However, in 
combination with overexpression of ex, wing size is reduced by only 39% for 
CG3431, or 41% for CG30421 (Table 7-1), with the wings being much larger  
 
Figure 7-4 DUB screen identifies the MCPIP family member CG10889 as a regulator of 
tissue growth in vivo 
Graph summarising the results of the in vivo screen for the role of the MCPIP family (A) in the 
regulation of tissue growth. Shown are the results obtained with RNAi-mediated depletion of 
CG10889 using nub-Gal4 or nub-Gal4, UAS-ex as drivers. Quantification of wing area was 
performed using ImageJ according to the protocol detailed in the Materials and Methods and 
wing area was normalised to control wings expressing GFP under the control of nub-Gal4 (A). 
Individual data points are shown as well as the average ± SD of each of the genotypes 
analysed. Dashed line at 100% represents the mean of nub-Gal4, UAS-GFP controls and the 
dashed line at 60% represents the average relative size of nub-Gal4, UAS-ex controls. All 
groups showed statistical difference as determined by a one-way ANOVA analysis with a 
Dunnett’s multiple comparison post hoc test (*** = P < 0.0001). See Table 7-1 for details and 
statistical analysis (A). Adult wings expressing different transgenes under the control of nub-
Gal4. Shown are the adult wings of flies expressing a GFP transgene as control (B), ex (C) 
CG10889R-2 (D) and ex,CG10889R-2 (E).  
than with expression of DUB RNAi alone. This manifested itself as a highly 
negative value when comparing the percentage difference between the 
nub>DUBIR and the nub>ex, DUBIR, purple circles highlighting these data points 
(Figure 7-5 - highlighted by purple circles). Raw data for these DUBs (i.e. adult 




Figure 7-5 Compilation of DUB screen results 
Pairwise comparison of the relative wing areas quantified in the in vivo RNAi screen. Blue 
inverted triangles represent data obtained with DUB depletion using nub-Gal4 as a driver, while 
the green triangles depict the data obtained when DUBs were depleted in the presence of UAS-
ex co-expression (nub-Gal4, UAS-ex) (A) (Continued on next page). 
164 
 
(Continued from previous page) Wing area was normalised to the average size of control 
wings expressing nub-Gal4, UAS-GFP. Data are organised by descending wing area relative 
to the nub-Gal4, UAS-GFP mean value. Dashed line at 100% represents the average wing size 
of nub-Gal4, UAS-GFP controls, while the dashed line at 60% represents the average relative 
wing size of wings expressing UAS-ex under the control of the nub-Gal4 driver. Pairwise 
percentage difference between the mean relative wing size of nub-Gal4, UAS-DUBIR samples 
and the mean relative wing size of nub-Gal4, UAS-ex, UAS-DUBIR (B). Dashed line at 40% 
represents the difference between the nub-Gal4 and nub-Gal4, UAS-ex values obtained in 
control genotypes (UAS-GFP). Dashed line at 0% represents no difference between the nub-
Gal4 and nub-Gal4, UAS-ex values (B). Red and purple circles/lines highlight the genes that 
are further discussed in the main body of the thesis (CG10889, CG3431 and CG30421) (A-B). 
See Table 7-1 for details and statistical analysis. 
 
alone causes a large reduction in tissue size, it is difficult to explain how depletion 
of a DUB that causes tissue undergrowth could be rescued by overexpression of 
ex. One possible explanation for this comes with the observation that for both 
CG3431 and CG30421, the nub>ex, DUBIR value is statistically indistinct from the 
nub>ex control (Figure 7-5, Table 7-1). This could suggest that there has been 
an error during phenotypic analysis, and that the Drosophila whose wings were 
analysed did not possess the DUBIR, but only the UAS-ex construct. This would 
be a very simple explanation for wings of animals of these genotypes being 
exactly the same size as nub>ex control animals. However, this analysis needs 
to be repeated in order to confirm this conclusion, as it cannot yet be ruled out 
that overexpression of ex results in modification of key DUB substrates such that 
expression of UAS-DUBIR no longer regulates growth.  
The other positive candidate for further analysis based on these parameters is 




 CG10889 – A Regulator of Growth and a Novel Yorkie 
Interacting Protein 
One of the positive candidates form the DUB screen was CG10889, the 
Drosophila orthologue of mammalian ZCH12A/MCPIP1, which is a putative DUB 
that regulates JNK and NF-κB signalling, but is more commonly thought to be an 
RNA-interacting protein (Fraile et al., 2012; Liang et al., 2010). Results from the 
screen showed depletion of CG10889 caused a modest, but significant 12% 
reduction in wing size compared to nub>GFP (Figure 7-4, Table 7-1). 
Interestingly, nub>ex, CG10889IR dramatically enhanced the effect of either ex or 
CG10889IR alone (Figure 7-4, Table 7-1). Of all of the DUBs analysed, CG10889 
showed by far the largest enhancement of the nub>ex undergrowth phenotype 
(Figure 7-5), highlighted by a percentage-difference score of 75%, compared to 
the 40% between the controls (Figure 7-5 - highlighted by red circles). These data 
suggest that CG10889 and ex genetically interact with regards to wing size, which 
is particularly interesting as a global mass spectrometry study in Drosophila 
identified CG10889 as a putative interaction partner of the Hippo pathway effector 
Yki (Guruharsha et al., 2011). In order to confirm preliminary data demonstrating 
RNAi-mediated knockdown of CG10889 reduced wing size without disrupting 
patterning, depletion of CG10889 was repeated using nub>Gal4, and 
MS1096>Gal4, a whole wing driver (Capdevila and Guerrero, 1994). 
Consistently, depletion of CG10889 resulted in a decrease in total wing area 
(Figure 7-6B, F, G-H). As a potential genetic interaction between ex and 
CG10889 was identified genetic interaction with the key Hippo pathway kinase 
Wts was also assessed. CG10889 depletion was able to suppress the overgrowth 
induced by RNAi-mediated depletion of wts (Figure 7-6C-D), suggesting that 
CG10889 may positively interact with Yki, alluding to a potential involvement in 
Hippo signalling.  
Biochemically, the interaction between Yki and CG10889 was confirmed through 
co-immunoprecipitation experiments where FLAG-tagged Yki was purified from 




Figure 7-6 CG10889 regulates tissue growth in vivo 
Adult wings expressing GFP under the control of nub-Gal4 (A) were used as controls for the 
expression of CG10889R-2 (B), wtsR-1 (C), or CG10889R-2,wtsR-1 (D). Adult wings expressing 
GFP under the control of MS1096-Gal4 (E) were used as controls for the expression of 
CG10889R-3 (F). Note that the results obtained with knockdown of CG10889 using nub-Gal4 
as a driver were obtained independently of the main DUB in vivo screen. Quantification of wing 
area was carried out in ImageJ and wing area was normalised to the average wing size of 
controls expressing GFP under the control of nub-Gal4. Individual data points are shown as 
well as the average ± SD of each of the genotypes analysed. The statistical significance of the 
differences in the relative wing area size between the indicated genotypes was assessed by a 
one-way ANOVA with a Dunnett’s multiple comparison post hoc test (* = P < 0.05, ** = P < 
0.001 and *** = P < 0.0001) (G). Comparison between nub-Gal4, UAS-wtsR-1 and nub-Gal4, 
UAS-CG10889R-, UAS-wtsR-1 was obtained by performing a Student’s T-test analysis (G). 
Quantification of results obtained using MS1096-Gal4 as driver. Wing area was normalised to 
the average wing size of controls expressing GFP under the control of MS1096-Gal4. The 
statistical significance of the differences in the relative wing area size between the indicated 
genotypes was determined by a one-way ANOVA with a Dunnett’s multiple comparison post 
hoc test (*** = P < 0.0001) (H). 
 
mutations in conserved amino acid residues of the putative DUB enzymatic 
domain of CG10889 (D138N or C154A) (Liang et al., 2010) (Figure 7-7A lanes 3-
5). This suggests that enzymatically inactive CG10889 interacts more robustly 




Figure 7-7 CG10889 interacts with Yki in S2 cells 
Immunoblot of S2 cell lysates after co-immunoprecipitation of FLAG-tagged NTAN as a 
negative binding control (A - lane 1) or FLAG-tagged Yki (A – lanes 2-5). HA-tagged CG10889, 
CG10889D138N and CG10889C154A associated with Yki (A – lanes 3-5). Schematic 
representation of CG10889 (B) and Yki (C) highlighting their respective domain architecture. 
The different domains of CG10889 are UBA (Ubiquitin Associated Domain), ZnF (Zinc Finger), 
CCR (C-Terminal Conserved Region) and their nomenclature is based on Liang et al. (Liang 
et al., 2010) (B). For Yki, the different protein domains are Sd BD (Sd Binding Domain) and 
WW domains. Circled Ps represent Wts phosphorylation sites S111, S168 and S250 (Oh and 
Irvine, 2009), while the asterisks depict the termini of Yki truncations used in (E). Yki domain 
architecture nomenclature was based on Wu et al. (Wu et al., 2008) (C). S2 cell lysates after 
co-immunoprecipitation of FLAG-tagged NTAN as a negative binding control (D – lanes 1 and 
2), FLAG-tagged CG10889 (D – lane 3), PPxY point mutant CG10889Y413A (D – lane 4) or 
FLAG-tagged Yki (D – lanes 5 and 6). (Continued on next page). 
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(Continued from previous page) HA-tagged Yki associated with FLAG-tagged CG10889 but 
not CG10889Y413A (compare D – lanes 3 and 4). HA-tagged CG10889 but not CG10889Y413A 
interacted with FLAG-tagged Yki (D – compare lanes 5 and 6). S2 cell lysates expressing HA-
tagged CG10889 after co-immunoprecipitation of FLAG-tagged NTAN as a negative binding 
control (E – lane 1), FLAG-tagged Yki (E – lane 3), Yki1-140 (E – lane 4), Yki1-300 (E – lane 5), 
Yki1-369 (E – lane 6), YkiΔWW2 containing a point mutation in the WW2 domain (E – lane 7), or 
YkiΔWW1+2  containing point mutations in WW1 and WW2 (E – lane 8). HA-tagged CG10889 only 
bound FLAG-tagged Yki constructs with an intact WW2 domain (E – lanes 3, 6). S2 cell lysates 
and purified immunoprecipitates were analysed with the indicated antibodies and Tub was used 
as a loading control (A, D and E). 
which CG10889 can no longer cleave. Many of the Hippo pathway interactions 
are governed by WW-PPxY domain interactions, and Yki contains two 
WWdomains (Figure 7-7C) (Genevet and Tapon, 2011). Analysis of the protein 
sequence of CG10889 revealed a C-terminal PPxY motif, in addition to ubiquitin 
binding domains, an RNase domain, a zinc finger and a C-terminal conserved 
region (Figure 7-7B) (Liang et al., 2010). A cDNA construct containing a point 
mutation in the CG10889 PPxY motif, Y413A, was unable to interact with Yki 
through reciprocal co-IP experiments in S2 cells (Figure 7-7D), suggesting that 
the PPxY motif in CG10889 is essential for this interaction. To further characterise 
this binding, co-IP experiments were carried out using Yki truncations or 
mutations that remove one or both of its WW domains. Deletion of both WW 
domains, or mutation of the C-terminal WW domain (WW2) completely abrogated 
binding between CG10889 and Yki (Figure 7-7E). Together, these data suggest 
that the interaction between Yki and CG10889 is dependent on the PPxY motif 
of CG10889, and the WW2 domain of Yki.  
Due to the interaction with Yki, and the fact that depletion of CG10889 caused a 
decrease in wing area, the ability of CG10889 to modulate the expression of the 
Yki-target ex was assessed, using the ex-lacZ enhancer trap as an in vivo 
readout. Using the hh-Gal4 driver, RNAi-mediated depletion of CG10889 showed 
no obvious reduction in the expression of β-Gal, as would be expected if the 
undergrowth observed were the result of Yki inhibition (Figure 7-8A-B). In 
contrast, there even appeared to be a slight elevation in β-Gal staining upon 
CG10889 depletion (Figure 7-8C-D). Other Yki-transcriptional targets must be 
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assessed to assess the potential for CG10889 to regulate Hippo signalling, 
particularly as some reports suggest some Hippo pathway genes can regulate 
particular subsets of Yki-targets such as mop (Gilbert et al., 2011) or through 
perturbation of BMP signalling (Oh and Irvine, 2011).  
These preliminary results point to a role of CG10889 in the regulation of tissue 
growth, however, more work needs to be done to assess by what mechanism 
growth is regulated, and whether the interaction with Yki has any functional 
relevance in this regard.  
 
Figure 7-8 CG10889-mediated regulation of ex-lacZ in vivo 
Confocal micrographs of third instar larvae wing imaginal discs expressing the ex-lacZ enhancer-
trap (A-D’). Single channel images show β-Gal staining in a planar section in line with the nuclei 
of the wing pouch. Nuclei are marked by DAPI staining (blue) and the posterior compartment 
where hh-Gal4 is expressed is marked by the presence of GFP. Expression of GFP under the 
control of hh-Gal4 had no effect on the levels of β-Gal (A). Expression of hpoIR was used as 
positive control and resulted in a marked increase in the levels of β-Gal (B). hh-Gal4-mediated 
expression of CG10889R-2 mildly increased β-Gal levels (C), unlike the expression of CG10889R-




 Concluding Remarks 
Screening for DUBs that regulate tissue growth, and genetically interact with the 
Hippo pathway has yielded several candidate genes which, when knocked down 
reduce overall tissue size (Figure 7-5, Table 7-1). Moreover, several of these 
candidates also interact with ex. Of particular note was CG10889 which 
genetically interacts with ex and wts, and physically interacts with Yki, thus is a 




 The Regulation of Ex Stabilty by Phosphorylation and 
Deubiquitylation  
Crb promotes the phosphorylation and interaction of Ex with the E3 ligase 
component Slmb, ultimately targeting Ex for proteasomal degradation (Chen et 
al., 2010; Grzeschik et al., 2010; Ribeiro et al., 2014; Robinson et al., 2010). The 
coordinated regulation of Ex stability requires the involvement of many proteins, 
including kinases that trigger the initial binding between Slmb and Ex, and 
potential negative regulators of this mechanism such as a DUB that could reverse 
the Ex degradative signal. During the course of this thesis, evidence has been 
presented to suggest the CK1 family of kinases, and the DUB Usp2 may play 
antagonistic roles in the regulation of Ex stability and therefore the Hippo 
pathway.  
Indeed, at least in S2 cells, the CK1orthologue Gish interacts with Ex (Figure 
5-1C-D), stimulates interaction of Ex with Slmb (Figure 5-4C), and can stimulate 
Ex phosphorylation and degradation (Figure 5-2). Moreover, RNAi-mediated 
depletion of gish stabilises Ex, even in the presence of Crb overexpression 
(Figure 5-5), as well as inhibiting Crb-induced Ex interaction with Slmb (Figure 
5-6A), and ubiquitylation (Figure 5-6B). On the contrary, expression of the DUB 
Usp2 stabilises Ex protein in S2 cells, and in vivo (Figure 6-1 and Figure 9-1), 
which regulates wing growth (Figure 9-2) and influences Yki activity (Figure 6-2). 
These data allude to a model whereby Crb stimulates the CK1 family kinases 
triggering Ex phosphorylation and ubiquitylation by Slmb, which is antagonised 
by the DUB Usp2 (Figure 8-1). Interestingly, the CK1s play a prominent role in 
regulating the stability of many key signalling proteins in Drosophila and 
mammals, including Per/PER2 (Chiu et al., 2008; Eide et al., 2005; Price et al., 
1998)), which is a substrate shared with USP2 (Yang et al., 2012; Yang et al., 
2014). Per/PER2 protein levels are rhythmically regulated by coordinated 
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degradation by Slmb/β-TrCP (Eide et al., 2005; Grima et al., 2002), which 
requires phosphorylation by Dco/CK1δ/ε (Chiu et al., 2008; Eide et al., 2005) 
analogous to the regulation of Ex (see ‘Chapter 5 - Results 3 – The Role of Casein 
Kinase 1 Family Kinases in the Regulation of Expanded’) (Ribeiro et al., 2014; 
Zhang et al., 2015a). In the case of PER, USP2 regulates its subcellular 
localisation rather than stability, although this still depends on the DUB catalytic 
activity, relocating PER from the nucleus to the cytosol (Yang et al., 2012; Yang 
et al., 2014). Therefore there is a possibility that the CK1/Slmb/Usp2 axis is 
conserved in the regulation of Ex and Hippo signalling, as well as Per and the 
circadian rhythm. 
 
Figure 8-1 A revised model of Crb-mediated regulation of Ex 
Crb-mediated regulation of Ex phosphorylation and degradation requires the action of the CK1 
family kinases, and can be reversed by the DUB Usp2. 
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In addition to the CK1s and Usp2, the BMP kinases Sax, Tkv and Put could 
potentially be involved in the regulation of Ex stability (see 4.1), because at least 
in S2 cells, dsRNA-mediated depletion of these kinases results in mild 
stabilisation of Ex levels (Figure 4-3), and overexpression of Tkv causes 
phosphorylation of Ex, despite not stimulating Ex degradation (Figure 4-5). In 
mammals, CRB3 inhibits the BMP and Hippo pathways by limiting the 
translocation of a SMAD:YAP complex into the nucleus, which is dependent on 
the functional orthologue of Ex AMOT (Varelas et al., 2010). The interaction 
between YAP and SMAD is conserved in Drosophila, Yki and Mad forming dimers 
(Oh and Irvine, 2011), and it may therefore be possible that the Crb-mediated 
regulation of Mad may also be conserved, which would be particularly interesting 
if Ex played a similar role to AMOT in Drosophila, physically tethering both Yki 
and Mad away from the nucleus in a Crb-dependent manner, as Ex is known to 
do with Yki alone (Badouel et al., 2009; Oh et al., 2009). If the receptor kinases 
of the BMP pathway regulate Ex, stimulating either its degradation, or by 
degradative-independent phosphorylation, it would be interesting to see whether 
this process could disrupt a Yki:Mad complex, this relieving Crb-dependent 
inhibition, contributing to the activation of Mad. However, it is not yet known 
whether the interaction between Yki and Mad is regulated by Crb in Drosophila, 
or if this is the case, whether the BMP kinases would have any influence over this 
regulation of Yki:Mad, let alone whether Ex and Ex phosphorylation would be 
involved. In mammals at least, the TGFligand and the TGFReceptor I are able 
to promote the interaction between SMAD and YAP and their nuclear 
translocation by stimulating the E3 ligase ITCH to ubiquitylate and degrade 
RASSF1A, which otherwise inhibits SMAD:YAP interaction (Pefani et al., 2016). 
Therefore, the BMP receptors in Drosophila could possibly regulate the Hippo 
pathway, and this could be dependent on Ex.  
One caveat for much of the work presented is the discrepancy between results 
generated in S2 cells, and in vivo data, and many of positive findings of this thesis 
were identified using S2 cells. Whilst using S2 cells and cell lines in general can 
be of great benefit to dissecting the molecular detail of signalling pathways, and 
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individual relationships between proteins, care must be taken when extrapolating 
hypothesis to the whole organism. S2 cells only represent one population of cells, 
and thus cannot be entirely representative of the complex interplay between 
many genes in many cell types throughout a whole tissue or animal. Therefore 
perhaps some of the biochemical data obtained in this thesis may not truly reflect 
what occurs in Drosophila, or alternatively the in vivo techniques used are not 
sensitive enough to detect the observations made in S2 cells. To this end, robust 
methods to quantify levels of the ubi-ex1-468::GFP and the ex-lacZ reporters would 
be extremely beneficial for in vivo analysis and could provide more conclusive 
evidence as to whether the CK1s or the BMP kinases, or Usp2 do regulate levels 
of Ex protein, and whether these genes influence Yki activity.  
One of the prominent discrepancies between S2 cell and in vivo data is the 
difference between the CK1 family kinases. In S2 cells, much of the work has 
been focussed on Gish, which at least in this context, is a very promising 
candidate for a regulator of Ex stability downstream of Crb (see Chapter 5 -. 
However, in vivo mutations in gish do not influence levels of the ubi-ex1-468::GFP 
reporter, or Yki activity as measured by ex-lacZ, whereas ck1 mutation both 
increases levels of the ubi-ex1-468::GFP and decreases levels of ex-lacZ 
(collaborator data not shown). Moreover, overexpression of CK1also stimulates 
a decrease in the ubi-ex1-468::GFP reporter (Figure 5-3) and an increase in ex-
lacZ (Figure 5-7 ), in keeping with the model whereby Ex stability is negatively 
regulated by the CK1 kinases . Therefore, undue focus may have been put onto 
Gish, and instead CK1is likely to be the primary kinase in vivo in the regulation 
of Ex stability. It would be interesting to perform the same biochemical analysis 
of CK1in S2 cells as has been carried out with Gish, analysing binding of 
CK1to Ex, and whether dsRNA-mediated knockdown of ck1causes 
stabilisation of the Ex protein, inhibition of Ex:Slmb interaction and inhibition of 
Ex ubiquitylation.  
Another important issue that remains unresolved is whether the CK1 family 
kinases act synergistically or redundantly to regulate Ex stability. These kinases 
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are all highly conserved within the kinase domain, despite containing variable C-
termini (Knippschild et al., 2005; Knippschild et al., 2014), (Figure 5-1A). The high 
homology between CK1 kinases possibly explains why many family members 
induce Ex electrophoretic mobility shift and/or depletion in a kinase-dependent 
manner (Figure 5-2, Figure 5-3). This includes uncharacterised CK1s (Figure 
5-2C), such as CG7094, which is able to partially recover ubi-ex1-468::GFP levels 
in vivo (collaborator data not shown). Interestingly, combined expression of 
CK1α, Dco and GishisoI results in a more robust electrophoretic mobility shift when 
compared to individual kinase expression (Figure 5-2D). The ability of several 
members of the CK1 family to induce phosphorylation of Ex, raises a serious 
limitation in the identification of the Ex degradative kinase, as throughout this 
thesis, potential redundancy between these kinases is never explicitly tested, and 
so there can be no conclusion as to whether these kinases act synergistically or 
redundantly. Therefore it would be very interesting to perform double or even 
triple mutant knockouts of members of this kinase family assessing levels of Ex.  
Previous studies analysing the role of CK1 kinases have reported some degree 
of synergy between family members. In S2 cells and in vivo, the Ft kinase Dco, 
which promotes Ft-dependent growth inhibition (Sopko et al., 2009), is also 
influenced by CK1α (Feng and Irvine, 2009). Furthermore, several CK1s can act 
on Hh signalling, regulating Ci and Smo phosphorylation, and in Wnt signalling in 
the regulation of LRP5/6 (Jia et al., 2005; Li et al., 2016; Swarup et al., 2015; 
Swarup and Verheyen, 2012; Zeng et al., 2005).  
It may also be important to analyse the effect of CK1 family mutants in 
combination with Crb overexpression by generating Mosaic Analysis with a 
Repressible Marker (MARCM) clones (Lee and Luo, 1999). In cells, loss of 
function of gish was always carried out in the presence of Crb overexpression. 
Therefore, the reason for the discrepancy between the results in cells and in vivo 
may be the fact that the system needs to be primed by Crb overexpression. In 
the developing wing, the homeostatic regulation of Ex stability by Crb is likely to 
be subtle, and thus priming the system with Crb may be necessary in order to 
detect the changes in Ex (Figure 8-1).  
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In addition, to fully elucidate the mechanisms of Ex degradation, the specific 
residue(s) that are phosphorylated must be identified through in vitro kinase 
assays or phosphoproteomics. If the CK1 kinases are found to directly 
phosphorylate Ex, the residues they regulate will go some way to help dissect 
whether these kinases act synergistically or redundantly. Previously, the ExS453 
residue has been shown to be vital for Crb-mediated regulation of Ex stability, as 
its mutation to alanine abrogated Ex:Slmb binding, ubiquitylation and degradation 
(Ribeiro et al., 2014). ExS453 is part of the canonical Slmb phosphodegron 
452TSGIVS457, where it is assumed that S453 phosphorylation is required for Slmb 
recognition (Figure 5-4B) (Ribeiro et al., 2014). Within the phosphodegron, S457 
appears to be an attractive potential site for Ex phosphorylation. However, 
previous reports failed to uncover any effect of this residue on regulating Ex 
stability or interaction with Slmb (Ribeiro et al., 2014). S462 was also analysed, 
and its mutation limited but did not abolish the ability of Slmb to bind and degrade 
Ex (Ribeiro et al., 2014).  Interestingly, Crb-induced electrophoretic mobility shift 
occurred in single or double point mutations of these residues suggesting that 
despite regulating Ex stability, further residues of Ex are phosphorylated upon 
Crb stimulation (Ribeiro et al., 2014). The functional significance of the S453 
residue had not previously been established in vivo. The inability of Crbi to 
degrade ubi-ex1-468 S453A::GFP (Figure 3-1C-D), and the fact a UAS-exS453A 
transgene regulated growth in a manner insensitive to Crbi overexpression 
(Figure 3-3), suggest that S453 is important for Ex function. However, this does 
not prove that S453 residue is the target for CK1 phosphorylation.  
Interestingly, the ExS453 site does not conform to the canonical CK1 consensus 
site of pS/T-X1-2-S. However, analysing the sequence of Ex1-468 using online ELM 
(http://elm.eu.org/) and NetPhos (http://www.cbs.dtu.dk/services/NetPhos/) tools, 
a combined total of fourteen potential S/T residues within Ex1-468 conform to the 
CK1 consensus sequence (Table 8-1). As Crbi or Gish overexpression does not 
affect Ex1-450 (Figure 5-4A), this suggests that CK1s phosphorylate Ex within 
Ex450-468. Of the potential CK1 sites identified, only two lie within this region, ExT451 
and ExT452. Therefore, follow-up work should address whether these residues are 
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important. Interestingly, ExT452 is highly conserved among most insect species 
(Ribeiro et al., 2014). Moreover, conserved S/T residues exist immediately 
upstream to Slmb/βTrCP phospho-recognition sites in mammalian PER1, PER2 
(Ribeiro et al., 2014), and Ci (Smelkinson et al., 2007) suggestive of potential 
functional significance of this sequence.  
Table 8-1 A Summary of Potential CK1 Sites Within Ex1-468
A table highlighting sites within Ex1-468 conforming to CK1 the consensus sequences 
identified using ELM (http://elm.eu.org/) and NetPhos 
(http://www.cbs.dtu.dk/services/NetPhos/). 
Residue Sequence Context Identification Software 
ExS25 SPGSRFL ELM 
ExS93 SKLSKYG ELM 
ExS102 SWRSSHT ELM 
ExT105 SSHTHGL ELM 
ExS185 TSNSKDD NetPhos 
EXT208 SATTTLP ELM 
ExS338 STNSSSN ELM 
ExS396 SGESRIT ELM 
ExT372 SRITLYA ELM 
ExS445 SVISSTS ELM 
ExS448 SSTSSNT ELM 
ExS449 STSSNTT ELM / NetPhos 
ExT451 SSNTTSG ELM 
ExT452 SNTTSGI ELM / NetPhos 
   
 
Ft, which is phosphorylated by Dco, and to a lesser extent CK1α, contains up to 
forty six potential CK1 phosphorylation sites within the intracellular domain, the 
electrophoretic shift induced by Dco corresponding to multiple phosphorylation 
events (Feng and Irvine, 2009; Sopko et al., 2009). This has made the 
identification of a specific phosphorylation site in Ft difficult, and no single 
reported residue exists. In a similar fashion, Crb-mediated phosphorylation of Ex 
appears to involve several phosphorylation events, and the S453A point mutation 
is still shifted upon Crb expression, despite Ex increased stability (Ribeiro et al., 
2014). Perhaps one or more CK1 kinases phosphorylate Ex, which is the case 
with Ft (Feng and Irvine, 2009) Ci (Jia et al., 2005; Smelkinson et al., 2007) and 
Per (Chiu et al., 2011; Chiu et al., 2008). Alternatively, multiple kinases 
phosphorylate Ex upon Crb stimulation, of which the CK1s are only one family. It 
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is likely that an initial phosphorylation, probably within the Ex450-468 region, primes 
Ex for further phosphorylation to ultimately stimulate Ex degradation. If the 
hypothetical CK1 ExT451 and ExT452 sites are important for regulating Ex stability, 
as is the ExS453, these phosphorylation sites could cooperate in regulating Ex 
stability. 
Whilst the importance of the apical localisation of Crb and Ex has been discussed 
(Chapter 3 - and Chapter 5 -, in addition to localisation at the apical membrane, 
Crb can be internalised into endosomes. Inhibiting the function of genes such as 
cdc42, Rab11 or aPKC promotes Crb internalisation (Fletcher et al., 2012; Harris 
and Tepass, 2008; Kim et al., 2009; Roeth et al., 2009), whereas genes such as 
adaptor protein-2 (AP-2) or neuralised (neu) promote uptake of Crb into the 
endosomes (Lin et al., 2015; Perez-Mockus et al., 2017). Overexpressed Crb 
localises at the membrane and is also found in endosomes (Fletcher et al., 2012). 
Moreover, Crb can be recycled back to the membrane after endocytosis through 
the action of the retromer complex, interacting with Vacuolar Protein Sorting 35 
(Vps35) and Vacuolar Protein Sorting 26B (Vps26B) (Pocha et al., 2011; Zhou et 
al., 2011). Interestingly, Ex is also important for Crb stabilisation at the plasma 
membrane (Fletcher et al., 2012), and it has been proposed that Ex promotes 
endocytosis of apical proteins, with mutation in ex and mer resulting in 
accumulated apical receptors (Maitra et al., 2006). It may therefore be important 
to investigate the site of Crb-mediated Ex degradation and the role of the CK1 
family and Usp2 play here, particularly since Gish is able to regulate Rab11 
localisation in the developing wing (Gault et al., 2012), and in mammals, USP2 
regulates the  subcellular localisation PER2 (Yang et al., 2012; Yang et al., 2014). 
This could potentially be tested through Dynamin inhibition using the Dynamin 
inhibitor dynasore in cells (Macia et al., 2006), or the Dynamin mutant shibirets-1 




 Physiological Relevance of Crumbs-Mediated Expanded 
Degradation 
Crb is able to regulate Ex stability via interaction between the FBM of Crb, and 
the Ex FERM domain (Figure 3-1) (Chen et al., 2010; Grzeschik et al., 2010; Ling 
et al., 2010; Ribeiro et al., 2014; Robinson et al., 2010). However, besides the 
artificial overexpression of CrbFL or Crbi, which have both been used to stimulate 
Ex degradation, the physiological context that represents Crb overexpression 
remains an open question. One of the main upstream activators of Hippo 
signalling is the ability to sense changes in tissue architecture. To this end, Crb-
Crb trans-homodimers, which may be important for cell-cell communication, 
adhesion and stabilisation of Crb at the apical membrane (Chen et al., 2010; 
Fletcher et al., 2012; Hafezi et al., 2012; Letizia et al., 2013; Pellikka et al., 2002; 
Thompson et al., 2013; Zou et al., 2012), are ideally placed to allow tissues to 
respond to changes in morphology or integrity. The response of Crb to epithelial 
status can be observed in wing imaginal discs, where Crb staining is lost in 
wildtype cells in direct contact with crb mutant tissue (Chen et al., 2010; Hafezi 
et al., 2012). Moreover, Crb wildtype cells in contact with cells expressing a Crb 
extracellular domain construct (CrbECD) concentrate along the expression 
boundary (Hafezi et al., 2012). Indeed, as well as losing Crb, the membrane of a 
wildtype cell directly in contact with crb mutant tissue also loses Ex and Patj 
(Chen et al., 2010). These data imply Crb is able to sense epithelial integrity 
through its homophilic trans-interactions and can transit extracellular signals, into 
the intracellular domain. Therefore, if Crb levels are disrupted, for example by 
loss of polarity or apoptosis, this may trigger signalling downstream of Crb 
(Ribeiro et al., 2014). Interestingly, genetically wounding wing imaginal discs by 
disrupting polarity or inducing apoptosis causes non-autonomous activation of 
Yki, which facilitates tissue regeneration and wound healing (Grusche et al., 
2011; Sun and Irvine, 2011). This observation potentially provides context for 
physiological regulation of Ex by Crb, as Crb is regulated non-autonomously by 
loss of polarity in neighbouring tissue (Chen et al., 2010; Hafezi et al., 2012) and 
the ability of these genes to regulate regeneration should be investigated. In a 
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recent paper, which generates wounds through the ‘pinch and puncture’ 
technique in the larval epidermis, suggests ex is vital in regulating regeneration 
as ex overexpression completely blocks the regenerative capacity of the tissue. 
Interestingly, the capacity for ex to regulate regeneration is much greater than 
that of wts, suggesting the activity of Ex independent of the kinase cascade is 
crucial in its regulation of regeneration (Badouel et al., 2009; Tsai et al., 2017). 
If Crb is lost from the wound/wildtype interface, as it is at the crb mutant/wildtype 
interface (Chen et al., 2010; Hafezi et al., 2012), a non-autonomous increase in 
Yki activity could be the result of a loss in apical Ex. In this model, Crb may be 
asymmetrically redistributed away from the mutant or wound cell interface. If Crb 
is asymmetrically distributed, it would be expected that this increased membrane 
concentration of Crb would result in more trans- and cis-homodimers, as is the 
case inside the salivary gland placode during development (Roper, 2012). 
Moreover, this increased Crb would also increase membrane concentrations of 
Ex (Hafezi et al., 2012), negating the potential for these cells to stimulate Yki 
activity. Perhaps the increased number of Crb-homophilic interactions stimulates 
Ex degradation, promoting full activity of Yki, thus allowing the cell to recover. 
However, in contrast to this hypothesis, Ex expression and interaction with Crb is 
also important for stabilising Crb at the apical membrane (Fletcher et al., 2012).   
The role of YAP/TAZ in regulating tissue regeneration is conserved in tissues 
such as the intestine or liver (Cai et al., 2010; Su et al., 2015; Wu et al., 2013; 
Yimlamai et al., 2014). However, the role of CRB orthologues, or indeed Ex 
orthologues FRMD6 and AMOT in regeneration has not been determined. 
Recently, the Hippo pathway was shown to be important in regulating optimal 
myelin elongation in mouse neurones, which is dependent on YAP 
phosphorylation and activity (Fernando et al., 2016). Interestingly, this process 
relies on CRB3 and the mammalian Ex N-terminal orthologue FRMD6, which limit 
the myelin elongation to the appropriate length. In this system, growth is 
directionally regulated, and therefore could be analogous to regeneration, where 
proliferation occurs towards the wound. While the authors did not demonstrate 
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the molecular mechanisms employed in this system, it is possible that in this 
context CRB3 regulates FRMD6 directly in a similar manner to regulation of Ex 
by Crb in Drosophila. Analysing the protein sequence of FRMD6, there appears 
to be a conserved putative β–TrCP consensus site: 435TSGVES440 (Ribeiro et al., 
2014). Therefore, it will be interesting to see whether CRB3 can regulate FRMD6 
directly, and whether this potential regulation is in part via β–TrCP-mediated 
regulation of FRMD6 stability. Can CRB3 also regulate AMOT in a regenerative 
context? AMOT inhibits cell migration (Aase et al., 2007; Dai et al., 2013), and 
this function is modulated by direct LATS phosphorylation (Dai et al., 2013), and 
therefore could be involved in regenerative growth. AMOT protein stability is also 
regulated by ubiquitylation, mediated by the Nedd4-like E3 ligase family (Wang 
et al., 2012), and this process is counteracted by DUB3 and USP9x (Nguyen et 
al., 2016; Nguyen et al., 2017). AMOT localisation is controlled by CRB3 (Varelas 
et al., 2010), but whether the regulation of AMOT turnover is dependent on CRB3 
remains to be established.  
In addition to sensing major epithelial disruption such as wounds, the Hippo 
pathway and YAP are important mediators of contact inhibition (Zhao et al., 
2007). Mouse kidney epithelial cells lacking CRB3 are refractory to contact 
inhibition (Karp et al., 2008). This is consistent with the finding that Crb mediates 
density sensing, as CRB3 is able control the activity of YAP/TAZ through 
interaction with AMOT, stimulating their phosphorylation and cytoplasmic 
retention at high density (Varelas et al., 2010). If this system is conserved, Crb 
may sense epithelial density in Drosophila tissues, and control Yki activity in an 
Ex dependent manner. The Hippo pathway is also responsive to tension through 
regulation by the cytoskeleton, and in particular F-actin (Dupont et al., 2011; Yu 
and Guan, 2013). The spectrin cytoskeleton has also recently been shown to 
regulate Hippo signalling, interacting with both Crb and Ex (Deng et al., 2015; 
Fletcher et al., 2015; Wong et al., 2015). In the wing and eye epithelium, βH-
Spectrins may aid the formation of an active Hippo pathway complex containing 
Crb and Ex (Fletcher et al., 2015). Individual Spectrins and the Spectrin network 
can respond to tension (Fletcher et al., 2015; Johnson et al., 2007; Meng and 
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Sachs, 2012). In certain situations, changes in cellular tension may change the 
activity of Crb, stimulating the degradation of Ex to promote tissue growth. 
Moreover, one study suggested the spectrin network can interact with cortical 
actomyosin through non-muscle myosin II to regulate Hippo signalling, further 
compounding the links between tension and Hippo signalling (Deng et al., 2015). 
Crb is able to regulate the activity of the Rok in an aPKC-dependent manner 
(Roper, 2012), and perhaps there is a dynamic relationship between tension and 
growth through Spectrin, Actin and Crb complex interactions. 
 CG10889 – A Regulator of Growth 
Through screening for DUBs that regulate tissue size, and interact with the Hippo 
pathway gene ex, CG10889 was identified as a potential regulator of growth 
(Figure 7-4). This uncharacterised protein was also identified as a putative Yki-
interacting protein in Drosophila (Guruharsha et al., 2011). In S2 tissue culture 
cells, the Yki:CG10889 interaction was confirmed through co-
immunoprecipitation experiments, and mapped to the PPxY motif of CG10889 
and the WW domains of Yki, particularly the C-terminal WW domain (Figure 7-7). 
PPxY-WW domain interactions are particularly prominent in the Hpo pathway, 
with Sav, Kib and Yki containing WW domains and Ex, Wts and Hpo all containing 
PPxY domains. The Yki:CG10889 interaction could therefore prove important for 
growth control. It remains to be determined whether the PPxY motif of CG10889 
facilitates its interaction with other members of the Hpo pathway, for example the 
WW domain protein Sav. It is conceivable that CG10889 regulates growth in a 
Sav-dependent manner and this would partially explain the lack of effect on Yki 
target genes, as sav mutants have the weakest effect on Yki target gene 
expression of the Hpo cassette, despite displaying overgrowth phenotypes (Wu 
et al., 2003). It is also possible that the CG10889 interaction with Yki modulates 
the interaction between Yki and other binding partners in a similar mechanism to 
that used by Rassf or Jub to regulate Hpo and Wts, respectively (Das Thakur et 
al., 2010; Khokhlatchev et al., 2002; Polesello et al., 2006). 
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Growth control via the Hpo pathway involves regulation of the transcriptional co-
activator Yki. As CG10889 genetically interacts with ex, and physically interacts 
with Yki, its effect on growth was analysed. Indeed, RNAi-mediated knockdown 
of CG10889 results in tissue undergrowth, which is enhanced by co-expression 
of ex in adult wings (Figure 7-4, Figure 7-6). Furthermore, combining CG10889 
and wts depletion resulted in a partial suppression of the wts-RNAi overgrowth 
phenotype in adult wings (Figure 7-6). When analysed with the knowledge of 
Yki:CG10889 binding in cells, these data suggest that CG10889 may be required 
for growth control through the Hippo signalling, and that CG10889 could regulate 
the ubiquitylation status of Yki, cleaving Ubi to stabilise Yki and promote Yki 
function, although a genetic interaction with yki itself is yet to be confirmed.  
Interestingly, preliminary data presented here suggests mutations in the putative 
DUB domains of CG10889 result in increased association of Yki:CG10889 
(Figure 7-7) suggesting inability of CG10889 to deubiquitylate Yki could result in 
a prolonged interaction. As of yet, no Yki E3 ligase has been identified in 
Drosophila, whereas in mammals β-TrCP has been proposed to regulate YAP 
stability. However, the β-TrCP recognition sequence is not conserved in Yki 
(Zhao et al., 2010). 
When assessing the activity of Yki through the ex-lacZ reporter, there was no 
change, or even a mild enhancement of Yki activity upon CG10889 knockdown. 
Despite this, adult wings were decreased in size, which is inconsistent with the 
effect on Yki target gene expression (Figure 7-8), and analysis of different Yki 
target genes may yield positive results. It also remains a possibility that despite 
detecting a Yki:CG10889 interaction in cells, and the genetic interactions of 
CG10889 with ex and wts, CG10889 may regulate growth via a different 
signalling pathway in parallel to Hippo signalling, or that the growth phenotype 
observed is a result of off target effects of the RNAi line.  
The mammalian orthologue of CG10889 is Monocyte Chemotactic Protein-
Induced Protein (MCPIP) 1. MCPIP was initially identified as a protein 
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upregulated in human peripheral blood monocytes treated with Monocyte 
Chemotactic Protein 1 (MCP1) (Zhou et al., 2006), which is also transcriptionally 
induced by pro-inflammatory molecules such as TNF, IL-1β (Interleukin 1β) and 
LPS (Lipopolysaccharide), and as such is important during inflammatory 
responses (Jura et al., 2012; Kasza et al., 2010; Liang et al., 2010; Matsushita et 
al., 2009; Skalniak et al., 2009). MCPIP contains a CCCH-type zing finger domain 
commonly associated with RNA binding proteins. Indeed, MCPIP contains an 
RNase domain highly homologous to PilT N-terminus (PIN) domain, as well as a 
Ubiquitin Associated (UBA) domain (Figure 7-7) (Liang et al., 2010; Xu et al., 
2012). In addition to its RNase activity, MCPIP has been identified as a putative 
DUB, although the direct enzymatic DUB activity remains controversial (Liang et 
al., 2010; Niu et al., 2013). MCPIP promotes the deubiquitylation of TNF Receptor 
Associated Factor (TRAF) 2, 3 and 6, TRAF Family Member-Associated NF-κB 
Activator (TANK) and NEMO to inhibit the cellular response to NF-κB in response 
to genotoxicity and inflammation as part of a NF-κB negative feedback loop 
(Liang et al., 2010; Niu et al., 2013; Wang et al., 2015a). Intriguingly, two of these 
studies suggest the DUB activity of MCPIP is conferred through interaction with 
the bona fide DUB USP10, MCPIP acting as a scaffold to promote interaction of 
USP10 with its substrates (Niu et al., 2013; Wang et al., 2015a). It remains to be 
confirmed whether CG10889 possesses DUB activity, or whether CG10889 
provides a scaffold for an additional Yki regulating protein, for example the 
Drosophila USP10 orthologue CG32479. Interestingly, depletion of CG32479 in 
the adult wing caused a large reduction in adult wing size, previously associated 
with disruption of Notch signalling (Zhang et al., 2012) (Figure 7-1A). This size 
reduction is enhanced in combination with ex overexpression, but to a lesser 
extent than CG10889 (Figure 7-4), suggesting that CG32479 could also interact 
with ex and the Hippo pathway. Consistent with a potential role for CG10889 in 
regulating Yki and growth, MCPIP knockout mice display undergrowth (Liang et 
al., 2010). It will be important to analyse whether the CG10889 genetically 
interacts with yki, and whether this is dependent on CG32479, if the RNase 
activity of MCPIP is conserved in Drosophila, and whether this could influence 
Yki activity.  
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 Concluding Remarks 
This study has identified the CK1 family as novel regulators of Ex stability and 
therefore Hippo signalling. Overexpression of the CK1 kinases results in 
depletion of Ex in S2 cells and in vivo and promote Yki function accordingly. 
Furthermore, knockdown of specific CK1 family members can increase Ex levels, 
consistent with a role of CK1 family members in regulating Ex stability. More work 
needs to be done in order to clarify whether this phosphorylation is direct, and to 
determine the importance of each family member, resolving the potential 
redundancy observed between these highly homologous family members (Figure 
8-1).  
Usp2 has also been identified as a putative regulator of Ex stability, and is able 
to stabilise Ex levels in a catalytic-dependent manner, reversing degradative 
stimulus induced by Crb expression.  It will be interesting to identify the specific 
physiological context of Crb-mediated regulation of Ex stability, and therefore the 
context in which the CK1s and Usp2 may specifically regulate Ex levels (Figure 
8-1).  
In addition, the DUB CG10889 was identified as a novel DUBs which regulates 
growth, interacting with key Hippo pathway members ex, wts and yki. The 
mechanisms by which CG10889 regulates growth remain to be determined, and 
it will be informative to see whether this is dependent on the ability of CG10889 




Initial experiments obtained for ‘Results 4 – The Reversibility of Expanded 
Degradation’ was performed by Paulo Ribeiro, Barts Cancer Institute, and is 
included here in the ‘Appendix’ with his permission, because its inculsion is vital 
as explanation to the experimental rational: 
 
Figure 9-1 Usp2 regulates Ex protein levels in S2 cells 
Immunoblot of S2 cell lysates expressing FLAG-tagged Ex1-468 (A, B). Compared to Ex1-468 alone 
(A, B – lanes 1), expression of CrbFL caused depletion of Ex1-468 (A – lane 2, B - lanes 2, 5). 
Expression of FLAG-tagged Usp2isoA (A, B – lanes 3) or Usp2isoC (B – lane 6) caused stabilisation 
of Ex1-468 despite co-expression of CrbFL. Expression of FLAG-tagged Usp2isoA C504A (B – lane 4) 
or Usp2isoC C622A (B – lane 7) was not as efficient in the stabilisation of Ex1-468 in the presence of 
CrbFL. Lysates were analysed with the indicated antibodies and Tub was used as a loading control 




Figure 9-2 Usp2 as a regulator of wing growth 
Adult wings expressing different transgenes under the control of nub-Gal4. Shown are the adult 
wings of flies expressing a GFP transgene as control (A), ex (B) usp2(III) (C), ex; usp2(III) (D), 
usp2R-1 (E), ex; usp2R-1 (F), usp2R-3 (G), ex; usp2R-3 (H), usp2KK (I) or ex, usp2KK (J). Quantified 
using ImageJ and wing area was normalised to nub>GFP expressing control wings (K, L). Results 
obtained with usp2 overexpression (K), or with different Usp2-RNAi lines (L). Individual data 
points are shown as well as the average ± SD for each of the genotypes analysed (K, L). All 
genotypes obtained with usp2 overexpression (K) were statistically different (*** = P < 0.0001) 
determined through a one-way ANOVA analysis with a Turkey’s range post hoc test. All 
genotypes obtained with different Usp2-RNAi lines (L) were statistical different (*** = P < 0.0001) 
with the exception of the comparison between nub>ex and nub>ex, usp2KK where the statistical 
difference was * = P < 0.05, determined through a one-way ANOVA analysis with a Turkey’s 
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